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1. INTRODUCTION 
 
1.1 Prostate cancer 
 
1.1.1 Prostate cancer incidence 
 
Prostate cancer is the most common cancer and the second leading cause of cancer death in 
men in Western countries. The American Cancer Society estimated lately that about 217,000 
new cases of prostate cancer will be diagnosed and 32,000 men will die of prostate cancer in 
2010 in United States (1). Despite a recent increase in prostate cancer cases and related death, 
the prevalence of prostate cancer in Asian countries is 20 times lower than in Western 
countries (2). This geographic variation most likely reflects differences in lifestyle. Many 
factors like diet, environmental carcinogens, and inflammatory diseases have been linked to 
an increased risk of prostate cancer (3).  
 
1.1.2 Multistep process of prostate carcinogenesis 
 
The development of prostate cancer is believed to be a multi-step process with distinct 
cellular and molecular alterations in each phase. A number of mutations are required to 
initiate, promote and progress the disease through a series of morphological defined stages 
(4). Genetic and epigenetic alterations promote transformation of normal glandular 
epithelium to preneoplastic lesions to invasive carcinoma (5, 6). Proliferative inflammatory 
atrophy (PIA) is a precursor of prostatic intraepithelial neoplasia (PIN) and characterized by 
down-regulated p21/WAF gene expression which functions as a regulator of cell cycle 
progression. PIN lesions are highly proliferative and often show silencing of tumor 
suppressor genes such as GSTPi and NKX3.1. Hypermethylation of the promoter CpG 
islands of GSTPi is the most common epigenetic alterations that is also observed in prostatic 
adenocarcinoma (6, 7). During further progression of prostate adenocarcinoma, the tumor 
suppressor gene PTEN is frequently silenced, which is a negative regulator of the 
serine/threonine protein kinase Akt that plays a key role in cell proliferation and migration (8, 
9). The final stage of prostate cancer is characterized by hormone-independent proliferation 
with AR mutations and down-regulation of p53 (6, 10) (schematic description in Fig. 1). 
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Fig. 1: Model for the progression of prostate carcinogenesis. The normal prostate epithelium 
progresses through a series of morphological changes forming PIA and PIN lesions followed by 
adenocarcinoma to hormone refractory prostate cancer. Genetic alterations of each stage of prostate 
cancers are shown. Modified from (11). 
 
 
1.1.3 AR signaling in prostate cancer progression 
  
Early-stage prostate cancers depend on androgens for growth and survival, and androgen 
ablation therapy causes them to regress. However, during prostate cancer progression,  
hormone-responsive prostate cancer may turn into a hormone-refractory stage. More 
aggressive, invasive and metastatic prostate cancer cells move to other organs where they do 
not need hormones to proliferate. Therefore they do not respond to hormone withdrawal 
therapy. Testosterone is the main circulating androgen, secreted primarily by the testes. When 
free circulating testosterone enters prostate cells, 90% is converted to dihydrotestosterone 
(DHT) by the enzyme 5 reductase. DHT is the more active hormone, having fivefold higher 
affinity to the androgen receptor (AR) than does testosterone. Like other nuclear receptors, in 
the basal state, the AR is bound to heat shock proteins (HSPs) and other proteins in a 
conformation that prevents DNA binding. Binding to androgens induces a conformational 
change in the AR that leads to dissociation from the heat-shock proteins and receptor 
phosphorylation, in part mediated by protein kinase A. The ligand-induced conformational 
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change facilitates the formation of AR homodimer complexes that can then bind to androgen 
response elements (AREs) in the promoter regions of target genes. The activated DNA-bound 
AR homodimer complex recruits co-regulatory proteins, co-activators or co-repressors, to the 
AR complex. The co-activators allow interaction of the AR complex with the general 
transcription apparatus to stimulate target gene transcription. Many AR target genes have 
been identified, including prostate specific antigen (PSA), insulin-like growth factor-1 
(IGF-1), prostate binding protein C3 (PBPC3), resulting in proliferation and survival of 
prostate cancer (reviewed in (12) and schematic description in Fig. 2). 
 
 
 
Fig. 2: AR signaling Free testosterone enters prostate cells and is converted to DHT by active 5 -
reductase. Binding of DHT to the AR induces dimerization and phosphorylation of AR which leads to 
conformational changes of the AR. Translocated AR dimer can bind to the androgen response element 
(ARE). One of the major target genes is PSA, which leads to biological responses including cell 
growth. Adapted from (12). 
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1.1.4 Prostate cancer cell lines 
 
Various cell lines have been established from prostatic tissue and different stages of prostate 
cancer. Benign prostatic hyperplasia cell line (BPH-1) has been derived from highly 
proliferative human prostate tissue (13). Primary epithelial cell cultures were immortalized 
with SV40 large T antigen. Tumor suppressor genes PTEN and p53 are expressed in this cell 
line, which is induced to proliferate by growth factors; however testosterone has no direct 
effect on BPH-1 cell proliferation. Although 5α-reductase is detected in BPH-1 cells, 
expression of AR and the secretory markers, PSA and prostatic acid phosphatase, are not 
detectable (13). The LNCaP cell line was established from a metastatic lesion of human 
prostatic adenocarcinoma. The LNCaP cell line is characterized by GSTPi mutation, loss of 
PTEN and low levels of p53 expression. High-affinity specific AR is present in the cytosol 
and nuclear fractions of LNCaP cells (14). Estrogen receptors (ER) are detectable in the 
cytosol. This cell culture model is hormone-responsive, and produces PSA in response to 
testosterone. The PC-3 cell line is from a human prostatic adenocarcinoma metastatic to bone. 
PC-3 cells have a greatly reduced dependence upon serum for growth when compared to 
normal prostatic epithelial cells and do not respond to androgens, glucocorticoids, or 
epidermal or fibroblast growth factors. The tumor suppressor genes GSTPi and p53 are 
mutated (15). The DU145 cell line is a highly aggressive and metastatic prostate cancer cell 
line. This long-term tissue culture cell line has been derived from a human prostate 
adenocarcinoma metastatic to the brain (16). Among the prostate cancer cell lines, LNCaP 
cells are hormone dependent and express AR and PSA secretion. However, more aggressive 
PC-3 and DU145 cell lines show hormone independent growth and do not produce PSA.  
 
1.2 Chemoprevention  
 
The association between life style and prostate cancer risk has been widely studied and 
indicate that diet, alcohol consumption, obesity and lack of exercise are considered as cancer 
risk factors (17). It has been estimated that more than 60% of human cancers could be 
prevented through appropriate lifestyle modification (18). There has been a lot of effort to 
precisely assess the mechanisms by which components of fruit and vegetables prevent 
different types of cancer in laboratory studies (17) .  
Chemoprevention is defined as the use of specific agents to delay or block the development, 
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progression or recurrence of carcinogenesis. The aim of chemoprevention is to reduce the 
cancer incidence by delaying or suppressing the process of cancer development (19). The 
NCI has determined that more than 1,000 different phytochemicals, plant-derived compounds, 
possess cancer-preventive activity.  
Many of the prominent chemopreventive agents have multiple intracellular targets. 
Carcinogenesis is generally recognized as a multistep process in which distinct molecular and 
cellular alterations occur. Tumor development is considered to consist of tumor initiation, 
promotion and progression. Fig. 3 shows several key mechanisms during the multistep 
process of carcinogenesis that serve as targets for cancer prevention.   
 
 
Fig. 3: Multistep process of carcinogenesis and target mechanisms of chemoprevention. 
Carcinogenesis is initiated by transformation of a normal cell into a cancer cell (initiated cell). These 
cells undergo tumor promotion into preneoplastic cells and progression into neoplastic cells. Distinct 
mechanisms are involved in each step of carcinogenesis. Modified from (17).   
 
 
 
During the rapid and irreversible initiation stage, a reactive carcinogen, either directly or  
after metabolic activation through Phase I enzymes, reacts with DNA and leads to DNA 
damage, which may lead to DNA mutations if not repaired. Inhibition of Phase I metabolic 
enzymes may block the activation of pro-carcinogen, and induction of Phase II enzymes 
contributes to increased detoxification of pro-carcinogens. The Phase II enzyme system of 
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xenobiotic metabolism is an important component of the cellular stress response by which a 
diverse array of electrophilic and oxidative toxicants can be removed from the cell before 
they are able to damage the DNA. The induction of Phase II enzymes is mediated via the 
activation of the transcription factor Nrf-2, which induces the transcription of several 
detoxifying enzymes, such as glutathione-S-transferase (GST), NAD(P)H:quinone 
oxidoreductase, uridine diphosphate glucuronosyl-transferases (UGTs), Thioredoxin 
reductase (TRx-R) and many others. Modulation of xenobiotic metabolizing enzymes is a 
target of several chemopreventive agents including isothiocyanates derived from cruciferous 
vegetables (19) (further detailed description in Chapter 1.2.2.2). 
Another target of the initiation step of carcinogenesis is epigenetic gene regulation. Interest in 
targeted epigenetic modifications by chemopreventive agents has been recently raised. 
Inhibition of histone deacetylase (HDAC) activity results in histone hyperacetylation and 
consequently an open chromatin which facilitates gene transcription. HDAC inhibitors up-
regulate the cyclin-dependent kinase inhibitor p21 and increased cell cycle arrest and cell 
differentiation (20, 21). Another epigenetic modification often observed in cancer is DNA 
methylation that causes inhibition of gene transcription of tumor suppressor genes and other 
key regulators. Inhibition of DNA methyltransferases by chemopreventive agents such as 
genistein from soy and EGCG from green tea is considered as a novel interesting 
chemopreventive mechanism to block carcinogenesis (22).  
In contrast to the initiation stage, tumor promotion stage is considered to be a relatively long-
lasting event, in which actively proliferating cells accumulate to preneoplastic lesions. In this 
phase, inhibition of inflammation, induction of cell cycle arrest and modulation of signal 
transduction may postpone the development of carcinogenesis. Inflammation is a driving 
force of the progression of carcinogenesis and possibly reduced by inhibition of pro-
inflammatory mediators, such as nuclear factor B (NF-B), subsequently leading to reduce 
transcriptional activation of inflammation mediators, inducible nitric oxide synthase (iNOS), 
cyclooxygenase2 (Cox2), tumor necrosis factor  (TNF), and hypoxia inducible factor  
(HIF-1). Anti-inflammatory properties by modulating pro-inflammatory signaling mediated 
by these factors is also considered as effective target of chemoprevention by dietary 
compounds such as quercetin, curcumin and sulforaphane (reviewed in (17)).  
The final progression stage involves malignant transformation of pre-neoplastic cells to 
neoplastic lesions, resulting in tumor growth with metastasizing potential. Therefore the 
target can be the inhibition of cell proliferation, angiogenesis, metastasis and differentiation. 
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Chemopreventive drugs, such as resveratrol and PEITC have been reported to potentially 
inhibit tumor angiogenesis and metastasis by inhibition of HIF-1mediated induction of 
vascular endothelial growth factor (VEGF) (19, 23).  
 
1.2.1 Chemoprevention of prostate cancer 
 
A large body of evidence describes the role of dietary factors and physical activity in the 
development and progression of prostate cancer. Dietary factors are major elements 
accounting for the international and inter-ethnic differences in the rate of prostate cancer. 
Identifying molecular mechanisms involved in carcinogenesis provides the rationale for 
developing strategies for prostate cancer prevention. When we consider the multistep 
progress of prostate cancer (Fig. 1) as well as many risk factors to develop prostate cancer, 
dietary intervention targeting multiple pathways might be particularly effective to prevent 
prostate cancer.  
 
1.2.2 Chemopreventive agents of prostate cancer 
 
Many agents have been evaluated for their primary and secondary chemopreventive 
capacities to targets different stages and molecular signaling of prostate cancer, including 
selenium, vitamin E, isothiocyanates, lycopene, polyphenols and green tea. These agents 
potentially interact with a range of carcinogenic pathways in the prostate. An overview is 
given in Table 1. Prominent examples of prostate cancer chemopreventive agents are 
described in the following sections.  
 
Table 2. Summary of chemopreventive agents and target mechanisms against prostate cancer 
adapted from (24).    
Dietary agent Model system Targets/mechanism of action 
Selenium 
Selenomethionine In vitro cell culture Cell cycle arrest (G2/M) 
  Apoptosis 
  Androgen receptor-mediated response 
Sodium selenite In vitro cell culture Redox mechanism 
Methylseleninic acid In vitro cell culture Caspase-mediated, cytochrome c 
release and DNA fragmentation 
  Phosphorylation of c-Jun and p38 
  p53 phosphorylation 
  TRAIL-mediated apoptosis 
  Regulation of phosphor-Akt 
  Modulate androgen-regulated genes 
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 In vivo (Lady transgenic) No reduction in prostate cancer 
incidence 
Cruciferous vegetables   
Sulforaphane In vitro cell culture Cell death, caspase-mediated apoptosis 
  Generation of ROS 
  Activation of MAPK 
  Modulation of NF-B and AP-1 
  Inhibition of HDAC 
  Destabilization of AR associated with 
HSP90 
  Lowered AR protein/ gene expression 
Sulforaphane In vivo Protective against tumorigenesis 
  Induction of phase II enzymes 
Broccoli sprouts In vivo xenografts Retards tumor growth 
 TRAMP mice Inhibition tumor growth 
  Apoptosis with suppression of Akt 
pathway 
Vitamin E   
-Tocopherol In vitro cell culture Cell cycle arrest(G1 or G2/M) 
  Induced apoptosis 
  Inhibition AR and PSA expression 
 In vivo-Lady transgenic No reduction in prostate cancer 
incidence 
 Xenograft Reduced incidence of prostate cancer 
Lycopene   
 In vitro cell culture Inhibition of DNA strand breaks 
  Mitotic arrest 
  Apoptosis and altered mitochondrial 
function 
  Reversal of the effect of DHT 
  Reduces AR and  catenin level 
  Inhibits IGF  
 In vivo Increased necrosis 
Green tea polyphenols   
Epigallocatechin gallate In vitro cell culture Cell cycle arrest 
  TRAIL-induced apoptosis 
  Inhibition of NF-B and AP-1 
  Inhibits biomarkers of 
angiogenesis/metastasis 
 In vivo Inhibits prostate cancer development 
and progression 
  IGF-1 inhibition 
 TRAMP mice Inhibition of MMP-2 activation and 
invasion 
  PSA-triggered basement membrane 
degradation 
 
 
1.2.2.1 Selenium 
 
The micro-nutrient selenium exists naturally in food such as button mushrooms, cod, calf‘s 
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liver, tuna and salmon predominantly in the organic form as selenomethionine and 
selenocysteine. Several large prospective studies reported 50-65% reductions in risk of 
developing prostate cancer associated with high versus low selenium levels as measured in 
plasma (25, 26). The Nutrition Prevention of Cancer Trial (NPC) observed a 50% reduction 
in prostate cancer incidence among men randomized to selenium supplements (27).  
The benefit of selenium was also tested in SELECT (Selenium and Vitamin E Cancer 
Prevention Trial), a phase III randomized, placebo-controlled study, designed to determine 
whether selenium and vitamin E, alone or in combination, decrease the risk of prostate cancer 
in healthy men. A total of 35,534 men randomized from 400 clinical sites across United 
States, Puerto Rico and Canada received selenium (200 g/day of selenomethionine) and/or 
vitamin E (400 IU/day of all rac--tocopheryl acetate) supplementation or placebo for a 
minimum of 7 years (maximum 12 years) (28). The result was that selenium or vitamin E, 
alone or in combination at the doses and formulations used, did not prevent prostate cancer in 
this population of relatively healthy men (28). The difference between the earlier NPC study 
was that NPC study used selenized yeast, whereas SELECT used selenomethionine. These 
forms of selenium may have significantly differences in their biologic effects. 
Selenium has several activities and targets different mechanisms, depending on its form (29). 
Selenomethionine inhibits proliferation and induces cell cycle arrest of human prostate cancer 
cells (30). Selenium in the form of selenomethionine induces apoptosis and inhibits 
angiogenesis, mediated in part by the androgen receptor, reviewed in (24, 31). Another form 
of selenium, methylseleninic acid, induces apoptosis through a caspase-mediated pathway, 
mediated through the release of cytochrome c, cleavage of poly[ADP-ribose]polymerase 
(PARP) and DNA fragmentation (32). Methylseleninic acid also modulates expression of 
many androgen-regulated genes in human prostate cancer cells in vitro (33). The anticancer 
effects of sodium selenite are thought to be mediated via a redox-related mechanism 
involving induction of oxidative stress (34).  
Generally, most of the selenium (inorganic/organic) serves as a precursor to the synthesis of 
selenoproteins, such as glutathione peroxidase (GPx), TRx-R, and selenoprotein P. 
Polymorphisms of selenoprotein P and Sep15, by altering their ability to incorporate 
selenium, may be important in protecting against the development of prostate cancer (35). 
GPx is a major Se-containing protein which converts toxic H2O2 to harmless H2O (36). Five 
different members of the GPx family have been reported. GPx-1 is the major cytoplasmic 
glutathione peroxidase, GPx-4 acts on lipid hydroperoxides and cholesterol ester 
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hydoperoxides within cell membranes, and GPx-3, called plasma glutathione peroxidase, is 
mainly expressed in lung and kidney (35, 37). TRx-R is another key selenoprotein that is the 
primary catalyst for the NADPH-dependent reduction of thioredoxin (36).  
Modulation of the redox status by selenium seems to have dual effects on prostate cancer 
proliferation – on one hand inhibition of therapeutic effectiveness (34), on the other hand 
induced apoptotic potential and increased sensitivity of cells to radiation-induced killing (38). 
Regarding these opposing effects, we may have to consider the concentration of selenium. 
Regarding the relation between selenium dose and prostate carcinogenesis, it was showed 
that over-accumulation of selenium intake may be potentially dangerous, indicated by a 
U-shaped dose-response curve of Se in association with increased DNA damage in aging 
dogs (39, 40). Thus, optimization of the use of selenium as potential prostate cancer 
chemopreventive agent is required. 
 
1.2.2.2 Cruciferous vegetables 
 
Cruciferous vegetables of the family Brassicaceae include vegetables such as broccoli, 
cauliflower, kale, Brussels sprouts and Chinese cabbage have been suggested as promising 
candidates to modulate prostate cancer risk (41). Evidence for the protective effect of 
cruciferous vegetable against prostate cancer comes from epidemiological studies of dietary 
intake (42). Table 2 listed several epidemiological studies that analyzed the association 
between intake of cruciferous vegetables and prostate cancer risk.  
 
Table 2. List of epidemiology studies of cruciferous vegetables and prostate cancer risk 
Country Participants No. of Cases Effect Reference 
USA >45.000 3000 10% ↓ 
Giovannucci et 
al., 2003 (42) 
USA >80.000 3000 No 
Stram et al., 
2006 (43) 
Canada >29.000 1.300 
40% ↓ 
(advanced) 
Kirsh et al., 
2007 (44) 
Germany >11.000 300 
40% ↓ 
(low-grade) 
Steinbrecher et 
al., 2009 (45) 
USA >3.000 cases + controls 
30% ↓ 
(advanced) 
Kolonel et al., 
2000 (46)  
USA >1.200 cases + controls 40% ↓ 
Cohen et al., 
2000 (47) 
 
A prospective study in the US with more than 45,000 participants demonstrated that there is 
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no compelling evidence for a protective influence of cruciferous vegetables on prostate 
cancer risk, and only a slight inverse association between cruciferous vegetable intake and 
prostate cancer risk was found (42). Another prospective study reported no significant 
protective association of any vegetable consumption and prostate cancer risk (43). However, 
two other recent prospective studies showed significantly negative associations between 
prostate cancer risk and consumption of cruciferous vegetables, although the number of cases 
of these studies were smaller that in earlier studies (45). Two case-control comparisons of 
people with histological confirmed prostate cancer and cancer-free controls demonstrated that 
intake of cruciferous vegetables was inversely related to prostate cancer (46). Although the 
results of these studies are not conclusive, most of the studies show a trend to an inverse 
relationship between the consumption of cruciferous vegetables and prostate cancer risk 
(Table 1). 
Reduction of prostate cancer risk by dietary cruciferous vegetables is attributed to 
glucosinolates (GS) in the vegetables. GS are substituted -thioglucoside N-hydroxysulfates, 
formed by the plant. Over 115 naturally occurring glucosinolates have been identified. Each 
cruciferous vegetable contains a mixture of glucosinolates that varies according to the strain 
of the plant. Inhibition of carcinogenesis by glucosinolates is not primarily attributable to this 
class of compound, but is rather due to their break-down products. Hydrolysis of these 
phytochemicals is catalyzed by myrosinase, an enzyme that is stored in ‘myrosin‘ cells in the 
plant. Upon wounding of the vegetable, for example during harvesting, freeze–thawing, food 
preparation, or chewing while being eaten, myrosinase is released from the ‗myrosin‘ cells 
and catalyses the hydrolysis of glucosinolates within the damaged plant. In addition, 
myrosinase activity may be present in human colonic microflora, suggesting that it is possible 
that glucosinolates are hydrolysed in the gastrointestinal tract during digestion of food (48). 
Fig. 4 illustrated examples of hydrolysis of GS by active myrosinase. Glucoraphanin, which 
is an abundant GS in broccoli, is catalyzed to sulforaphane by active myrosinase. A indolyl 
glucosinolates, glucobrassicin, generates indole-3-carbinol at neutral pH by active 
myrosinase. In the acidic environment of the stomach, I3C condenses to form various 
condensation products including 3,3‘-diindolymethane (DIM) (48).  
Various chemopreventive mechanisms stimulated by ITCs in many cancers, including 
prostate cancer, have been demonstrated over the years. Basically all the steps of 
carcinogenesis have been identified as targets of ITCs. Early studies focused on the modes of 
action of isothiocyanates as inhibitors of phase I enzyme CYP450 and inducers of phase II 
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detoxification, thereby blocking the metabolic activation of pro-carcinogens and facilitating 
carcinogen excretion. Recent studies suggest that ITCs also offer protection against tumor 
development during the "post-initiation" phase and mechanisms for suppression effects of 
ITCs including cell cycle arrest and apoptosis induction in prostate cancer. Mechanisms of 
ITCs include induction of antioxidant and detoxification genes mediated by activation of Nrf-
2 and AhR (arylhydrocarbon receptor), inhibition of pro-inflammatory reactions by 
repression of NF-B (49), AP-1 (activator protein 1) signaling, inhibition of cytochrome 
P450 enzyme activity, inhibition of histone deacetylase, and stimulation of cell cycle arrest 
and apoptosis, and inhibition of metastasis and angiogenesis, as reviewed in (24, 50). There is 
a dose-dependency in these responses. Generally induction of metabolic genes occurs at 
relatively low concentrations of ITCs, whereas activation of cell cycle arrest and apoptosis 
occurs at higher concentration (51, 52).  
A major mechanism of anti-proliferative effects of ITCs on prostate cancer is related to cell 
cycle arrest and apoptosis. The first report on the involvement of caspases in SFN-mediated 
apoptosis was by Chiao and colleagues in prostate LNCaP cells [116]. Induction of apoptosis 
by ITCs are mediated by caspase activation, death ligand induction, ROS formation, mitogen-
activated protein kinase (MAPK) activation, modulating Bcl/Bax protein expression in 
prostate cancer in vitro and in vivo (reviewed in (50)). Subsequently, SFN was shown to 
activate the mitochondrial/ intrinsic apoptotic pathway. This involves release of cytochrome c 
from the mitochondria into the cytosol, which in turn binds to the apoptosis protease 
activation factor-1 (Apaf-1) and leads to activation of caspase-9 (53). Recently, SFN was also 
shown to activate the death receptor/extrinsic pathway of apoptosis in prostate cancer cells. 
This pathway is initiated when the death ligands, such as Fas-L and TRAIL or tumor necrosis 
factor  (TNF) through their cell surface receptors activate the downstream intracellular 
apoptotic machinery, which involves induction of caspase-8 and subsequent activation of 
effector caspases (54). More recently, SFN and PEITC mediated apoptosis was linked with 
the generation of ROS in prostate cells (55, 56). Increased levels of ROS in response to SFN 
and PEITC treatment were accompanied by disruption of mitochondrial membrane potential, 
cytosolic release of cytochrome c and apoptosis.  
Anti-proliferative effects of ITC on prostate cancer are also related to cell cycle arrest (57). 
Inhibition of proliferation of SFN was link to irreversible G2/M phase cell cycle arrest by 
activation of checkpoint kinase 2 (Chk2) and increased phosphorylation of cell division cycle 
protein 25C (Cdc25C) (50, 58). Allyl isothiocyanate (AITC) significantly inhibits 
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proliferation of cultured PC-3 (androgen-independent) and LNCaP (androgen-dependent) 
human prostate cancer cells in a dose-dependent manner associated with reduction in the 
expression of cyclin B1 protein cycle dependent kinase 1 (Cdk1), Cdc25B and Cdc25C (59). 
Re-expression of the p21 tumor suppressor gene mediated by histone acetylation also causes 
cell cycle arrest in LNCaP cells treated by PEITC and SFN (60, 61). Another mechanism to 
induce cell cycle by ITCs is mediated by proteasome-mediated degradation of Cdc25C and 
Cdk1 in PC-3 human prostate cancer cells (62).  
Androgen signaling is a key mechanism to maintain proliferation of prostate cancer. 
Androgen signaling targeted by ITCs has been reported in many studies. PEITC represses AR 
transcription and expression in both androgen-dependent and -independent prostate cancer 
cell lines (63). Recent study newly defined that SFN treatment enhances HSP90 acetylation 
by inhibition of HDAC6, thereby inhibiting its association with AR. Moreover, AR is 
subsequently degraded in the proteasome, which leads to reduced AR target gene expression 
(64). DIM, the condensed form of I3C, suppresses DHT-stimulated cell proliferation by 
inhibiting AR translocation into the nucleus. This study suggested that DIM binds to AR 
competitively to DHT (65).  
In addition to single ITC‘s effects on prostate cancer, effects of dietary cruciferous vegetables 
have been investigated. Studies in TRAMP mice have evaluated the pharmacodynamic action 
of broccoli against prostate tumorigenesis (66). Mice given 240 mg broccoli sprouts per day 
exhibited a significant inhibition of prostate tumor growth, accompanied by increased 
expression of cleaved caspase-3, cleaved PARP and apoptosis regulator Bax, and decreased 
levels of Bcl-xL protein.  
 
1.2.2.3 Vitamin E 
 
Vitamin E contains a group of naturally occurring compounds such as the tocopherols, 
tocotrienols, and their natural and synthetic derivatives which can classified into  ,  and  
isoforms (67). Vitamin E is rich in many dietary sources including vegetable oils, nuts and 
egg yolks. Several epidemiological studies suggest that men in the highest quintile of plasma 
concentration of -tocopherol had reduced risk of prostate cancer (68). In addition, the ATBC 
trial (Alpha-tocopherol, Beta-carotene cancer prevention study) indicated that daily 
supplementation of vitamin E potently reduce the incidence of prostate cancer among men 
who smoked (69). The mechanisms which were targeted by vitamin E in prostate cancer have 
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been investigated in several studies. The biologically active form of vitamin E is a potent 
intracellular antioxidant which inhibits lipid peroxidation and DNA damage (70). Besides its 
antioxidant function, vitamin E and its analogues can modulate transforming growth factor 
and AR/PSA signaling pathway and regulate cell cycle through DNA synthesis arrest in 
LNCaP, PC-3, and DU-145 prostate cancer cells (71). Induction of apoptosis by causing 
depletion of cytosolic death receptor Fas, inhibition of VEGF production, and inhibition of 
matrix metalloproteinases (MMPs) are other mechanisms through which vitamin E inhibits 
prostate carcinogenesis (72). 
 
1.2.2.4 Lycopene 
 
Lycopene is a lipophilic carotenoid presented in tomatoes at high concentration (73). In a 
recent clinical study, consumption of tomato paste resulted in a significant reduction in mean 
plasma PSA levels in patients with benign prostatic hyperplasia (74). The chemical structure 
of lycopene is a linear hydrocarbon containing a series of conjugated and un-conjugated 
double bonds. This structure contributes to the limiting of oxidative damage and confers high 
affinity for quenching singlet oxygen molecules (73, 75). For the target mechanisms of 
lycopene against prostate cancer, cell cycle arrest, apoptosis, and growth factor signaling 
have been demonstrated with lycopene administration. Lycopene induced mitotic arrest in the 
G0/G1 phase, with decreased levels of cyclins D and E as well as CDK in LNCaP, PC3 and 
DU145 human prostate cancer cells (76). Lycopene mediated apoptosis in a concentration-
dependent manner in LNCaP cells shown by decreased mitochondrial trans-membrane 
potential (77). Lycopene, in dietary relevant concentration, reversed the androgen-regulated 
effects of dihydrotestosterone by reducing androgen receptor and -catenin nuclear 
localization and inhibiting IGF-1 stimulation (78). 
 
1.2.2.5 Green tea polyphenols 
 
Tea consumption has been associated with a reduced prostate cancer risk, partly via the 
antioxidative properties of tea polyphenols (Table 1) (79). Two randomized clinical trials 
testing green tea in patients with high-grade prostatic intraepithelial neoplasia and advanced 
prostate cancer demonstrated negative result, which might reflect a lack of power to confirm 
a modest benefit of green tea (80-82). However, several molecular anticancer mechanisms 
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have been proposed, including cell cycle arrest in both androgen-sensitive and androgen-
insensitive prostate cancer cells (24). Induction of apoptosis via inhibition of transcription 
factors, such as NF-B and AP-1 has been reported (83). Epigallocatechin gallate (EGCG), a 
polyphenolic compound, is abundant in green tea. Administration of EGCG led to negative 
regulation of the NF-B pathway, which caused a decrease in the expression of the pro-
apoptotic protein Bcl-2. In addition, several studies have indicated that this compound 
inhibited the IGF-1 pathway (84). 
Similar benefits of tea polyphenols have been observed in preclinical models. In the TRAMP 
mouse model, which mimics the pathogenesis of human prostate cancer, the consumption of 
green tea polyphenols significantly inhibited the development of prostate cancer and 
metastasis (85, 86). Consumption of polyphenol early in life might be important; intervention 
of green tea polyphenols by 6 weeks of age demonstrated the absence of tumors in TRAMP 
mouse model, whereas delaying intervention beyond this time resulted in high-grade prostatic 
intraepithelial neoplasia followed by well-differentiated cancer with metastasis (86). 
 
1.3 Selenium-enriched broccoli  
 
As described above, chemopreventive agents target distinct mechanisms to prevent or inhibit 
prostate carcinogenesis. The idea to combine potent dietary agents to prevent prostate cancer 
may increase effects of individual compounds.    
One such idea is to increase selenium levels in cruciferous vegetables to combine potential 
preventive activities of Se and glucosinolates breakdown products. Se is accumulated in 
accumulator plants primarily in methylated forms such as SeMSC, -glutamyl SeMSC, 
selenocystathione, -glutamyl selenocystathione, and methyl selenol (87). Broccoli (B. 
oleacea var. italica) has high glucosinolate content, but it also has a high capacity for SeMSC 
biosynthesis. However, under field conditions SeMSC formation is limited by low selenate 
availability in most soils. By addition of sodium selenate in the soil broccoli accumulated 
almost 1,000 mg Se per gram of dry plant tissue (88). However, something to consider is 
whether modulation of Se levels has no side effects.  
In the plant, sulfate and selenate share the initial route for uptake, absorption and 
incorporation into O-acetylserine, follow by the formation of cysteine and seleno-cysteine, 
respectively (89, 90). The predicted competition between sulfate and selenate for uptake and 
assimilation has been suggested by using same transporter and enzymes (91); accumulation 
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of SeMSC was dependent on selenate addition to the growth medium, addition of sulfate 
reduced the formation of SeMSC by selenate inoculation (91). Although there is predictable 
competition in the biosynthesis of these two chemopreventive agents in one plant, an optimal 
range of selenium accumulation may increase the chemopreventive efficacy of broccoli.  
As described previously, consumption of broccoli was inversely correlated with prostate 
cancer incidence. This was mainly attributed to glucosinolates derivatives. Several studies 
reported that addition of Se to cruciferous vegetables could provide even greater protection 
from cancer, including prostate cancer (88, 92-94). There has been an investigation in a 
prostate cancer model that Se-enriched broccoli sprouts were superior to normal broccoli 
sprouts in inhibiting cell proliferation, decreasing prostate-specific antigen secretion, and 
inducing apoptosis of prostate cancer cells. (92). In addition to prostate cancer prevention, 
high-Se broccoli has been proven to be protective against colon cancer in the Apc
Min/+
 mouse 
model. The Apc
Min/+
 mouse mimics the rapid development of adenomatous polyps that affect 
humans with germ line inactivation of one Apc gene. Mice fed high-Se broccoli (2 mg Se per 
g of diet) showed significantly fewer total tumors and a lower total tumor burden (by almost 
50%) than mice fed low-Se broccoli (88, 93). In the DMBA-induced rat mammary tumor 
model, high-Se broccoli significantly reduced tumor incidence, total tumor number, and 
tumor burden about 30% compared to animals fed adequate amounts of Se (0.1 mg/g) 
without broccoli (94). Similar effects have also been shown in another study with Sprague-
Dawley rats that consumed diets containing 3 g of Se/g of diet supplied as high-Se broccoli. 
High-Se broccoli fed rats had significantly fewer mammary tumors than rats fed 0.1 g of Se 
as selenite with or without the addition of regular broccoli (94). Besides Se-enriched broccoli 
florets, Se-enriched broccoli sprouts have been investigated in a similar model. Fisher F-344 
rats fed 2 g of Se/g of diet supplied as high-Se broccoli sprouts had significantly fewer 
aberrant colon crypts than rats fed 0.1 or 2 g of Se/g of diet supplied as selenite with or 
without the addition of low-Se broccoli (94). Although these report suggest the possibility of 
Se-enriched broccoli as a potential chemopreventive agent, there is only a few studies 
regarding prostate cancer prevention. Therefore optimization of Se accumulation in  
broccoli and detailed mechanisms for the protection against prostate cancer have to be further 
investigated.  
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1.4 Kale sprouts – a potential dietary agent for prostate cancer prevention 
 
Another possibility to prevent prostate cancer development by dietary chemopreventive 
agents may be to increase the level of active compounds in the vegetables. For example, 
recently a super broccoli has been developed without any genetically modification of the 
plant. It contains three fold more of glucosinolate compared to standard broccoli and 
consumption resulted in increasing sulforaphane metabolites in human plasma (95). Also, it 
induced gene expression associated with xenobiotics and cell cycle arrest in human gastric 
mucosa (96).  
Sprouts of cruciferous vegetables are also a good source of glucosinolates. Sprouts were 
shown to contain about 10-100 fold more of glucoraphanin than the corresponding mature 
cruciferous vegetables (97). For example, broccoli sprouts, grown from broccoli seeds, 
contain glucoraphanin in quantities similar to seed levels which range from 5-100 mol/g 
(98). Hence, small quantities of sprouts may protect against risk of cancers as effectively as 
much larger quantities of mature vegetables of the same variety. Not only the quantities but 
also dramatic differences in the glucosinolate profiles are presented. Young broccoli sprouts 
contain glucoraphanin as a major glucosinolates and less than 10% of glucobrassicin is 
present. However in mature broccoli, although the composition varies considerably among 
the cultivars, on average, 67% of the total glucosinolates is glucobrassicin (98).  
Following this concept, kale sprouts may have powerful potential to prevent prostate cancer 
carcinogenesis because they contain about five fold higher levels of glucosinolates compared 
to standard broccoli (Fig. 5). Kale sprouts have not been investigated so far with respect to 
prostate cancer preventive potential. Mature kale is a family member of Brassica oleracea 
which is also referred to as cruciferous vegetable. It is widely cultivated and popular in North 
Western Europe and served as food vegetable. Kale is considered to be highly nutritious with 
-carotene, vitamin K, vitamin C and is rich in glucosinolates. Because of its high contents in 
glucosinolates, kale is considered a candidate to protect against prostate cancer (42, 44).  
The major group of glucosinolates in the kale sprouts is aliphatic glucosinolates. The most 
abundant glucosinolate is sinigrin, which will be converted to allyl isothiocyanate (AITC) 
during digestion. The chemopreventive effects of AITC on prostate cancer have been shown 
in many studies (59, 99-101). AITC induces cell cycle arrest and apoptosis, and inhibits 
HDAC activities and angiogenesis (59, 99-101). The second leading ITC in the kale sprouts 
is glucoiberin which will be converted to iberin by hydrolysis during consumption. Recently 
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the potential of iberin to prevent prostate cancer development has been suggested by gene 
expression profiling after treatment of primary prostate epithelial and stromal cells with 
iberin (102) in comparison to sulforaphane. Iberin induced mainly genes related to 
detoxification and cell cycle arrest. The comparison on between iberin and SFN showed that 
iberin is more effective on stromal cells than epithelial cells whereas SFN caused opposite 
effect (102). 
 
Fig. 5: Glucosinolate contents of kale sprouts compared to standard broccoli. The names of 
glucosinolate-derived products are indicated beside or above bars. 
 
The glucoraphanin content in kale sprouts is relatively similar to broccoli. The role of SFN 
against prostate cancer development was described earlier (Chapter 1.2.2.2) Another ITC 
abundant in kale sprouts but almost not presented in broccoli is PEITC. Mechanisms to 
prevent prostate cancer development by PEITC include induction of caspase-mediated 
apoptosis, inhibition of EGFR signaling and induction of p21 by epigenetic modification (61, 
103-106). When summing up the potential prostate cancer preventive effects of different 
types of ITCs abundantly present in combination in kale sprouts, kale sprouts can be regarded 
as an interesting novel potential chemopreventive cruciferous vegetables against prostate 
cancer progression.  
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1.5 Inhibition of angiogenesis as a promising target mechanism of cruciferous 
vegetables 
 
As described above, ITCs have been shown to alter cancer development by multiple 
mechanisms. One mechanism, which was discovered relatively recently, is the inhibition and 
prevention of angiogenesis (107-109). 
 
1.5.1 The process of angiogenesis 
 
Angiogenesis, the formation of new vessels from pre-existing vasculature, usually occurs 
during development, is involved in tissue regeneration and in chronic inflammatory 
conditions (110). Cancer cells begin to promote angiogenesis early in tumorigenesis and 
consequently, angiogenesis is an important mechanism used by tumors to promote growth 
and metastasis (110). Tumor angiogenesis features are significantly different from 
physiological angiogenesis. Differences include aberrant vascular structure, altered 
endothelial-cell–pericyte interactions, abnormal blood flow, increased permeability and 
delayed maturation (111). Tumor angiogenesis is regulated by an intricate balance between 
pro-angiogenic factors and anti-angiogenic factors (111). Pro-angiogenic factors include 
oncogene-driven pro-angiogenic proteins, such as vascular endothelial growth factor (VEGF), 
basic fibroblast growth factor (bFGF), interleukin- 8 (IL-8), placenta-like growth factor 
(PlGF), transforming growth-factor-β (TGF-β), matrix metallo-proteinase (MMPs) and others 
(112-114). As a consequence of fast growing and large consumption of oxygen, 
environmental conditions of nearby tumor cells are usually hypoxic. Tumor-associated 
hypoxic condition activate hypoxia-inducible factor-1α (HIF-1α), which promotes up-
regulation of several angiogeneic factors (112). These pro-angiogenic factors are secreted 
from the tumor cell itself, vascular endothelial cells, fibroblasts, invaded immune cells and 
inflammatory cells in or near the tumor site (Fig. 6). Triggering of angiogenesis also involves 
down-regulation of angiogenesis suppressor proteins, such as angiostatins, thrombospondin 
and prostate specific antigen in case of prostate cancer cell (112, 115). The orchestrated 
induction of pro-angiogenic factors and inhibition of anti-angiogenic factors initiates the 
degradation of vascular basement membrane and leads to proliferation and migration of 
vascular endothelial cells. New vascular structures are then covered with new basement 
membrane and connected with pre-existing vasculature. For further facilitated construction, 
endothelial cells are covered with pericytes (mural cells) (Fig. 6).  
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Fig. 6: New blood-vessel formation in cancer. Initiation of new blood vessels is started by release of 
proangiogenic factors such as VEGF, bFGF and PDGF secreted from the indicated cell types. These 
factors activate MMPs, which degrade the vascular basement membrane (VBN). Proliferation (1) and 
migration (2) of endothelial cells contribute to the construction of new blood vessel with reforming of 
VBM assembly (3) and pericyte coverage (4). Adapted from (116). 
 
 
Evidence is accumulating to indicate that tumors cannot grow without being connected to the 
blood vessel system necessary for delivery of oxygen and nutrients to the tumor (112, 117). 
Therefore, targeting of angiogenesis for anti-tumor therapy has been investigated intensively 
in many clinical and laboratory studies (117). For example, targeting of VEGF has been 
validated in various types of human cancers (118-120). Different agents including antibodies, 
peptides and small molecules have been extensively investigated to block VEGF and some of 
these agents currently used in clinical trials (121-123).  
 
1.5.2 Vascular normalization as an anti-angiogenic approach 
 
During cancer progression un-organized vascular structure is rapidly formed. It permits the 
growth and invasiveness of cancer cells leading to metastasis to distant organs. Unlike normal 
angiogenesis which is tightly regulated by pro- and anti-angiogenic factors, cancer 
angiogenesis is structurally and functionally abnormal and caused a by persisting unbalance 
of these pro- and anti-angiogenic factors (Fig. 7)(124, 125).  
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Fig. 7: Vascular normalization by anti-angiogenic therapy. Oppose to normal pathological 
angiogenesis tumor angiogenesis is structurally un-organized and functionally abnormal. The balance 
between anti- and pro- angiogenic factors is collapsed. Treatment with anti-angiogenic drugs 
promotes normalization of blood vasculature and function by re-balancing of anti- and pro- 
angiogenic factors. Adapted from (124) 
 
 
The stabilizing pericytes that cover normal vessels are often absent or have an abnormal 
distribution among tumor vessels that show chaotic feature of mal-functional vessels (124). 
This leads to hemorrhage, characterized by leaky blood which leads to necrosis of tumor. 
Normalization of tumor vasculature has been proposed as a new rationale for anti-angiogenic 
therapy. Hellmann et al. found first evidence of drug-induced normalization of tumor blood 
vessels, and described that use of razoxane, a drug targeting VEGF signaling, normalized the 
characteristically chaotic tumor vasculature and prevented tumor hemorrhages, necrosis, 
blood-borne tumor-cell dissemination and metastasis (125, 126). The normalization of blood 
vessels could improve the availability of oxygen to cancer cells to prevent hypoxic conditions 
and angiogenesis as well as tumor growth (124). Suggested targets underlying the vascular 
normalization were restoring the balance between anti-angiogenic and pro-angiogenic factors 
to the levels of non-pathogenic angiogenesis. 
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1.5.3 ITCs as anti-angiogenic agents 
 
Several reports have described effects of ITCs on endothelial cell functions essential for 
angiogenesis in HUVEC cells, human vascular endothelial cells, mainly targeting pro-
angiogenic factors expression (100, 108, 127, 128). SFN was shown to inhibit microcapillary 
growth in an ex vivo model of angiogenesis with an IC50 value of 0.08 M. Using human 
micro-vascular endothelial cells as a model, it inhibited cell migration and prevented 
hypoxia-induced up-regulation of VEGF, HIF1, c-Myc, and MMP2 mRNA expression 
(109). SFN inhibited hypoxia-induced HIF-1 expression through activating JNK and ERK 
signaling pathways, but not Akt pathway which is involved in cell survival. Further, 
inhibition of HIF-1resulted in decreased expression of VEGF in human tongue squamous 
cell carcinoma and prostate cancer DU145 cells (107).   
The capillary-like tube structure formation (in vitro neovascularization) and migration 
(invasion potential) by HUVEC was inhibited significantly in the presence of PEITC at 
pharmacologically relevant concentrations (< 1M). The PEITC-mediated inhibition of 
angiogenic features of HUVEC in vitro was associated with suppression of vascular 
endothelial growth factor (VEGF) secretion, down-regulation of VEGF receptor 2 protein 
levels, and inactivation of pro-survival serine-threonine kinase Akt (108). The PEITC 
treatment reduced migration by PC-3 human prostate cancer cells, which correlated with 
inactivation of Akt and suppression of VEGF, epidermal growth factor (EGF), and 
granulocyte colony-stimulating factor (G-CSF) secretion (108). Anti-angiogenic efficacy of 
AITC has also been shown. The pro-inflammatory cytokine TNF is a mediator of nitric 
oxide synthesis. AITC inhibited tumor angiogenesis through down regulation of NO and 
TNF production in B16F-10 melanoma cells (100). Another study with ATIC also supported 
previous findings that AITC significantly inhibited tumor proliferation and VEGF expression 
in tumor-bearing mice in vivo. It also reduced vessel sprouting and exhibited potent anti-
angiogenic activity in the chorioallantoic membrane and cornea of the rat (129). These 
studies indicate that prevention or inhibition of angiogenesis represents an important 
mechanism contributing to the cancer preventive potential of ITCs.  
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1.6 Epigenetic regulation of gene expression through HDAC inhibition 
 
Another mechanism which was recently identified as a contributor to the cancer preventive 
potential of ITCs and other sulfur-containing compounds is the inhibition of histone 
acetylation.  
 
1.6.1 Regulation of histone acetylation 
 
Chromatin is composed of histone octamers wrapped with DNA. Pairs of core histones (H2A, 
H2B, H3, H4) assemble to form an octamer which is positively charged and wrapped with 
DNA which is negatively charged. All four core histones have an amino-terminal tail. This is 
lysine rich and contains about half of the positively charged residues and most of the post-
translational modification sites of the core histone. The modification of the structure of the N-
terminal tails of histones — by acetylation/deacetylation — is crucial in modulating gene 
expression, as it affects the interaction of DNA with transcriptional regulation (130). 
Increased histone acetylation results in an ‗opened‘ chromatin structure and genes are 
transcribed. Reduced histone acetylation causes ‗closed‘ chromatin structure which shuts 
down the transcription (130).  
 
Fig. 8: Histone acetylation. Chromatin is composed of histone octamers wrapped with DNA. Histone 
acetylation leads to ‗open‘ chromatin and increased transcription of genes which, in turn, leads to 
downstream effects that result in cell-growth arrest, differentiation and/or apoptotic cell death and, as 
a consequence, inhibition of tumors growth. Ac, acetyl group; HAT, histone acetyltransferase, HDAC; 
histone deacetylase. Modified from (130). 
 
INTRODUCTION 
36 
 
There are two key enzymes to modulate histone acetylation. Histone acetyl transferase (HAT) 
catalyze the addition of acetyl groups to lysine residues of the histone tails and histone 
deacetylase (HDAC) remove acetyl group from the histone tails (130) ( Fig. 8).  
HDACs can be divided into two subfamilies, that is the Zn
2+
-dependent HDACs (classes I, II, 
and IV) and the NAD+-dependent sirtuins (SIRT) (class III). Class I, related to yeast RPD3 
deacetylase, includes HDACs 1, 2, 3, and 8 that are primarily nuclear and ubiquitously 
expressed, whereas class II HDACs are primarily localized to the cytoplasm but are known to 
shuttle in and out of the nucleus. Class II HDACs are related to yeast Hda1 (histone 
deacetylase-1). This class is divided into class IIa, comprising HDACs 4, 5, 7, and 9; and 
class IIb, comprising HDACs 6 and 10, which contain two catalytic sites. Class III SIRTs are 
NAD+-dependent deacetylases that have been linked to regulation of caloric utilization in 
mammals and have non-histone proteins as substrates. Class IV is represented by HDAC 11, 
with limited identity to classes I and III, although it is most related to HDACs 3 and 8. 
To date, many HATs have been identified and classified on the basis of a number of highly 
conserved structural motifs. GCN5, PCAF, HAT1 mainly acetylate lysines on the histone H3 
and H4 tails. Mof and TIP60 are linked to acetylation of H4 and H2A. p300 and CBP  
acetylate substrate H2A and H2B. Likewise, different HATs have different preference to 
many substrates. However, target substrates of specific HATs are not yet clearly known. Also, 
direct cancer prevention by specific modulators of HAT has not been demonstrated so far 
(131).  
 
1.6.2 Histone acetylation in prostate cancer 
 
Alterations in aceylated histone levels may be important in the progression of prostate cancer. 
In contrast to the non-malignant prostatic cell lines, cancer cell lines like LNCaP, DU-145, 
and PC-3 possess histones which have reduced acetylation compared to non-malignant 
prostate epithelial cells (132). A previous study described that HDAC levels are up-regulated 
in prostate cancer compared to benign hyperplasia (133). Recently, several clinical trials and 
in vivo studies suggested therapeutic efficacy of HDAC inhibitors in many solid tumors (134-
136). Inhibitors of HDAC, including suberoylanilide hydroxamic acid (SAHA), trichostatin 
(TSA), valproic acid, depsipeptide (137) and sodium butyrate, have been demonstrated to be 
effective against prostate cell lines and xenograft models (60, 138-142). For example, 
treatment of SAHA enhanced radiation-induced cytotoxicity in DU145 cell line and 
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synergistically induced cell death in the LNCaP and PC-3 cell lines in combination with 
zoledronic acid, a bisphosphonates anti-cancer drug (140). TSA can lead to TRAIL-induced 
cell death in prostate cancer xenograft model (139). 
The beneficial effects of HDAC inhibitors (HDACi) in cancer treatment are mainly mediated 
through the activation of genes related to cell cycle arrest, apoptosis as well as angiogenesis 
(143). Inhibition of HDAC class I (HDAC1,2,3,8) and II (HDAC 4,5,6,7,9,10) showed 
changes of gene expression which have an impact on apoptosis and cell cycle arrest such as 
p21/Waf-1, cyclins, Bax and Bcl-2 (144, 145). Non-histone deacetylation-based gene 
repression involves deacetylation of transcription factors by HDACs. For example, increased 
p53 acetylation- induced transcriptional activity by inhibition of class III HDACs sirtuins has 
been reported (146-148).  
 
1.6.3 Effects of ITCs on histone acetylation 
 
Several isothiocyanates have been reported as HDAC inhibitors in various cancer models, 
including prostate cancer (101). SFN inhibits HDAC activity and increased histone 
acetylation status in BPH-1, LNCaP and PC-3 prostate cancer cell lines and in an in vivo 
xenograft model (143, 149). The HDAC inhibitory effect of SFN was also supported by a 
human intervention study with broccoli sprouts. Dietary broccoli sprouts led to an inhibition 
of HDAC activity and increased histone acetylation after ingestion in human peripheral blood 
cells (60). Phenylhexyl isothiocyanate, a synthetic isothiocyanate, also inhibited HDAC 
activity and increased p21 expression in prostate cancer (150) Phenylhexyl isothiocyanate 
induced HAT expression and remodeling of chromatins resulting in growth arrest in human 
leukemia cells (151). A study by Batra et al. showed that benzyl isothiocyanate-mediated 
inhibition of HDAC led to NF-B turn off in a human pancreatic carcinoma cell line (152). 
Like these aliphatic isothiocyanate, indolic glucosinolate derivatives also presented potential 
to inhibit HDAC activity. DIM selectively induced proteasome-mediated degradation of class 
I histone deacetylases (HDAC1, HDAC2, HDAC3, and HDAC8) without affecting the class 
II HDAC proteins (153).  
These reports indicated that the modification of histone acetylation by HDAC inhibition or 
modulation of HAT activity is a relevant mechanism for cancer chemoprevention by ITCs 
and other glucosinolate derivatives. 
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2. AIM OF THESIS 
 
Cruciferous vegetables are rich in ITCs with a broad spectrum of chemopreventive activities 
in prostate cancer (154). The present thesis aimed to further investigate detailed mechanistic 
modes of action of two cruciferous vegetables, Se-enriched broccoli and kale sprouts. 
 
The first aim of the thesis was to investigate the effects of Se-enriched broccoli on prostate 
cancer in in vitro and in vivo models. Targeted mechanisms included modulation of drug 
metabolism, anti-oxidant effects and anti-proliferative effects. Prior to evaluate these 
mechanisms we planned to optimize Se levels in broccoli by fertilization. Se and 
glucoraphanin contents were measured in broccoli and compared to the activities and 
expression of Se-containing antioxidant enzymes and phase II detoxifying enzymes in 
prostate cancer cell lines. Using optimized broccoli we further planned to compare the effects 
of Se-enriched broccoli in various preparations in an in vivo human prostate cancer xenograft 
model using LNCaP cells. In this study, endpoints to investigate were tumor growth and 
modulation of anti-oxidant and Phase II detoxifying enzymes in liver and tumor tissue. 
Furthermore, we intended to compare enzyme activities with levels of most abundant 
metabolites of broccoli constituents in mouse plasma, urine and feces samples. 
 
The aim of the second part of this thesis was to elucidate the prostate cancer preventive 
potential of kale sprouts in the LNCaP xenograft model. Based on reported activities of ITCs 
as outlined above, we planned to focus our studies on putative anti-angiogenic and anti-
necrotic modes of action. To detect effects on tumor vasculature, we intended to perform 
detailed histopathological analyses with H&E stained tissue sections. Further, we planned to  
use immunofluorescent staining of cryosections to detect endothelial and murals cells and  
to analyze pericyte coverage as a measure of vessel maturation. Mechanistic investigations 
were to include determinations of the expression of pro- and anti-angiogenic factors by 
quantitative RT-PCR and Western blotting. Another aspect of this study was to analyze the 
effect of kale sprout intervention on AR-mediated effects, including AR expression and PSA 
secretion. To clarify mechanistic details, concomitant incubations of LNCaP cells with kale 
sprouts in cell culture were planned.   
 
Epigenetic alterations have been identified as a hallmark of prostate carcinogenesis. The 
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third part of the present thesis aimed to investigate the effects of kale sprouts on histone 
modifications. Alterations in acetylated histone levels may be important in the progression of 
prostate cancer. In this part of the project, we aimed to determine the effect of dietary kale 
sprouts on histone acetylation and tom investigate underlying mechanisms. Further we aimed 
to analyses functional consequences of increased histone acetylation, and planned to analyze 
p21 gene expression and phosphorylated H3 as a marker of mitotic cells by 
immunohistochemistry. To determine the relevance of these findings with kale sprouts for 
human ingestion, we planned a small pilot human intervention study with five female 
subjects.  
 
Overall, we expected to gain insight into the potential use of Se-fertilized broccoli as a 
functional food for prostate cancer prevention. Another expected outcome was to clarify the 
potential role of kale sprouts to reduce prostate cancer growth, and to provide detailed 
information on mechanisms of cancer prevention, with a focus on anti-angiogenesis and 
histone modifications.   
 
MATERIALS AND METHODS 
40 
 
3 MATERIALS AND METHODS 
 
3.1 Instruments 
 
Name Company 
  
-20 °C freezer Bosch, Stuttgart, Germany 
20x gauge needle BD, Heidelberg, Germany 
-80 °C freezer Thermo Fisher Scientific, Inc, Waltham, USA 
Agfa Classic E.O.S developer Siemens, Erlangen, Germany 
Beckman Ultracentrifuge Beckman, Fullerton, USA 
Electrophoresis power supplier Power Pac BioRad, Munich, Germany 
Eppendorf Microfuge Eppendorf, Hamburg, Germany  
Eppendorf PCR Thermocycler Eppendorf, Hamburg, Germany  
Eppendorf spectrophotometer Eppendorf, Hamburg, Germany  
FACS Calibur BD Biosciences, Heidelberg, Germany 
Fluorimeter Cytoflour 4000 Perseptive Biosystems, Framingham, MA, USA 
Fluorimeter SpectraMax Gemini XS Molecular Devices, Munich, Germany 
Gel Electrophoresis Chamber BioRad, Munich, Germany 
Forma Scientific Incubator Thermo Fisher Scientific, Inc, Waltham, USA 
Laminar Flow Heraeus, Hanau, Germany 
Microscope DM IL Leica, Wetzlar, Germany 
Nanodrop Peqlab, Erlangen, Germany 
Proteinmini-gel Wet Transfer System BioRad, Munich, Germany 
Real time PCR, iCycler Thermal Cycler IQ5 BioRad, Munich, Germany 
Refrigerator Liebherr, Biberach, Germany 
Rocking Shaker Eppendorf, Hamburg, Germany  
SDS-PAGE electrophoresis equipment BioRad, Munich, Germany 
SpectraMax 340 PC Molecular Devices, Munich, Germany 
Tissue Lyser II Qiagen, Hilden, Germany 
 
3.2 Disposables 
 
Name Company 
  
Cell culture flasks 75T and 25T Falcon, BD, Heidelberg, Germany 
Cell culture petri dishes Falcon, BD, Heidelberg, Germany 
Flat bottom 96well plates Greiner, Frickenhausen, Germany 
Photosensitive films GE Healthcare, Fairfield, USA 
Pipette tips Gilson, Middleton, USA 
Pipettes Gilson, Middleton, USA 
PVDF membrane BioRad, Munich, Germany 
RNase and DNase free filter tips Starlba, Ahrensburg, Germany 
Sterile pipettes Falcon, BD, Heidelberg, Germany 
Tuber Falcon, BD, Heidelberg, Germany 
 
3.3 Materials 
 
3.3.1 Chemicals 
 
Name  Company 
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5,5‘-dithiobis(2-nitrobenzoic acid) Sigma Aldrich, Taufkirchen, Germany 
Adenosine diphosphate Sigma Aldrich, Taufkirchen, Germany 
Agarose Sigma Aldrich, Taufkirchen, Germany 
Ammonium persulfate Sigma Aldrich, Taufkirchen, Germany 
Avidin solution  DAKO, Hamburg, Germany 
Blocking Solution  Invitrogen, Karlsruhe, Germany 
Bradford reagent BioRad, Hercules, USA 
Broccoli extract powder NIG, Magdeburg, Germany 
Bromophenol blue Sigma Aldrich, Taufkirchen, Germany 
1-Chloro-2,4-dinitrobenzene Sigma Aldrich, Taufkirchen, Germany 
Chloroform Sigma Aldrich, Taufkirchen, Germany 
C 18 solid phase cartridges Sigma Aldrich, Taufkirchen, Germany 
Dextran  
Dimethylsulfoxide 
Sigma Aldrich, Taufkirchen, Germany 
Sigma Aldrich, Taufkirchen, Germany 
Dithiotheitol (DTT) Sigma Aldrich, Taufkirchen, Germany 
ECL Reagent (Western Lightning Plus) PerkinElmer,Waltham, USA 
EDTA Sigma Aldrich, Taufkirchen, Germany 
EGTA Sigma Aldrich, Taufkirchen, Germany 
Ethanol Merck, Darmstadt, Germany 
7-Ethoxyresorufin Invitrogen GmbH, Karlsruhe 
Ethidiumbromide Sigma Aldrich, Taufkirchen, Germany 
Fluorescein Sigma Aldrich, Taufkirchen, Germany 
G-Agarose/Salmon Sperm DNA beads  Millipore, Temecula, CA 
Gelatin. Sigma Aldrich, Taufkirchen, Germany 
Glucose-6-phsophate-dehydrogenase Sigma Aldrich, Taufkirchen, Germany 
Glutathione reduced Sigma Aldrich, Taufkirchen, Germany 
Glutathione reductase Sigma Aldrich, Taufkirchen, Germany 
Glycerol Sigma Aldrich, Taufkirchen, Germany 
Hemoglobin Sigma Aldrich, Taufkirchen, Germany 
Hoechst dye Sigma Aldrich, Taufkirchen, Germany 
Hydrocortisone Sigma Aldrich, Taufkirchen, Germany 
Insulin Sigma Aldrich, Taufkirchen, Germany 
Isopropanol Merck, Darmstadt, Germany 
Kale sprouts powder wHc service, Neuenbuerg, Germany 
K2HPO4 Sigma Aldrich, Taufkirchen, Germany 
KCl Sigma Aldrich, Taufkirchen, Germany 
LiCl Sigma Aldrich, Taufkirchen, Germany 
Matrigel™ Matrix Phenol Red-Free BD biosciences, Heidelberg, Germany 
Methanol Sigma Aldrich, Taufkirchen, Germany 
MgCl2 Sigma Aldrich, Taufkirchen, Germany 
Milk powder Sigma Aldrich, Taufkirchen, Germany 
MOPS Serva, Heidelberg, Germany 
3-(4,5-Dimethylthiazo-2-yl)-2,5-
diphenyltetrazolium bromid 
Sigma Aldrich, Taufkirchen, Germany 
NaHCO3 Sigma Aldrich, Taufkirchen, Germany 
Na2HPO4 Sigma Aldrich, Taufkirchen, Germany 
Na2SeO3 Sigma Aldrich, Taufkirchen, Germany 
Na2SeO4 Sigma Aldrich, Taufkirchen, Germany 
NADP
+
 Sigma Aldrich, Taufkirchen, Germany 
PMSF Sigma Aldrich, Taufkirchen, Germany 
PVDF membrane Bio-Rad, Munich, Germany 
7- Pentoxyresorufin Invitrogen Gmbh, Karlsruhe 
SeMSC Sigma Aldrich, Taufkirchen, Germany 
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Sodiumdodecylsulfate (SDS) Serva, Heidelberg, Germany 
Sucrose Sigma Aldrich, Taufkirchen, Germany 
Temed Sigma Aldrich, Taufkirchen, Germany 
Testosterone Sigma Aldrich, Taufkirchen, Germany 
Transferrin Sigma Aldrich, Taufkirchen, Germany 
Tris Base Sigma Aldrich, Taufkirchen, Germany 
Tris HCl Sigma Aldrich, Taufkirchen, Germany 
TRIzol Invitrogen, Karlsruhe, Germany 
Tween 20 Sigma Aldrich, Taufkirchen, Germany 
 
3.3.2 Ready to use kit 
 
Name Company 
  
BCA protein assay kit Sigma Aldrich, Taufkichen, Germany 
PSA Total Elisa Assay DRG Diagnostics, Marburg, Germany 
VECTASTAIN ABC Kit Vector Laboratories, Inc., Burlingame, CA 
 
3.3.3 Antibodies 
 
Name Company 
  
GPX-1 (LF-MA0206) AbFrontier, Seoul, Korea 
GPX-3 (LF-MA0114 AbFrontier, Seoul, Korea  
GPX-4 (LF-PA0055) AbFrontier, Seoul, Korea  
MnSOD (sc-30080) SantaCruz, Heidelberg, Germany 
β-actin (sc-4778) SantaCruz, Heidelberg, Germany 
TRx-R anti-serum provided by Prof. John Arthur, Aberdeen, UK 
AR (#3202) Cell Signaling Technology, HD, Germany 
TNF (abb6671) Abcam, Cambridge, UK 
Angiostatin(ab2904) Abcam, Cambridge, UK 
Rat anti-mouse CD31 (#557355) BD Bioscience, Heidelberg, Germany 
Rabbit anti-mouse desmin (#ab15200-1) Abcam, Cambridge, UK 
Rabbit anti-rat-Alexa488 (#A21210) Invitrogen, Karlsruhe, Germany 
Biotinylated goat anti-rabbit (Dako, #X0590) Vector Laboratories, Inc., Burlingame, CA, USA 
anti-SMA-Cy3 (#C6198) Sigma Aldrich, Taufkirchen, Germany  
phospho-H3(ab5176) Abcam, Cambridge, UK 
p21 (sc-6246) Santa Cruz Biotechnology, HD, Germany 
HDACs ((#9928) Cell Signaling Technology, HD, Germany 
Sirt-1 (sc-15404) Santa Cruz Biotechnology, HD, Germany 
Ac-H3 (06-599) Millipore, Temecula, CA, USA 
Ac-H4 (06-598) Millipore, Temecula, CA, USA 
PCAF (#3378) Cell Signaling Technology, HD, Germany 
 
3.3.4 PCR reagents 
 
Name Company 
  
dNTPs Eppendorf, Hamburg, Germany 
EvaGreen Biotium, Inc., Hayward, USA 
MATERIALS AND METHODS 
43 
 
Fluorescein Sigma Aldrich, Taufkirchen, Germany 
Immolase Taq polymerase Bioline, Inc., Taunton, USA 
MgCl2 Bioline, Inc., Taunton, USA 
Moloney murine leukemia reverse transcriptase Promega, Madison, USA 
Nuclease free water Qiagen, Hilden, Germany 
Primers Sigma Aldrich, Taufkirchen, Germany 
Randeom Primers Roche, Mannheim, Germany 
RNase Sigma Aldrich, Taufkirchen, Germany 
 
3.4 Cell culture 
 
3.4.1 Cell lines 
 
Name Company 
  
BPH-1 Hayward et al., [12] 
LNCaP ATCC, Wesel, Germany 
PC-3 DFKZ Tumorbank, Heidelberg, Germany 
 
3.4.2 Cell culture reagents 
 
Name Company 
  
RPMI1640 media  Invitrogen, Karlsruhe, Germany 
Fetal bovine serum PAA, Pasching, Austria 
Transferin Sigma Aldrich, Taufkirchen, Germany 
Trypsin 0.25% Invitrogen, Karlsruhe, Germany 
Trypsin/EDTA Invitrogen, Karlsruhe, Germany 
 
3.4.3 Cell culture condition 
 
BPH-1 cells, non-transformed human benign prostate hyperplasia were cultured in RPMI 
1640 media, supplemented with 10% charcoal stripped fetal bovine serum (FBS) and 
10 µg/ml hydrocortisone, 1 µg/ml insulin, 50 ng/ml testosterone and 5 µg/ml transferrin. The 
androgen-responsive prostate cancer LNCaP cell line, derived from a lymph node metastasis 
of human prostatic adenocarcinoma, was obtained from ATCC (Wesel, Germany). LNCaP 
cells were cultured in phenol red-free RPMI 1640 medium, supplemented with 10% FBS, 
4.5 g/L glucose, 2.4 g/L HEPES, and 10 mM sodium pyruvate. PC-3 cells were cultured in 
RPMI 1640 medium with 10% FBS. All the media contained 10% antibiotics. The multiplex 
cell contamination test was conducted with all three cell lines.  
For the experiments, 2 x 10
4 
BPH-1
 
cells/ml , 5 x 10
4
 LNCaP cells/ml , 4 x 10
4 
PC3 cells/ ml 
were seeded for 24 hr (BPH-1, PC-3) to 48 hr (LNCaP) in 5% CO2 incubator under 
humidified conditions at 37°C. Further detailed experimental conditions are described in 
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Chapter 3.6.3. 
 
3.5 Animals 
 
3.5.1 Animal strain 
 
Name Company 
  
Balb-c nude mice Charles River Laboratories, Sulzfeld, Germany 
 
3.5.2 Animal diet 
 
The diets for the animal study were prepared weekly in our laboratory. Broccoli sources were 
grounded by and electric mill and mixed with control diet powder (1:5) together with some 
water. Broccoli extract powder was mixed with control diet at a 1: 10 ratio. Diet sticks were 
dried for overnight at 30 °C under air blowing and stored at 4°C until used. Detailed 
description about the broccoli sources are indicated below. 
 
Broccoli Broccoli field cultivation (var. Ironman) was performed by a regional vegetable 
farmer (Gemüsebau Mohr, Frankental, Germany) between May and August 2008 according 
to the growers standard conditions (= standard broccoli). A subset cultivation received an 
additional foliar fertilization with selenium spray (300 L per ha of Na2SeO4 0.012%) 
(selenium-enriched broccoli). Directly after harvesting the broccoli was manually cut into 
florets and immediately transported to an industrial vegetable processor located nearby. 
 
Frozen blanched broccoli: Florets from either standard or selenium-enriched broccoli were 
washed, blanched at 94°C for 120 seconds, immediately frozen, packed and stored at -30°C 
until use (Rheintal-Tiefkühlkost, Bobenheim-Roxheim, Germany).  
 
Broccoli extract: Blanched frozen selenium broccoli florets were used to prepare extract 
(NIG, Magdeburg, Germany). Broccoli extract contains 443.99 g/g sulforaphane and 201.97 
g/g sulforaphane-nitril.  
 
Broccoli puree: Blanched frozen selenium broccoli florets were used for puree processing 
(Fruchtsaft Bayer, Ditzingen, Germany). Florets were thawed, puréed in a cutter with 125 ml 
lemon juice per kg florets, and filled in glasses. Sterilization was performed as follows: 
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continuous heating-up (40 min) to 121°C, temperature was held for 5 min. and cooled down 
to 98°C in the course of 40 min. Then the glasses were allowed to cool down to room 
temperature. Broccoli puree was freeze-dried and stored at -20°C until use. 
 
3.5.3 LNCaP xenograft model 
 
Pathogen-free, 5-6 week old male Balb-c nude mice were purchased and housed in sterile 
filter-capped microisolator cages, climate controlled room with a 12h light/12h dark cycle 
and provided with sterilized rodent diet and water. Animals were randomized and grouped 
with ten animals and started to feed with broccoli-contained diet or control diet one day 
before LNCaP cells injection until they sacrificed. In case of kale sprout diet, animals were 
started to feed one week before the cells injection. Mice were inoculated s.c. with 100 µl 
volume of 2 x 10
6
 human prostate cancer LNCaP cells mixed with Matrigel™ Matrix Phenol 
Red-Free (BD biosciences, Heidelberg, Germany) 1:1 in both side of flanks. Tumor size, 
body weight and amount of food consumption were measured two times per week. After 7.5 -
9 weeks, animals were transferred to metabolic cages to collect urine and feces before they 
were euthanized through CO2 asphyxiation in a numerical order across groups, equally 
representing the experimental groups throughout necropsy. After sacrifice, tumors, livers and 
lung tissues were excised, weighed, and stored in liquid nitrogen. Some parts of tissues were 
placed in phosphate-buffered formalin at room temperature for 48 h and then paraffin 
sections were prepared. Blood was collected by cardiac puncture and processed for separation 
of serum, plasma, and red blood cells. 
 
3.6 Methods – Effects of Se-enriched broccoli 
 
3.6.1 Fertilization of Se-enriched broccoli (Prepared by HIP) 
 
3.6.1.1 Broccoli sprouts 
 
Broccoli (Brassica oleracea var. italica) cv. Monaco was used to study the effects of Se-
treatment at the seedling (liquid culture) and the adult plant stage (leaf application), 
respectively. 0.1g Monaco seeds were cultured in 100 ml half-strength MS (Murashige 
and Skoog) plant culture medium (pH 5.8) and treated with 50 μM sodium selenite or sel
enate for the last week before harvested. Seedlings were harvested at an age of 2 weeks 
and 3 weeks. 
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3.6.1.2 Broccoli florets 
 
Three-month-old adult broccoli plants cultivated under field conditions and at a uniform 
stage of 2.0±0.5 cm head diameter were chosen. Sodium selenate solution was sprayed once 
onto the leaves (40 ml per plant, corresponding to 0, 2, or 20 mg Se per plant) after protection 
of soil and young broccoli heads from the direct contact with selenate by covering with 
aluminum foil. After 1 week, when the broccoli head diameter had reached 10 cm, they were 
harvested for further experiments. 
 
3.6.2 Determination of enzyme activities in mouse liver tissue 
 
3.6.2.1 Sample preparation 
 
Approximately 150 mg of murine liver were homogenized in 3 ml of cold homogenizing 
buffer containing 60 mM Na2HPO4 and 60 mM KHPO4, 0.5% KCl, 250 mM sucrose using a 
tissue grinder. Tissue homogenates were centrifuged at 9000 g for 10 minutes. Lipids were 
discarded using a cotton filter and supernatant were ultra-centrifuged for 45 minutes at 
100.000 g. A clear supernatant was collected as cytosolic fraction. Microsome pellets were 
resuspended in 500 µl of microsome buffer (pH 7.4) containing 200 mM KH2PO4, 10 mM 
MgCl2 as microsomal fraction. Eight livers in each group were used for the enzyme activity 
measurements. Glutathione S-transferase (GST), quinone reductase (QR), thioredoxin 
reductase (TrxR) activities and glutathione (GSH) were determined in cytosolic fractions and 
Cyp1A1/Cyp2B1 in microsomal fractions. Protein determination of both fractions was 
performed using the BCA method.
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3.6.2.2 Cyp1A1/Cyp2B1 
 
Cyp1A1 and Cyp2B1 activities were measured in liver microsomal fractions as described by 
Pohl and Fouts (155). Briefly, liver microsomal fraction (diluted 1:10 with phosphate buffer, 
contained 200 mM KH2PO4 and 10 mM MgCl2, pH 7.4) was incubated with 2 µM 
7-ethoxyresorufin (for Cyp1A1) or 25 µM 7-pentoxyresorufin (Cyp2B1), 1.3 mM NADP
+
, 
3.4 mM glucose-6-phosphate and 5 U glucose-6-phosphate dehydrogenase. Fluorescence 
intensity was measured at 37 °C every 30 s for 10 min using a microplate spectrofluorometer 
(Ex at 522 nm and Em at 580 nm). The results were quantified by using a resorufin standard 
(0.2 µM-20 µM) and normalized to the protein concentration. Reagents are indicated below. 
 
Cyp1A1/Cyp2B1 activity determination  
  
Phosphate Buffer (KH2PO4, pH 7.4)  0.2 M 
Glucose-6-phosphate  3.4 mM 
Glucose-6-phosphate dehydrogenase  5 U 
NADP 
+
 1.3 mM 
7-Ethoxyresorufin 2 µM 
7-Pentoxyresorufin 25 µM 
 
3.6.2.3 NAD(P)H: quinone oxidoreductase (QR) 
 
QR activity in mouse liver cytosolic fractions were determined by measuring the NADPH-
dependent menadione-mediated reduction of MTT [3-(4,5-dimethylthiazo-2-yl)-2,5-
diphenyltetrazolium bromid] to a blue formazan as described previously (156).  
Liver cytosol was diluted 1:30 in homogenizing buffer and 50 µl each were used for 
determination. Plates were measured at 595 nm using a SpectraMax 340 PC plate reader every 
30 s during a 15 min interval and the rate of MTT reduction was calculated using the molar 
extinction coefficient (ε) of 11,600 M
–1
 cm
–1
 and a path length of 0.75 cm. Values were 
normalized to protein content. Reagents are indicated below: 
 
QR  
  
BSA 0.08 % 
MTT 0.87 mM 
Tris/HCl buffer pH 7.4  20 mM 
Tween 20 0.01% 
FAD
+
 5 µM 
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NADP
+
 23 µM 
Glucose-6-phosphate 0.75 mM 
Glucose-6-phosphate dehydrogenase 1.5 U 
Menadione 38 µM 
 
3.6.2.4 Glutathione S-transferase (GST) 
 
GST activity was determined using cytosolic liver protein supernatants as source of GST and 
CDNB (1-chloro-2,4-dinitrobenzol) as described previously (157). The mix was incubated 
briefly at 37 °C. Liver cytosols were diluted 1:300 in homogenizing buffer and 20 µl 
(approximately 30-80 µg protein) each were used for determination. The absorbance was 
recorded at 340 nm with a SpectraMax 340 PC plate reader at 37 °C, using its kinetic mode at 
15 s intervals during a 15 min reaction time. The rate of conjugated CDNB formation was 
calculated using the extinction coefficient (ε) 9.6 mM−1 cm−1 and normalized to protein 
concentration. Reagents are indicated below: 
 
GST  
  
KH2PO4 / K2HPO4 buffer, pH 6.5 90 mM 
CDNB 0.9 mM 
GSH 2.25 mM 
 
3.6.2.5 Thioredoxin reductase (TRx-R) 
 
TRx-R activity was measured in cytosolic fractions via the NADPH-dependent reduction of 
DTNB [5,5-dithiobis-(2-nitrobenzoic acid] to 2-nitro-5-thiobenzoic acid at 412 nm. TR-
independent reduction of DTNB was controlled by parallel incubations in the presence of the 
TR-inhibitor auranofin (158). Liver cytosolic fractions (40-90 µg) were incubated in the 
presence of auranofin (5 µM) or buffer. Plates were incubated at 37 °C for 20 minutes. The 
absolute TRx-R activity was calculated using the difference in absorbance of auranofin (total 
reductase enzymatic activity) and presence of auranofin (total reductase activity in absence of 
TRx-R activity). Kinetics was determined over 15 minutes taking one measure every 30 
seconds at 412 nm. The rate of DTNB reduction was calculated using the molar extinction 
coefficient of 13,600 M
–1
 cm
–1
 and normalized to protein content. Reagents are indicated 
below: 
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TRx-R  
  
KH2PO4 buffer, pH 7.4 70 mM 
EDTA 1.5 mM 
BSA 0.004 % 
DTNB 0.3 mM 
NADPH 0.2 mM 
 
3.6.2.6 Glutathione (GSH) 
 
Determination of GSH was performed as described previously by Tietze et al. (159), using 
5,5-dithiobis-(2-nitrobenzoic acid) (DTNB), Ellman‘s reagent. Cytosol was deproteinized 
using 1 % sulfosalicylic acid (SSA). One volume of cytosol was mixed with 2 volumes of 1 % 
SSA and centrifuged for 5 minutes at 10.000 rpm. After deproteinization, cytosol was diluted 
1:10 in water and 40 µl was used for the assay. GSH standards (from 800 pmol to 20 pmol) 
were prepared from 100 µM GSH stock solution (diluted in water). Five minute kinetics were 
determined taking one measure every 30 seconds at 412 nm using a SpectraMax 340 PC plate 
reader. GSH content was calculated using the standard curve (10 µM to 0.25 µM GSH in 
stock buffer) and normalized to protein concentration measured prior to deproteinization. 
Reagents are indicated below: 
 
GSH   
  
Tris-HCl, pH 7.4 16 mM 
Glucose- 6- phosphate 0.61 mM 
NADP
+
 18.7 µM 
DTNB 0.57 mM 
Glucose-6-phosphate dehydrogenase 0.26 U 
Gluthatione Reductase 0.24 U 
Na2HPO4 125 m 
Na-EDTA 6.3 mM 
 
3.6. 3 Determination of protein expression by Western blotting 
 
BPH-1 (2.5 x 10
4 
cells/ml), PC-3 (4 x 10
4
 cells/ml) and LNCaP (5 x 10
4
 cells/ml) cells were 
seeded in 30 cm petri dish (30 ml per dish) and grown over night for BPH-1 and PC-3 or 
grown for two days for LNCaP. Cells were treated with extracts of freeze-dried sprouts or 
broccoli florets. Total cells were destroyed by using SDS lysis buffer containing 62.5 mM 
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Tris/HCl (pH 6.8), 2 % SDS, 10 % glycerin, 1 mM DTT, proteinase inhibitor and 
phosphatase inhibitor. Total lysates were boiled at 98 °C for 10 min and 30 µg of proteins 
were loaded to SDS-PAGE. After gel electrophoresis and transfer to PVDF membranes, 
membranes were incubated in 5% non-fat dried milk/TBS-T for 1 hr at room temperature 
before incubation with primary antibodies against GPX-1,3,4 (1:10000), TR (1:1000) and 
MnSOD (1:1000) over night at 4°C, followed by incubation with secondary antibodies for 2 
hrs at room temperature. After washing three times with PBS-T, protein expression was 
detected by using ECL methodology on x-ray film. 
 
3.6.4 Determination of sulforaphane metabolites in mouse plasma, urine 
and feces (performed and provided by Johanna Hauder, DFA) 
 
Sample preparation: Plasma and urine samples for the analysis of glucoraphanin metabolites 
were prepared by first spiking the samples with the internal standards d8-SFN and d8-SFN-
NAC and homogenizing for 1 min. Proteins were then precipitated from plasma using pre-
cooled trifluoroacetic acid. After homogenization samples were centrifuged and the 
supernatant was subsequently loaded onto Discovery®  C18 solid phase extraction cartridges 
(100 mg, 1 mL; Supelco, Taufkirchen, Germany) which had been conditioned with methanol 
and equilibrated with formic acid (0.1 % in water) previously. After a washing step with 
methanol/water (5/95; v/v), the metabolites were eluted with ACN/water (90/10; v/v), 
evaporated to dryness under a nitrogen stream and dissolved in formic acid (0.1 % in water). 
Ten microliters of each sample were injected into the HPLC-ESI(+)-MS/MS system. A 
mobile phase gradient starting from 100% aqueous formic acid (0.1 % formic acid in water), 
decreasing up to flux 100 % of the 0.1 % formic acid in acetonitrile phase within 15 min and 
keeping at the organic phase for 5 min was used.  
HPLC-MS/MS analyses were carried out on a Finnigan Surveyor Plus HPLC system 
(Thermo Electron Corporation, Waltham, USA) equipped with a triple-quadrupole mass 
spectrometer (TSQ Quantum Discovery; Thermo Electron Corporation, Waltham, USA). For 
glucoraphanin metabolites, electrospray ionisation in positive mode and selected reaction 
monitoring (SRM) were selected. Analyses were performed on an Aqua C18 column (5 µm, 
12.5 nm, 150 x 2 mm) as stationary phase equipped with a guard column (C18, 4.0 x 2.0 mm; 
both from Phenomenex, Aschaffenburg, Germany). Mobile phase consisted of 0.1 % formic 
acid in water (A) and 0.1 % formic acid in ACN (B). It was operated with a flow rate of 0.2 
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mL/min and injection volume was 10 µL. UV detector wavelength was set at  = 210 nm in 
this case. Quantifications of all metabolites in plasma and urine samples were performed by 
comparing the peak areas of characteristic mass fragments of analyses and standards. 
 
3.6.5 Elemental analysis of total selenium (performed and provided by Fu-
Chou Hsu, HIP) 
 
Broccoli samples were dried at 65°C in an oven for 3 days. 20 mg of samples was incubated 
in 2 ml HNO3 at room temperature for 3 days, 95°C for 3 hours and followed by addition of 1 
ml H2O2 (30 %) and further incubation at 95°C for 1 hour. Thereafter, samples were diluted 
with double-distilled water to 10 ml. Total element contents were determined by inductively 
coupled plasma atomic emission spectrometry (ICP-AES, Thermo Elemental, Dreieich, Ger
many) using an IRIS Advantage Duo ER/S. Se was determined using the 196-nm line.  
 
3.7 Methods-Anti-angiogenic potential of kale sprouts 
 
3.7.1 RNA isolation, reverse transcription and quantitative real time PCR 
 
RNA of prostate cancer LNCaP xenograft was isolated with TRIzol®  following the 
manufacturer‘s instructions. 1 µg of total RNA was reverse transcribed with M-MLV 
(Moloney Murine Leukemia Virus) reverse transcriptase. mRNA expression of p21, HAT1, 
CBP, p300, PCAF was quantified by using iCycler iQ
™
 Real-Time PCR Detection System 
and normalized to the expression levels to the housekeeping gene HPRT-1 or -actin. PCR 
reaction was performed in by standard procedures. The PCR program was consisted of 
denaturation step 95 °C for 10 min followed by 40 cycles of 30s at 95 °C, 15 s at individual 
annealing temperatures of primers and 45 s at 72 °C elongation step. After final elongation 
step for 10 min at 72 °C, product formation was confirmed by melting curve analysis (55 °C 
– 96 °C). Primer sequences are described below. 
 
Primer Sequences for quantitative Real Time PCR 
Gene   Species Sequence 5’- 3’ T°[C] 
    
PSA Human For gtgcttgtggcctctcgt 60 
  Rev agcaagatcacgcttttgttc  
AR Human For atggtgagcagagtgcccta 61 
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  Rev gtggtgctggaagcctctcct  
uPA Human For ggactacagcgctgacacg 61 
  Rev ggcaggcagatggtctgtat  
MMP-2 Human For ataacctggatgccgtcgt 62 
  Rev aggcacccttgaagaagtagc  
MMP-9 Human For gaaccaatctcaccgacagg 61 
  Rev gccacccgagtgtaaccata  
VEGF-c Human For agtgtcaggcagcgaacaaga 63 
  Rev cctcctgagccaggcatctg  
TNFa Human For cagcctcttctccttcctgat 60 
  Rev gccagagggctgattagaga  
HPRT-1 Human For tgaccttgatttattttgcatacc 60 
  Rev cgagcaagacgttcagtcct  
Actin Human For ccatcatgaagtgtgacgtgg 62 
  Rev gtccgcctagaagcatttgcg  
FGFb Mouse For cggctctactgcaagaacg 60 
  Rev tgcttggagttgtagtttgacg  
Prox-1 Mouse For cgacatctcaccttattcagga 60 
  Rev ttgcctttttcaagtgattgg  
TNFa Mouse For tcttctcattcctgcttgtgg 61 
  Rev ggtctgggccatagaactga  
HPRT-1 Mouse For tcctcctcagaccgctttt 59 
  Rev cctggttcatcatcgctaatc  
 
 
3.7.2 Detection of AR, TNF, angiostatin by Western blotting 
 
Approximately 10 mg of LNCaP xenograft tumor tissue was homogenized by Tissue lyser II 
with 150 µl of pre-heated SDS lysis buffer containing 62.5 mM Tris/HCl, pH 6.8, 2 % SDS, 
10% glycerol, 1 mM DTT, proteinase and phosphatase inhibitor tablets. Total lysates were 
boiled at 98 °C for 10 min, and 30 µg of proteins were loaded to SDS-PAGE gels. After 
electrophoresis and transfer to PVDF membranes they were incubated in 5% non-fat dried 
milk/TBS-T for 1 hr at room temperature before incubation with primary antibodies against 
AR, TNF and angiostatin over night at 4 °C, and secondary antibodies at room temperature 
for 2 hrs. ECL was used for protein detection by standard methods. 
 
3.7.3 Chromatin Immunoprecipitation-PSA promoter 
 
Approximate 50 mg of frozen tissue was crushed with liquid nitrogen. Chromatin 
immunoprecipitation assays were conducted as described previously (160). Briefly, cells were 
cross-linked at room temperature for 10 min by using 1% formaldehyde containing 20 mM 
Na-butyrate, protease inhibitor and 1 mM PMSF. After sonication, the resulting soluble 
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chromatin was diluted 1:10 with dilution buffer and immunoprecipitated by incubation with 
the AR antibody overnight at 4°C with rotation. The following day, chromatin-antibody 
complexes were isolated from solution by incubation with protein G-Agarose/Salmon Sperm 
DNA beads for 2 hr at 4 °C. The sepharose-bound immune complexes were washed two 
times with high salt buffer, for two times, LiCl buffer for one time and rinse with TE for two 
times. The immune complexes were eluted from beads with an elution buffer (1% SDS and 
0.1 M NaHCO3) followed by DNA extraction. DNA samples from chromatin 
immunoprecipitation preparations were analyzed by real-time PCR using an iCycler iQ
™
 
Real-Time PCR Detection System as described previously. The primers and probes were as 
following: human PSA enhancer forward (5 -´GCCTGGATCTGAGAGAGATATCATC-3 )´, 
reverse (5 -´ACACCTTTTTTTTTCTGGATTGTTG-3 )´; human PSA promoter forward (5 -´ 
CCTAGATGAAGTCTCCATGAGCTACA-3 )´, reverse (5 -´GGGAGGGAGA-
GCTAGCACTTG-3 )´; human GSTP1 promoter forward (5 -´
GACCTGGGAAAGAGGGAAAG-3 )´, reverse (5 -´CCCCAGTGCTGAGTCACG-3 )´. 
 
3.7.4 Quantification of PSA levels by ELISA (performed and provided by 
Dr. Achim Bub, MRI Karlsruhe) 
 
For the determination of PSA secretion, 25 ul of mouse serum was subjected to the PSA Total 
Elisa Assay according to the manufacturer‘s instructions.  
 
3.7.5 Measurement of Hb concentration in tumor xenografts 
 
15 mg of xenograft was homogenized with 1 ml PBS. Hemoglobin (Hb) concentration was 
measured by using Elisa Spectramax at a wave length of 410 nm. Hb standard curve was used 
for the calculation.  
 
3.7.6 Immunohistochemistry-CD31
+
, -SMA, AR (performed and 
provided by Mattthias Wieland, DKFZ) 
 
LNCap xenograft cryosections (8 µm) were fixed for 10 min in ice-cold methanol and 
washed afterwards two times in PBS. In case of the CD31- Desmin co-staining, sections 
were blocked with Avidin solution for 10 min at RT, washed 3 times in TBS-T, 0.1 % for 3 
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min, blocked with Biotin solution for 10 min at RT, and washed again. All sections were 
blocked using the Zymed Blocking Solution. Primary antibody incubation with rat anti-
mouse CD31, diluted 1:100 in Blocking Solution alone, or in case of the CD31- Desmin co-
staining together with a 1:200 diluted rabbit anti-mouse Desmin antibody, was performed 
over night at 4 °C. Sections were washed twice with TBS-T 0.1% for 5 min followed by 
incubation with 1:500 diluted rabbit anti-rat-Alexa488 antibody alone, or for the CD31- 
Desmin staining together with 1:200 diluted biotinylated goat anti-rabbit antibody, for 45 min 
at RT. After three washing steps with TBS-T 0,1 % for 5 min, sections for the CD31- SMA 
staining were stained using a 1:100 dilution of the directly labeled anti-SMA-Cy3 antibody 
for 1 h at room temperature. In case of the CD31- Desmin staining sections were incubated 
with 1:250 diluted Streptavidin-Alexa546 in PBS for 30 min at RT. After the antibody 
incubations sections were washed in TBS-T 0.1 % and nuclei were counterstained by Hoechst 
dye in a 1:5000 dilution. Finally, sections were mounted with fluoro-mount medium. 
 
3.7.7 Immunohistochemistry- androgen receptor  
 
Paraffin embedded sections were irrigated with xylol and ethanol. Endogenous peroxidase 
was inactivated by incubation in 0.3 % H2O2. 50 µl of blocking serum added to 5 ml TBS was 
used for blocking. Incubation with AR antibody was performed overnight (1:200, Santa Cruz 
Biotechnology, Heidelberg, Germany). After washing three times with TBS-T, 
VECTASTAIN ABC Kit for rabbit IgG was added for 30 min. Development was carried out 
by diaminobenzidine tetrahydrochloride (DAB) and H2O2. For H&E staining, paraffin 
embedded tissue sections were stained with basic dye hematoxylin and alcohol based acidic 
eosin. 
 
3.7.8 Gelatin zymography 
 
100 µg of total tumor cell lysate was mixed with sample buffer and incubated for 10 min at 
room temperature. Samples were loaded to 8 % SDS-PAGE containing 1 mg/ml gelatin. After 
electrophoresis, gels were washed and rinsed with renaturing buffer (2.5 % Triton X-100 in 
water) for 1 hr at room temperature followed by incubation with developing buffer 
(containing 50 mM Tris base, 50 mM Tris-HCl, 0.2 mM NaCl, 5 mM CaCl2, 0.02 % Brij 35) 
for 48 hrs at 37 °C. After staining with 0.5 % Coomassie blue R-250, gels were washed with 
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destaining solution containing 50 % methanol and 10 % acetic acid. Areas of gelatinase 
activity were detected as clear bands against blue-stained gelatin background.  
 
3.8 Methods- Histone modification by kale sprouts 
 
3.8.1 Determination of mitotic cells by immunohistochemistry  
 
Paraffin embedded sections were irrigated with xylol and ethanol. Endogenous peroxidase 
was inactivated by incubation in 0.3 % H2O2. After 1 hr blocking with serum, posphoH3 
antibody (1:200 dilution in TBS) was incubated overnight. After washing three times with 
TBS-T, 1:200 diluted VECTASTAIN ABC Kit for rabbit (PK-6102) was added for 30 min. 
Development was carried out by diaminobenzidine tetrahydrochloride (DAB) and H2O2. 
 
3.8.2 Immunoblotting  
 
The same method to prepare samples was used as previously described in Chapter 3.7.2. 
About 20-30 µg of total cell lysates were used for the western blot analysis, as described 
previously (chapter 3.7.2). Primary antibodies against phospho-H3 (1:2000), p21 (1:1000), 
HDACs (1:1000) and Sirt-1 (1:1000) were incubated over night at 4 °C followed by 
secondary antibodies (1:5000) incubation at room temperature for 2 hrs. ECL was used for 
protein detection by standard methods. 
 
3.8.3 Detection of histone acetylation  
 
Acid extracted histone samples, as described previously (161), were separated by 
electrophoresis. Ac-H3, Ac-H4 antibody from Upstate was blotted to detect histone 
acetylation and total H4 was used as a loading control in the same membrane. Membranes 
were incubated with primary antibodies (1:1000 diluted in PBS) over-night at 4 °C followed 
by secondary antibody incubation for 2 hrs at room temperature. ECL was used for detection 
by standard methods. 
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3.8.4 Nuclear protein extraction and PACF expression assay  
 
About 20 mg of tumors were homogenized using a Tissue lyser II with buffer A, containing 
10 mM HEPES (pH 7.9), 1.5 mM MgCl2 10 mM KCl, 0.5 mM DTT and 0.2 mM 
phenylmethylsulfonyl fluoride (PMSF). After incubation for 10 min on ice, the lysates were 
centrifuged and pellets were re-suspended in cold buffer C, containing 20 mM HEPES (pH 
7.9), 20 % glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, and 0.2 
mM PMSF and incubated for 20 min on ice. After a vigorous vortex, nuclear fractions were 
centrifuged and collected. 30 µg of nuclear protein was used for Western blotting. Anti-PCAF 
antibody was used to detect nuclear PCAF protein expression. Membranes were incubated  
over-night at 4°C with PCAF antibody (1:1000 dilution) followed by secondary antibody 
incubation for 2 hrs at room temperature. ECL was used for detection by standard methods. 
 
3.8.5 HDAC activity measurement (performed and provided by Julia 
Wagner, University of Freiburg)  
 
HDAC activity was determined using the Fluor-de-Lys substrate. Incubations were performed 
at 37°C for 10 min with tumor nuclear extracts, and the HDAC reaction was initiated by the 
addition of Fluor-de-Lys substrate (162). After 10 min, Fluor-de-Lys Developer was added, 
and the mixture was incubated for another 10 min at room temperature. Fluorescence was 
measured using a Spectra Max Gemini XS fluorescent plate reader (Molecular Devices), with 
excitation at 360 nm and emission at 460 nm. 
 
3.8.6 RNA isolation, reverse transcription and quantitative real time PCR 
 
Isolation of RNA and PCR conditions were as described previously in Chapter 3.7.1. Primer 
sequences are listed below. 
 
Gene Species  Sequence 5’- 3’ Temp. (°C) Size (bp) 
      
HAT1 Human For ggt tga ttc gtc ctt cct ca 61 150 
  Rev tta gtt caa ttg ctg tgt tgg tg   
CBP Human For cag agc gga tca tcc atg act 61 348 
  Rev gct tct cca tgg tgg cat ac  
P300 Human For cct gag tag ggg caa caa ga 60 353 
  Rev gtg tct cca cat ggt gct tg  
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PCAF Human For gcc tcc tcc aga aca tga ga 61 69 
  Rev ctc ttc tgg act tga ggc aaa   
p21 Human For ctc cgt cag aac cca tgc 62 155 
  Rev agt ggt gtc tcg gtg aca aa   
HPRT-1 Human For tgaccttgatttattttgcatacc 60 102 
  Rev cgagcaagacgttcagtcct   
-Actin Human For ccatcatgaagtgtgacgtgg 62 293 
  Rev gtccgcctagaagcatttgcg   
 
 
3.8.7 Chromatin Immunoprecipitation – p21, PCAF promoter 
 
The procedure of ChIP assay was performed as previously described in Chapter 3.7.3. The 
primers and probes were as following: human p21 promoter (forward primer, 5‘-
GGTGTCTAGGTGCTCCAGGT-3‘; reverse primer, 5‘- GCACTCTCCAGGAGGACACA-
3‘), PCAF promoter (forward primer, 5‘-CACCCAGAAACGAATCCTGT-3‘; reverse primer, 
5‘-TGTTTGAAAGTGCTGGTTGC-3‘). 
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4 RESULTS 
 
4.1 Se-enriched broccoli as a functional food for prostate cancer prevention 
(Induction of detoxifying and antioxidant enzymes) 
 
Since previous publications demonstrated chemopreventive effects of broccoli and selenium 
in prostate cancer by induction of antioxidant and Phase 2 enzymes, our first aim was to 
investigate the effects of Se-enriched broccoli on these mechanisms in prostate cancer cells in 
vitro and in vivo.  
We first compared the spectrum of bioactivities of experimental broccoli extracts in 
combination with selenium in vitro in cultured prostate (cancer) cell lines in comparison to 
SFN and in/organic selenium. We further performed an in vivo intervention study with Se-
fertilized broccoli in various preparations in nude mice bearing human prostate cancer 
xenografts. Enzyme activities were analyzed in liver and tumor samples and compared to 
selected metabolite levels in plasma, urine and feces samples determined by collaboration 
partners (described in 3.6.7). 
 
4.1.1 Combination of Se and broccoli extract in vitro 
 
Before we investigated the effects of Se-fertilized broccoli preparations, we first investigated 
the effects of SFN, Na2SeO3, Na2SeO4 and SeMSC as reference compounds and a special 
broccoli extract (containing free SFN) alone and in combination with SeMSC, as indicated in 
Table 3. An immortalized prostate cell line (BPH-1) and two prostate cancer cell lines 
(LNCaP, PC-3) were treated with SFN in comparison to selected Se sources for 5 days. SFN 
induced both QR and Trx-R activity in all three cell lines, with similar potential to induced 
QR and Trx-R activity in BPH-1 and LNCaP cells. In comparison to the two other cell lines, 
PC-3 cells were less responsive to SFN with respect to Trx-R induction. Both inorganic and 
organic Se sources at a dose of 25 nM potently induced Trx-R activity by 1.5 to 4.9 fold in all 
three cell lines, but had no effect on QR activity. Trx-R inducing potential increased in the 
order of Na2SeO3 > SeMSC > Na2SeO4. 
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Table 3. Induction of QR and Trx-R in prostate cancer cell lines by single and combined treatment 
with SFN/broccoli extract and organic/anorganic selenium 
 
BPH-1 LNCaP PC-3 
QR
a
 
(fold ind.) 
Trx-R 
(fold ind.) 
QR 
(fold ind.) 
Trx-R 
(fold ind.) 
QR 
(fold ind.) 
Trx-R 
(fold ind.) 
Control 1.0 ± 0.02 1.0 ± 0.02 1.0 ± 0.02 1.0 ± 0.02 1.0 ± 0.01 1.0 ± 0.02 
Pure compounds       
SFN  (1 µM) 1.4 ± 0.01† 1.5 ± 0.03† 1.6 ± 0.07† 1.5 ± 0.04† 1.4 ± 0.04† 1.1 ± 0.03† 
SFN  (4 µM) 2.1 ± 0.01† 2.5 ± 0.1† 2.2 ± 0.07† 1.9 ± 0.04† 2.1 ± 0.01 1.3 ± 0.1† 
Na2SeO3 (25 nM)
b
 1.1 ± 0.1 4.9 ± 0.05† 1.1 ± 0.04 4.1 ± 0.1† 1.0 ± 0.1 3.5 ± 0.1† 
Na2SeO4  (25 nM) 1.1 ± 0.05 2.6 ± 0.3
†
 1.1 ± 0.05 1.7 ± 0.05
†
 1.0 ± 0.05 1.5 ± 0.05
†
 
SeMSC (25 nM) 1.1 ± 0.07 4.1 ± 0.1† 1.0 ± 0.04 2.6 ± 0.1† 1.0 ± 0.07 1.8 ± 0.04† 
Combination of Broccoli extract with SeMSC (Se) 
Br-Ex
c 
1.9 ± 0.04
‡
 1.3 ± 0.02
‡
 2.5 ± 0.05
‡
 1.7 ± 0.06
‡
 2.1 ± 0.05
‡
 1.1 ± 0.02
‡
 
Br-Ex+Se (2 nM) 1.9 ± 0.09‡ 2.4 ± 0.03‡ 2.4 ± 0.12‡ 1.7 ± 0.07‡ 2.0 ± 0.1‡ 1.5 ± 0.02‡ 
Br-Ex+Se (20 nM) 1.8 ± 0.05‡ 5.6 ± 0.08‡ 2.1 ± 0.06‡ 2.4 ± 0.09‡ 1.7 ± 0.07‡§ 1.3 ± 0.02‡ 
Br-Ex+Se (100 nM) 1.7 ± 0.03‡§ 8.9 ± 0.12‡§ 2.2 ± 0.11‡ 4.6 ± 0.18‡§ 1.6 ± 0.08‡§ 2.1 ± 0.03‡ 
a 
Specific activities of solvent control: BPH-1 QR 25.2 ± 0.2 nmol/min/mg; Trx-R 2.6 ± 0.2 nmol/min/mg; 
LNCaP QR 23.1 ± 0.6 nmol/min/mg, Trx-R 6.2 ± 0.3 nmol/min/mg; PC-3 QR 1.9 ± 0.2 nmol/min/mg, Trx-R 3.1 
± 0.2 nmol/min/mg  
b 
Se intervention at 25 nM is equivalent to 4.3 ng/ml of Na2SeO3, 4.7 ng/ml of Na2SeO4 and 5.4 ng/ml of 
SeMSC  
c
 Br-Ex: broccoli extract (625 µg/ml, equivalent to 2.8 µM SFN), Se: SeMSC, 2 , 20, 100 nM are equivalent to 
0.4, 4, 20 ng/ml SeMSC 
Data indicate mean ± SD, 
‡
p<0.001 vs. control, 
§
p<0.05 vs. Br-Ex. Statistical significance was tested by one 
way ANOVA, followed by Tukey test for multiple comparisons. 
 
Next, we analyzed the inducing potential of broccoli extract alone and in combination with 
SeSMC as a source of Se. The broccoli extract was tested at a concentration of 625 µg/ml 
(equivalent to 2.8 µM SFN) and induced QR activity in all cell lines. Interestingly, co-
treatment with increasing concentrations of SeMSC in a range of 2-100 nM weakly, but dose-
dependently reduced QR enzyme activity (p<0.01) compared to treatment with broccoli 
extract alone. Induction of TRx-R activity in the immortalized BPH-1 cell line was higher by 
the combined treatment with extract and 20 nM SeMSC than by the individual treatments 
(although tested concentrations were not identical), indicating an additive effect on Trx-R 
induction by Se and SFN. In the cancer cell lines, the additive effect was less prominent, but 
SeMSC still dose-dependently induced Trx-R activity in the presence of the broccoli extract 
(Table 3).  
In line with the increase in Trx-R enzyme activity, incubation with increasing concentrations 
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of SeMSC in combination with broccoli extract induced Trx-R protein expression in a dose 
dependent manner. Induction was most prominent in the BPH-1 cell line (Fig. 9). 
  
Fig. 9: Effects of broccoli extract, selenium and their combination on expression levels of selenoproteins 
and antioxidant enzymes in prostate (cancer) cell lines. BPH-1, LNCaP and PC-3 cells were treated with 
broccoli extract 625 g/ml (eq. 2.8 M SFN), co-treated with SeMSC and SeMSC alone for 72hr. After 
incubation, total cell lysates were used to detect expression of the indicated selenoproteins and antioxidant 
enzymes by Western blotting. -Actin was used as a loading control. The numbers above the immuno-reactive 
bands represent fold changes relative to the corresponding vehicle control. Each experiment was repeated three 
times and representative data from one such experiment are shown. 
 
 
In addition to TRx-R expression, the expression of GPx as a selenium-containing antioxidant 
enzyme family was analyzed. Treatment with SeMSC induced GPx-1 and GPx-4 protein 
expressions in cancer cell lines in dose dependent manner (Fig. 9). However, broccoli extract 
alone had no effect on the expression of GPx-1 and -4. Different from the prostate cancer cell 
lines, the BPH-1 cell line was sensitive to extract treatment in a way that GPx-1 expression 
was down-regulated, although SeMSC treatment alone induced GPx-1 and -4 expression. 
Reasons for this discrepancy need to be further explored. Another GPx family member, 
GPx-3, was not responsive to both extract and SeMSC treatment in BPH-1 and LNCaP cell 
lines, but was induced by both treatments in the PC-3 cell line. We also analyzed the 
RESULTS 
61 
 
expression of the antioxidant enzyme MnSOD that inactivates superoxide anion radicals. This 
enzyme was only weakly induced in BPH-1 and PC-3 cells by broccoli extract or SeMSC, but 
there was no enhancement of induction by the combination. 
 
4.1.2 Effects of Se-enriched broccoli sprouts in vitro  
 
The effects of broccoli extract in combination with SeMSC on QR and Trx-R enzyme activity 
in prostate (cancer) cell lines indicated that it may be possible to maximize dual bioactive 
components in a single broccoli plant for beneficial effects on prostate cancer prevention. As 
a first approach to test this strategy, we cultured broccoli sprouts in a liquid culture system 
containing Na2SeO3 or Na2SeO4.  
Without changing the glucoraphanin contents, broccoli sprouts accumulated selenium in the 
plants in two to three weeks. Uptake of selenium was more efficient by inoculation with 
selenite compared to selenate. Selenium fertilization induced Se accumulation about 44 and 5 
fold, respectively, in 2 weeks, and the accumulation was higher after 2 weeks culture that 
after 3 weeks culture (Table 4).  
 
Table 4. Antioxidant enzyme induction by Se-enriched broccoli sprouts in prostate (cancer) cell lines 
Sample 
Total Se* 
(ng/ml) 
Gluco-
raphanin* 
(µM) 
BPH-1 LNCaP 
QR
a 
(fold ind.) 
Trx-R 
(fold ind.) 
QR 
(fold ind.) 
Trx-R 
(fold ind.) 
Solvent control - - 1.0 ± 0.02
 
1.0 ± 0.02 1.0 ± 0.02 1.0 ± 0.02 
2w control 0.3 ± 0.01 0.3 ± 0.04 1.6 ± 0.01
†
 1.0 ± 0.04 1.2 ± 0.01
†
 1.5 ± 0.01
†
 
2w SeO3
2-
 13.2 ± 0.2 0.3 ± 0.06 1.7 ± 0.03
†
 4.2 ± 0.03
†§
 1.2 ± 0.02
†
 4.8 ± 0.02
†§
 
2w SeO4
2-
 2.7 ± 0.5 0.3 ± 0.04 1.6 ± 0.1
†
 2.3 ± 0.11
†§
 1.1 ± 0.03
†
 2.5 ± 0.04
†§
 
3w control 0.7 ± 0.3 0.2 ± 0.04 2.2 ± 0.05
†
 1.7 ± 0.07
†
 1.5 ± 0.02
†
 1.5 ± 0.01
†
 
3w SeO3
2-
 7.8 ± 0.5 0.2 ± 0.04 1.8 ± 0.04
†§
 7.0 ± 0.06
†§
 1.2 ± 0.02
†§
 5.0 ± 0.08
†§
 
3w SeO4
2-
 5.3 ± 0.4 0.2 ± 0.04 2.1 ± 0.1
†
 4.5 ± 0.06
†§
 1.7 ± 0.01
†§
 2.5 ± 0.02
†§
 
Data indicate mean ± SD; w: culture period in weeks.  
* Concentration: This is the content in Se and glucoraphanin in the final cell culture incubation when 6.25 g/ml 
of the sprouts were used to prepare an extract 
a 
Specific activities of solvent control: BPH-1 QR 21.6 ± 0.5 nmol/min/mg; Trx-R 3.75 ± 0.3 nmol/min/mg, 
LNCaP QR 26.4 ± 0.8 nmol/min/mg, Trx-R 5.6 ± 0.3 nmol/min/mg  
Statistical significance was tested by one way ANOVA, followed by Tukey test for multiple comparisons.
 
†
p<0.05 vs solvent control,
 §
p<0.05 vs. control sprouts, respectively. 
QR activity 
Treatment with Se-enriched or standard broccoli sprouts at a concentration of 6.25 g/ml for 
5 days induced QR enzyme activity in BPH-1 and LNCaP cell lines (Table 4). Sprouts 
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cultured for 2 weeks induced QR activity approximately 1.6 fold. Interestingly, potential to 
induce QR enzyme activity by sprouts cultured with selenate for 3 weeks was about 20% less 
efficient than that of standard sprouts in both the BPH-1 and LNCaP cell line (p<0.05, 
ANOVA) (Table 4). Taken together, QR activity was mainly induced by SFN and little, or 
even negatively, influenced by culturing the sprouts with selenium.  
 
TRx-R activity  
Incubation of BPH-1 and LNCaP cell lines with Se-fertilized or standard broccoli sprouts at a 
concentration of 6.25 g/ml for 5 days also induced Trx-R enzyme activity (Table 4). 
Treatment with untreated sprouts weakly induced TRx-R activity in both cell lines by 1.5- to 
2.2-fold. The increase in Se-content by culture of the sprouts with selenite or selenate resulted 
in a significant increase in TRx-R induction, with a maximum 7-fold increase after incubation 
of BPH-1 cells with sprouts cultured for 3 weeks with selenite. These data indicate that both 
broccoli components as well as Se contribute to the induction of TRx-R, with selenium 
having a more prominent effect than SFN.  
 
GPx expression 
Treatment of BPH-1 and LNCaP cells with Se-enriched sprouts at a concentration of 6.25 
g/ml for 5 days also induced GPx-1 and -4 expression compared to control, as indicated in 
Fig. 10. 
Especially sprouts cultivated with selenite for 2 or 3 weeks resulted in a strong induction of 
GPx-1 and -4 expression in both the BPH-1 and LNCaP cell line. Cultivation with selenate 
resulted in lower Se-levels in the sprouts in comparison with selenite culture (as indicated in 
Table 4), and this was also reflected in a lower potential to induced GPx proteins. Treatment 
with standard sprouts also resulted in the induction of GPX-1 and -4 expression, especially in 
the BPH-1 cell line. This was different from our observations with the broccoli extract, which 
rather reduced GPx-1 and -4 expression in BPH-1 cells (Fig. 9).  
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Fig. 10: Induction of GPx expression in BPH-1 and LNCaP cell lines by broccoli sprouts which were 
cultivated in selenium-contained media. Freeze-dried broccoli sprouts which cultured for 2 or 3 weeks in the 
presence of water, 50 M of selenate or selenite were homogenized with water (detailed description in Materials 
and Methods). BPH-1 and LNCaP cells were treated with broccoli sprouts for 72 hrs and total cell lysates were 
used to detect GPx protein expression. The numbers above the immuno-reactive bands represent fold changes 
relative to the corresponding vehicle control, quantified by Image J software. 
 
 
Similar to TRx-R activity and total selenium contents, inducing potential of GPx expression 
increased in the order of sprouts cultivated with standard conditions < selenate < selenite in 
BPH-1 and LNCaP cell lines. Compared to the reference compound SeMSC at 100 nM, GPx 
induction by treatment with 6.25 µg/ml of Se-enriched sprouts which contains about 25 nM 
of SeMSC was more efficient in BPH-1 and LNCaP cells (compare Fig. 9 and Fig. 10). 
However, only total Se-levels were determined in the sprouts, it is presently unclear whether 
Se is contained in organic or anorganic form.  
 
4.1.3 Activity of Se-enriched broccoli florets in vitro 
 
Next, we investigated the chemopreventive potential of Se-enriched broccoli florets. Mature 
broccoli has previously been reported as a Se accumulator (88).To avoid competition 
between sulfur and selenium by sharing the same enzymes for uptake and further synthesis of 
glucoraphanin and organic selenium in the plant, as previously described (89, 163), we 
sprayed 0, 2, 20 mg of Na2SeO4 on to the broccoli leaves instead of inoculation into the soil. 
Direct contact of Se with soil and florets was avoided by coverage with aluminum foil.  
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The consequence of Se spraying was accumulation of Se in the broccoli florets without 
altering of glucoraphanin contents, as indicated in Table 5. Total Se content was increased in 
a dose-dependent manner. Spraying with 20 mg of selenate per broccoli head induced a 35-
fold accumulation of Se in the florets. 
 
Table 5. Antioxidant enzyme induction by Se-enriched broccoli florets in prostate (cancer) cell lines 
Sample 
Total Se
*
 
(ng/ml) 
Gluco-
raphanin
*
 
(µM) 
BPH-1 LNCaP 
QR
a 
(fold ind.) 
Trx-R 
(fold ind.) 
QR 
(fold ind.) 
Trx-R 
(fold ind.) 
Solvent control - - 1.0 ± 0.02
 
1.0 ± 0.02 1.0 ± 0.02 1.0 ± 0.02 
0 mg 0.1 ± 0.3 1.3 ± 0.2 1.9 ± 0.03
†
 2.4 ± 0.1
†
 1.5 ± 0.07
†
 1.6 ± 0.05
†
 
2 mg SeO4
2-
 0.8 ± 0.5 1.4 ± 0.1 1.9 ± 0.2
†
 3.5 ± 0.3
†§
 1.5 ± 0.09
†
 2.1 ± 0.05
†§
 
20 mg SeO4
2-
 3.5 ± 0.9 1.3 ± 0.2 1.8 ± 0.1
†
 3.3 ± 0.2
†§
 1.4 ± 0.07
†
 4.1 ± 0.2
†§
 
Data indicate mean ± SD.  
*
 Concentration: This is the content in Se and glucoraphanin in the final cell culture incubation when 625 g/ml 
of the sprouts were used to prepare an extract 
a 
Specific activities of solvent control: BPH-1 QR 21.6 ± 0.5 nmol/min/mg; Trx-R 3.75 ± 0.3 nmol/min/mg, 
LNCaP QR 26.4 ± 0.8 nmol/min/mg, Trx-R 5.6 ± 0.3 nmol/min/mg  
Statistical significance was tested by one way ANOVA, followed by Tukey test for multiple comparisons.
 
†
p<0.05 vs solvent control,
 §
p<0.05 vs. control florets, respectively. 
 
 
Treatment BPH-1 and LNCaP cells with homogenates of both Se-enriched broccoli florets 
(Se-florets) and standard broccoli florets at a concentration of 625 g/ml for 3 days induced 
QR enzyme activity 1.4 to 1.9 fold (Table 5).  
Compared to LNCaP cells, BPH-1 cells were more sensitive to induce QR enzyme activity 
after treatment with broccoli florets. As Se-fertilization accumulate Se in the broccoli florets, 
treatment with Se-florets induced Se-containing antioxidant enzymes in the cells. TRx-R 
enzyme activity was increased by 1.6- to 4.1-fold in a Se dose-dependent manner (0 mg 
florets < 2 mg florets < 20 mg florets), especially in the LNCaP cell line.  
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Fig. 11: Induction of GPx expression by Se-enriched broccoli florets in LNCaP cells. Freeze-dried broccoli 
florets of plants sprayed on to the leaves with water, 2 mg or 20 mg selenate once before harvesting (described 
in Materials and Methods) were homogenized with water. After the indicated incubation times, cells were 
harvested and GPx protein expression was analyzed by Western blotting. The numbers above the immuno-
reactive bands represent fold changes relative to the corresponding vehicle control, quantified by Image J 
software. 
 
Elevated total Se levels in the broccoli florets were also correlated with induction of GPx-1 
and GPx-4 protein expression in LNCaP cells after treatment with floret homogenates at a 
concentration of 625g/ml for 1 to 5 days, evaluated by Western blot analysis (Fig.11). 
Interestingly, highest induction was observed after incubation for 3 days, whereas relative 
expression levels declined after further treatment up to 5 days. Although spraying with 20 mg 
selenate resulted in more that 4-fold higher Se levels than spraying with 2 mg selenate, the 
inducing potential of both preparations was similar and weaker than that observed with 
broccoli sprouts enriched with selenium (compare Fig. 10). 
 
4.1.4 Se-enriched broccoli and food preparations in the LNCaP xenograft 
model 
 
After we optimized the Se fertilization conditions for Se-enriched broccoli and evaluated 
their effects on the induction of phase II and antioxidant enzymes in prostate (cancer) cell 
lines, we further tested these effects in vivo in the LNCaP xenograft model. In this animal 
experiment, we compared the effects of standard broccoli (broccoli), Se-enriched broccoli 
(Se-enriched broccoli), Se-enriched broccoli extract (extract), Se-enriched broccoli puree 
(puree), and kale sprouts (sprouts) used as a commercially available control product with a 
high content in glucosinolates (detailed described in chapter 3.5.2).  
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Description of experimental broccoli food preparations 
Extract and puree were prepared from Se-enriched broccoli. The aim was to test these 
preparations as food supplement or functional food. Glucosinolate and total Se contents in the 
various broccoli preparations are summarized in Table 6. 
 
Table 6. Glucosinolate contents in broccoli preparations and kale sprouts 
 Broccoli Se-enriched 
broccoli 
Se-broccoli 
*
extract 
Se-
br
occ
oli 
*
p
ure
e 
Kale sprouts 
Glucosinolates /SFN (µmol/g DW) 
Glucoiberin 0.7 ± 0.02 1.1 ± 0.04 0 0.2 ± 0.0003 18.1 ± 0.4 
Progoitrin 0   0 0 0 9.8 ± 0.5 
Sinigrin 0  0 0 0 22.3 ± 0.9 
Glucoraphanin 5.3 ± 0.4 6.6 ± 0.08 0 2.1 ± 0.01 9.2 ± 0.5 
Glucoalyssin 0.1 ± 0.01 0.1 ± 0.01 0 0 0 
Gluconapsin 0  0 0 0 2.4 ± 0.1 
4OH-Glucobrassicin 0.2 ±0.02 0.1 ± 0.01 0 0 5.7 ± 0.6 
Glucoiberverin 0  0 0 0 7.0 ± 0.4 
Glucoerucin 0  0 0 0 2.5 ± 2.5 
Glucobrassicin 3.1 ± 0.03 3.6 ± 0.05 0 0.5 ± 0.002 0.7 ± 0.03 
4OCH3-Glucobrassicin 0.7 ± 0.01 0.6 ± 0.01 0 0.06 ± 0.0004 0 
Neo-Glucobrassicin 3.9 ± 0.04 6.7 ±0.1 0 1.3 ± 0.04 0 
SFN 3.2 ± 0.3 1.2 ± 0.03 2.5 ± 0.08 0.7 ± 0.01 1.3 ± 0.01 
SFN-nitrile 1.7 ± 0.01 1.0 ± 0.01 1.4 ± 0.06 0 0 
Indol-3-acetonitril 0 0 0 20.9 ± 0.71  
Total  18.7 ± 0.8 21.1 ± 0.3 3.9 ± 0.1 25. 7 ± 0.7 79 ± 5.9 
Total Se (µg/g DW) 0.1 ± 0.0 3.9 ± 1.4 4.4  2.6 ± 0.2 - 
Data indicate mean ± SD of three determinations 
*
Se-brocoli extract: Se-enriched broccoli extract, Se-broccoli puree: Se-enriched broccoli puree. 
 
Standard broccoli and Se-enriched broccoli contained similar total amounts of glucosinolates 
in the range of 20 mol/g DW. Also, the composition was relatively similar. The most 
prevalent glucosinolate in both standard broccoli and Se-enriched broccoli was glucoraphanin, 
which is the precursor of SFN. Neo-Glucobrassicin was detected at an about 1.7-fold higher 
level in the Se-enriched sample in comparison to standard broccoli. The extract was produced 
following a specialized protocol to convert glucoraphanin to free SFN, in contrast to the 
broccoli products which contained glucosinolates. Consequently, glucosinolates were no 
longer detectable in the final extract, which mainly contained free SFN and SFN-nitrile. 
Interestingly, the puree contained large quantities of indole-3-acetonitrile, whereas the levels 
of glucosinolates and SFN were reduced during production (Table 6). As described before, 
kale sprouts are very rich in glucosinolates, mainly glucoiberin and sinigrin. Kale sprouts also 
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contained active myrosinase, whereas we expected that myrosinase activity of broccoli and 
its preparation would be destroyed during blanching and sterilization.  
For the preparation of experimental diets for the animal experiment, freeze-dried broccoli, 
Se-enriched broccoli, puree and kale sprout powder was weighed, grinded, and mixed with 
powdered control diet in a 1:5 ratio. The extract was mixed with the control diet in a 1:10 
ratio. After addition of a defined amount of water, the diet preparations were compacted using 
a plastic syringe and the resulting pellets were dried at 37 °C over night. A control diet was 
prepared accordingly without addition of any broccoli source. 
 
Effect on xenograft growth 
Balb-c nude mice (n=10 per group) were inoculated with LNCaP cells mixed with matrigel in 
both flanks as described in Chapter 3.5.3. After randomization, feeding with broccoli diets 
started one day after the injection of LNCaP cells. After seven to eight weeks intervention 
with the experimental diets, LNCaP tumor xenografts were isolated, weighed and stored 
at -80 °C until further use.  
Unexpectedly, none of the preparations reduced xenograft growth (Fig. 12). In the 
intervention study testing broccoli and SE-enriched broccoli preparations, tumor weights 
were in the range 10 to 600 mg wet weight with an average of about 200 mg in all groups 
(Fig. 12 left panel). In the kale sprout experiment, tumor weights in both the control and the 
kale sprout group were higher, with an average tumor wet weight of about 500 mg (Fig. 12, 
right panel). Independent of the tumor size, which may be due to differences in cell 
proliferation rate in both experiments none of the interventions significantly reduced tumor 
growth.   
 
 
Fig. 12: Tumor weight. Wet weight of tumors were measured. Each point indicates a single tumor; Horizontal 
bars indicate the mean  standard error with n= 17-24. Control (●), broccoli (○), Se-enriched broccoli (▲), 
extract (▼), puree (♦), kale sprouts (△).  
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Induction of Phase II and antioxidant enzymes in tumor tissue 
To get an impression whether the interventions had any biological effect in the animal model, 
we analyzed the activity and expression of Phase II and antioxidant enzymes in tumor 
xenograft samples, in analogy with our in vitro investigations. Tumor samples (four per group) 
were homogenized, and homogenates were used to measure QR and TRx-R activities. Results 
are expressed relative to the activities of the control group and summarized in Table 7.  
None of the broccoli-based dietary interventions significantly induced QR or TRx-R 
enzymatic activity. Only intervention with kale sprouts resulted in a significant 2.2-fold 
induction of QR activity (p <0.05) in comparison to the control group. 
 
Table 7 Relative QR and Trx-R activities in LNCaP xenografts 
Group QR (fold ind.) Trx-R (fold ind.) 
Control
a
 1.0 ± 0.1
b 
1.0 ± 0.1 
Broccoli
 
1.0 ± 0.06 1.1 ± 0.2 
Se-enriched broccoli  1.2 ± 0.04 1.3 ± 0.2 
Se-enriched broccoli extract  1.1 ± 0.06 1.3 ± 0.2 
Se-enriched broccoli puree 1.0 ± 0.1 1.4 ± 0.1 
Kale sprouts 2.2 ± 0.3
 †
 1.2 ± 0.4 
a
 Data are mean ± SE of four xenografts 
b 
Enzyme activities in the control: QR, 42 ± 1.2 nmol/min/mg; Trx-R, 6.7 ± 0.6 nmol/min/mg. 
Statistical significance was tested by one way Anova with post-hoc multiple comparison test by Tukey. 
†
p<0.01 
vs. dietary control. 
 
We attributed this effect to the high content in glucosinolates, which was in total about 4-fold 
higher than that of the broccoli, Se-enriched broccoli and puree preparation, and to the fact 
that kale sprouts contain active myrosinase necessary for the conversion of glucosinolates to 
bioavailable ITCs. Although the extract contained free SFN, total levels of broccoli 
components were lowest in comparison to the other preparations, and the extract was even 
used at a lower ratio in the diet as the other broccoli preparations. We therefore concluded 
that levels of bioactive compounds were too low to cause significant induction of enzyme 
activities in xenograft samples.   
This was further confirmed when the effects of broccoli and Se-enriched broccoli on GPx-1 
expression in LNCaP xenograft were analyzed by Western blotting. Similar to the effects on 
QR and TRx-R activities, GPx-1 protein expression was not influenced by dietary 
intervention with these two diets in vivo in LNCaP xenograft samples (Fig. 13).  
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Fig. 13 GPx expression in LNCaP xenograft samples after intervention with dietary broccoli or Se-
enriched broccoli preparation. Results of 8 individual xenograft samples of the control, broccoli and Se-
enriched broccoli group are depicted. The numbers above the immuno-reactive bands represent fold changes of 
GPx-1 expression relative to the actin expression, quantified by Image J software. 
 
 
Determination of Phase I and Phase II metabolizing and antioxidant enzymes in murine liver 
Liver is the major organ of drug and xenobiotic metabolism. SFN and other ITCs have been 
shown to modulate the activities of hepatic enzymes of drug metabolism and antioxidant 
enzymes in vivo in many previous studies (24, 50). Therefore we further analyzed the effect 
of dietary broccoli and kale sprout interventions on mouse liver antioxidant enzymes. Livers 
were homogenized and fractionated by centrifugation in microsomal and cytosolic fractions, 
as described in Chapter 3.6.2. 
 
Table 8 Induction of Phase I and II enzymes and GSH in mouse liver 
Group 
Phase I Phase II  
Cyp1A1
b 
(fold ind.) 
Cyp2B1 
(fold ind.) 
QR 
(fold ind.) 
GST 
(fold ind.) 
Trx-R 
(fold ind.) 
GSH 
(fold ind.) 
Control
a
 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 
Broccoli 1.1 ± 0.1 0.8 ± 0.2 2.5 ± 0.2
†
 1.3 ± 0.2 1.3 ± 0.2
 
 0.8 ± 0.1 
Se-enriched 
broccoli 
1.1 ± 0.1 1.0 ± 0.2 3.1 ± 0.3
†
 1.5 ± 0.2
†
 1.7 ± 0.2
 †
 1.0 ± 0.1 
Extract 1.0 ± 0.1 0.8 ± 0.3 1.9 ± 0.3
†*
 1.1 ± 0.2 1.3 ± 0.1
 
 0.8 ± 0.2 
Puree 1.1 ± 0.1 0.7 ± 0.2 1.4 ± 0.3
*
 1.1 ± 0.2 1.2 ± 0.1
*
 1.0 ± 0.1 
Kale sprouts 0.9 ± 0.1 0.8 ± 0.1 5.9 ± 0.7
†
 2.2 ± 0.2
†
 1.5 ± 0.1
†*
 1.5 ± 0.1
†
 
a
 Data are mean ± SE of 8 animals per group 
b
 Enzyme activities in control groups (1. intervention study, 2. intervention study, mean ± SE): EROD: 32.1 ± 
2.3, 40.3 ± 5.1 pmol/min/mg; PROD: 9.1 ± 0.4, 6.2 ± 0.5 pmol/min/mg; QR: 101.4 ± 6.7, 119.6 ± 8.6 
nmol/min/mg; GST 830 ± 73, 677 ± 29 nmol/min/mg; TRx-R 16.1 ± 1.3, 14.0 ± 0.9 nmol/min/mg; GSH 53.1 ± 
3.9, 60.1 ± 3.2 nmol/min/mg.  
Group comparison was tested by Wilcoxon Rank sum-Test, significant under multiple comparisons by 
Bonferoni-Holm test 
†
p < 0.05 vs. dietary control, *p < 0.05 vs. Se-enriched broccoli. 
 
As representatives of phase I drug metabolizing enzymes, enzyme activities of Cyp1A1 and 
Cyp2B1 were analyzed in microsomal fractions by the EROD and PROD activity assay. The 
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results are summarized in Table 8. None of the dietary interventions significantly inhibited or 
induced these activities in liver microsomes in comparison to the control group.  
We further investigated the effect of the dietary intervention on QR, GST, and TRx-R 
activities in cytosolic fractions, as well as on GSH levels. As indicated in Table 8, 
intervention with broccoli, Se-enriched broccoli, extract and kale sprouts significantly 
induced QR activities in the cytosolic fraction of liver tissue by 1.9- to 5.9-fold (p<0.01, 
Wilcoxon Rank sum-Test). Inducing potential of QR activity in the liver was correlated with 
glucoraphanin content and total glucosinolates contents of each dietary preparation in the 
order of kale sprouts > Se-enriched broccoli > standard broccoli > Se-enriched broccoli 
extract. Although the extract and puree were made from Se-enriched broccoli, potential to 
induce QR activity was significantly lower than that of Se-enriched broccoli. This indicates 
again that the processes to produce extract and puree reduces important glucosinolates or 
ITCs, respectively, with potential to induce QR activity.  
GST, another phase II enzyme regulated by transcription factors Nrf-2, was less efficiently 
induced by the broccoli preparations. Only interventions with Se-enriched broccoli and kale 
sprouts resulted in a significant induction of GST enzyme activity  in the liver cytosolic 
fraction (p<0.05, Wilcoxon Rank sum-test).  
The antioxidant enzyme TRx-R is regulated by Nrf-2 and Se-dependant. Again, only 
intervention with Se-enriched broccoli and kale sprouts significantly induced hepatic TRx-R 
activity by 1.7- and 1.5-fold. Although kale sprouts contained higher glucosinolate levels than 
Se-enriched broccoli, potential to induce TRx-R of Se-enriched broccoli was higher than that 
of the kale sprout intervention (Table 8). Also, TRx-R activity was higher in the dietary Se-
enriched broccoli group than in the standard broccoli group. These data further confirm that 
Se contributes to the induction of TRx-R activity.  
Similar to the activities of QR, GST and TRx-R, levels of the important intracellular 
antioxidant GSH are regulated in a Nrf-2 dependent manner. However, of all factors analyzed, 
the effect on GSH synthesis was weakest by all interventions. Only kale sprout intervention 
resulted in a significant 1.5-fold induction.  
While we could detect elevated TRx-R activity by Se-enriched broccoli, protein expression of 
the other selenium-dependant antioxidant enzymes GPx -1 and -4 was not influenced by 
dietary Se-enriched broccoli (Fig. 14). 
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Fig. 14: Effects of dietary broccoli and Se- enriched broccoli on GPx expression in mouse liver. Animals 
were fed with dietary broccoli and Se-enriched broccoli for 8 week (details were described in Materials and 
Methods). After sacrifice, livers (n=8) were homogenized. Liver cytosolic fractions were used to detect GPx 
protein expression by Western blotting. Four samples per group were directly compared on one gel. 
Representative Western blot images of GPx-1 and GPx-4 were normalized to actin expression. The numbers 
above the immuno-reactive bands represent fold changes of GPX-1 and -4 expression relative to the actin 
expression, quantified by Image J software. 
 
 
4.1.5 Sulforaphane metabolites in mouse plasma, urine and feces after the 
interventions. 
 
To identify and quantify the major glucosinolate metabolites as suitable biomarkers of 
broccoli intake and to find a correlation with antioxidant enzymes activity, we measured 
sulforaphane metabolites in mouse plasma, urine and feces obtained from our dietary 
intervention study with broccoli preparations and kale sprouts. After release of ITCs from 
glucosinolates by plant myrosinase or myrosinase activity of the gut microflora, they are 
absorbed and conjugated by GST activity with GSH or proteins bearing free sulfur groups. 
ITC-GSH conjugates are further processed via the mercapturic acid pathway, resulting 
in -cysteine-glycine (-Cys-Gly), -cysteine (-Cys), and -N-acetyl cysteine (NAC) conjugates as 
intermediates (164). We analyzed free SFN, SFN-GSH, SFN-Cys-Gly, SFN-Cys, and SFN-
NAC by HPLC coupled with mass spectrometry, as described in Chapter 3.6.4. 
As summarized in Table 9, plasma concentrations of free sulforaphane and sulforaphane 
metabolites in the control group were below 1 nmol/L or below the detection range. Levels of 
free SFN were elevated in all plasma samples of dietary broccoli and kale sprouts 
intervention groups, with the exception of the extract group. Among the sulforaphane 
metabolites, SFN-NAC was the most abundant metabolite circulating in the plasma after 
intervention with the broccoli preparations (about 70% of the total amount of free SFN and 
all metabolites), followed by free SFN (about 20%), SFN-Cys-Gly, SFN-GSH and SFN-Csy. 
One exception was the relatively high level of SFN-Cys-Gly in plasma from mice that were 
fed with the Se-enriched broccoli extract. As mentioned above, this extract contains free STN 
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and SFN-nitrile. Therefore uptake, metabolism and excretion might follow a different kinetic 
that that of the other broccoli preparations.  
 
Table 9 Sulforaphane metabolites in mouse plasma, urine and feces 
 SFN SFN-NAC SFN-Cys-Gly SFN-Cys SFN-GSH 
Plasma concentration [nmol/L] 
Control 0.6 ± 0.3 0.6 ± 0.3 n.d. 0.2 ± 0.2 n.d. 
Broccoli
 
54 ± 4.7
†
 208 ± 28
†
 16 ± 4.9
†
 1.7 ± 0.4
†
 4.1 ± 0.9
†
 
Se-enriched  
broccoli 
43 ± 7.4
†
 164 ± 42
†
 11 ± 2.6
†§
 0.9 ± 0.3 2.9 ± 0.9
†
 
Extract
a 
23 ± 3.5 63 ± 16 46 ± 20
†
 5.3 ± 2.9 5.1 ± 1.4
†
 
Puree 35 ± 7.0
†
 88 ± 17
†
 9.9 ± 3.1
†
 1.3 ± 0.6
†
 3.5 ± 0.8
†
 
Kale sprouts 55 ± 16
†
 116 ± 32
†
 1.1 ± 0.3 3.9 ± 2.3 5.0 ± 2.4 
Urine concentration [nmol/µmol creatinine] 
Control 0.1 ± 0.01 0.04± 0.03 0.01 ± 0.01  0.04 ± 0.02 n.d. 
Broccoli 15.6 ± 8.9 57 ± 9.2 0.1 ± 0.04 0.8 ± 0.4 0.03 ± 0.03 
Se-enriched 
broccoli 
15.3± 3.0
†
 73 ± 21
†
 0.2 ± 0.1 1.2 ± 0.8 n.d.  
Extract 6.8 ± 2.0 23 ± 0.5 0.1 ± 0.1 0.3 ± 0.2 n.d 
Puree 6.4 ± 1.5 51 ± 6.3 0.1 ± 0.1 0.4 ± 0.1 n.d. 
Kale sprouts 1.5 11 0.02 0.8 n.d. 
Feces concentration [nmol/g dry weight] 
Control n.d. n.d. n.d. n.d. n.d. 
Broccoli 4.3 ± 0.6
†
 1.1 ± 0.3
†
 0.7 ± 0.05
†
 0.4 ± 0.04
†
 n.d. 
Se-enriched  
broccoli 
5.6 ± 0.8
†
 0.8 ± 0.1 0.9 ± 0.2 0.4 ± 0.01
†
 n.d. 
Extract 3.4 ± 0.5
†*
 1.1 ± 0.4 0.6 ± 0.2 0.4 ± 0.05
†
 n.d. 
Puree 5.3 ± 0.4
†
 2.4 ± 1.8
†
 0.6 ± 0.07
†
 0.6 ± 0.04
†*
 n.d. 
Kale sprouts 1.9 2.6 n.d. 0.4 n.d. 
n.d. not detectable
  
a
 Extract: Se-enriched broccoli extract, Puree: Se-enriched broccoli puree. 
Data indicate mean ± SE,
 †
p<0.05 vs. dietary control, 
§
p<0.05 vs. Br, *p<0.05 vs. Se-enriched broccoli. 
Statistical significance was tested by one way Anova followed by Tukey post-hoc multiple comparison test.  
 
Overall, plasma concentrations of SFN and metabolites correlated with the concentrations of 
glucoraphanin and free SFN in the broccoli preparations. Those broccoli products which 
contained higher concentrations resulted in higher plasma levels of SFN and metabolites 
(broccoli > Se-enriched broccoli > extract > puree).  
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In urine samples, the major SFN-metabolite was also SFN-NAC in all intervention groups 
(about 80% of the total amount of free SFN and metabolites in urine). Similar to plasma SFN 
metabolites, about 15% of free SFN was detected as the second leading SFN metabolite in the 
urine samples. The other three metabolites were detectable only at very low concentrations  
1 nmol/µmol creatinine. In comparison to the dietary glucosinolate uptake provided by 
broccoli preparations and kale sprouts, dietary excretion of SFN and metabolites was lower in 
the kale sprout group than in the broccoli intervention groups.   
Different from plasma and urine samples, free SFN was the major form of SFN metabolites 
in feces samples. There were no significant differences in fecal levels of SFN metabolites 
between the dietary intervention groups, despite differences in uptake.  
Since induction of antioxidant and phase II enzymes can be affected by additional 
components of the broccoli preparations except glucoraphanin/SFN, it is statistically not 
‗correct‘ to calculate a correlation between SFN metabolites in the plasma samples and 
enzyme activities in liver samples after intervention. However, when comparing individual 
animals, we could still observe a linear trend of free SFN concentrations in mouse plasma and 
hepatic QR enzyme activities by using the Jump®  statistical calculation software.   
 
4.1.6 Summary  
 
The present study aimed to investigate the effects of Se-enriched broccoli preparations in 
prostate cancer prevention in vitro and in vivo. These studies were based on earlier reports on 
the anti-prostate cancer properties of selenium and broccoli as chemopreventive agents. We 
first tested the combination effects of Se and broccoli components at various concentrations 
in vitro in prostate (cancer) cell lines on the activities of antioxidant and detoxifying enzymes. 
In continuation, we analyzed broccoli sprouts cultivated in selenium-containing medium as 
well as broccoli florets Se-enriched by leaf fertilization to optimize the conditions of Se-
enrichment in broccoli. As expected, broccoli extract induced phase II detoxifying enzymes, 
such as QR activity, whereas Se-dependent antioxidant enzymes, such as TRx-R and GPx,  
were increased by treatment with Se in a dose-dependent manner. Interestingly, co-treatment 
of broccoli and selenium showed a competitive effect to induced QR activity. We found that 
Se-enriched broccoli florets increased both Nrf-2 dependent phase II enzymes and Se-
containing antioxidant enzymes in vitro. Furthermore, Se-enriched broccoli and preparations 
of it were tested in a mouse LNCaP xenograft study. After 8 weeks of dietary Se-enriched 
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broccoli intervention at a dose of 20% in the diet, none of the preparations had an effect on 
xenograft growth as well as phase II and anti-oxidant enzymes activities in LNCaP xenograft 
samples. However, they induced hepatic phase II metabolic enzyme activities such as QR, 
TRx-R, and GST. Although selenium concentration in the Se-enriched broccoli was elevated 
enough to induced Se-dependant antioxidant enzymes in vitro, Se-enriched broccoli did not 
induced GPx expression in xenograft or liver samples.   
To compare the different preparations in terms of bioavailability, SFN as the major ITC of 
broccoli and its metabolites were measured in mouse plasma, urine and feces samples after 
intervention for 7-8 weeks. The major form of SFN metabolites in the plasma and urine 
samples was SFN-NAC, which showed a linear correlation with the glucoraphanin content in 
the different broccoli preparations, as well as with QR enzyme induction in the liver. In 
summary, although selenium fertilization increased selenium contents in the broccoli 
preparations, these elevated levels did not induce antioxidant enzymes above control levels in 
mouse xenografts. 
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4.2 Anti-angiogenic potential of kale sprouts 
 
Angiogenesis (formation of new blood vessels) is implicated in cancer including prostate 
cancer. It permits the growth and invasiveness of cancer cells leading to metastasis to distant 
organs (165). Evidence is accumulating to indicate that ITCs potently inhibit tumor 
angiogenesis in in vitro models. In this second part of the thesis, we aimed to test the anti-
angiogenic potential of glucosinolate-rich kale sprouts as dietary compound in the LNCaP 
xenograft model and to further evaluate detailed underlying mechanisms. 
 
4.2.1 Influence on tumor growth, necrosis and hemorrhage 
 
In the present study, dietary intervention with kale sprouts (20% in the diet) was started one 
week before tumor injection in both sides of the flank of mal nude Balb/c mice (n=10-12). 
During the duration of the study we monitored tumor growth two times per week for 6.5 
weeks by measuring tumor dimensions using a Vernier caliper. Tumor size was then 
calculated using the following formula: 4.16 x a
2 
x b (a length < b width), as described in 
Chapter 3.5.3.  
As a first results of this study, we observed that dietary intervention with glucosinolate-rich 
kale sprouts did not inhibit tumor growth in LNCaP xenograft model (Fig. 15) (compare 
Chapter 4.1.4). 
 
 
Fig. 15: Influence of kale sprouts on LNCaP xenograft growth. Average tumor size  SE (n=20-24) in 
dietary kale sprouts (△) and control (●) group is indicated in the left panel. Tumor weights in dietary kale 
sprouts (△) and control (●) groups are indicated in the right panel.  
 
Cell growth is controlled by cell proliferation and cell death. To further analyze cell 
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proliferation in tumor xenografts, slices of paraffin-embedded tumor tissue were 
immunohistochemically stained to detect levels of proliferating cell nuclear antigen (PCNA), 
a maker of proliferating cells. To detect cells undergoing apoptosis, we analyzed cleaved 
PARP levels (cPARP) as a marker of caspase activation. As indicated in Fig. 16A, we did not 
observe any difference in PCNA staining in the tumor xenografts of both groups when PCNA 
positive cells were quantified by cell counting in tumor sections. Western blot analysis of 
PCNA protein expression confirmed the staining results of PCNA (Fig. 16B).  
 
 
Fig. 16: Kale sprouts has no effect on cell proliferation and apoptosis in LNCaP xenograft model A, PCNA 
expression in representative LNCaP xenograft sections of control and kale sprout intervention groups 
(magnification, 100x). The bar graph represents quantitative analysis of PCNA expression. Columns; mean 
(n=8), bars; SD. B, Western blotting of PCNA protein expression in LNCaP xenografts of control and kale 
sprouts intervention groups. The relative band intensity was normalized to -actin levels and is indicated above 
the immuno-reactive bands. C, IHC of cleaved PARP in paraffin-embedded LNCaP xenograft of control and 
kale sprout intervention groups. Columns; mean (n=8), bars; SD 
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As indicated in Fig. 16C, the percentage of cells undergoing apoptosis was very low, with an 
apoptotic index of about 1 in both intervention groups. We did not detect an increase in 
cleaved PARP staining in the kale sprout group. From this data we conclude that tumors of 
both groups have a high proliferation rate and low rate of apoptosis. 
Further evaluation of the tumor tissue included histolopathological analyses of H&E stained 
tumor sections by a trained pathologist. A quantitative summary of histological features is 
given in Table 10.  
 
Table 10. Main histological features kale sprout intervention group vs. control tumors 
 Sample Necrosis * 
(in %) 
Stroma  
(in %) 
Inflammation
a
 Hemorrhage
a 
* 
control tumors 
1L 45 5 1 1 
2R 50 5 1 2 
3L 55 5 1.5 2 
5L 50 15 2 2 
6R 47.5 3 1.5 2 
8L 40 12.5 1.5 2 
11L 35 10 1.25 2 
12L 40 15 1 2 
kale sprout 
1R 15 5 1 0 
2L 5 1 2 0 
3L 10 5  1 0 
4L 10 10 1 0 
4R 5 15 1 1 
5L 10 10 1 0 
6L 10 5 1.5 0 
7R 15 5 1 1 
a
: 0 = none; 1 = low; 2 = high 
*: Indicated significant difference between the groups. p < 0.0001, Student`t test , analysed by sigma plot 
version 10.  
 
Interestingly, control tumors showed a high percentage of necrosis in 35 to 55% of the tumor 
mass (median 46.25%, mean  SE: 45  2%) and (moderate to) severe hemorrhage in all 
samples (compare Fig. 17). Mild inflammation was also present. In contrast, tumors of the 
kale sprout-treated group showed significantly less necrotic areas (5 to 15 % of tumor mass; 
median 10%, mean 10% ± 1%, p< 0.0001, Student‘s t-test with n=8, in comparison to the 
control group) and almost no detectable hemorrhage (Table 10). Control tumor cells were less 
differentiated with highly pleomorphic nuclei and abnormal nucleus-plasma-relation, and 
displayed several mitotic figures and unsharply demarcated borders to the surrounding non-
tumorous tissue, representing a highly invasive tumor phenotype (Fig. 17). In contrast, 
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tumors of the kale sprout group were demarcated more sharply with a thin, partial fibrous 
capsule in some cases. Nevertheless, the tumor cells themselves presented much more 
homogenously with only slight pleomorphic nuclei.  
 
 
Fig. 17: Dietary kale sprout intervention inhibits tumor necrosis and hemorrhage. H&E staining of  
LNCaP xenografts of both dietary control and kale sprouts groups. Necrotic areas are indicate by asterisks in the 
upper panel. Arrows indicated hemorrhagic areas in the lower panel (magnification, 100x) 
 
 
Taken together, 
o
ne of the most significant effects of kale sprout intervention was to prevent 
hemorrhage in LNCaP xenografts and consequently to prevent tumor necrosis.  
Hemorrhage is known to be caused by defective angiogenesis, while inhibition of 
angiogenesis reduces hemorrhage (166). Since LNCaP cells are of human origin, whereas the 
host, and consequently any new blood vessels, lymph vessels or inflammatory cells near 
necrotic areas, is of mouse origin, we next stained mouse tissue with mouse IgG to detect any 
cells invading the tumor tissue. As shown in Fig. 18A and quantified by the pathologist, the 
area of mouse invading tissue in tumor sections was 23 ± 1 % in control tumors and 
significantly reduced to 4 ± 0.2 % (p < 0.01, tested by Student‘s t-test) in tumors of kale 
sprout group.  
These results were confirmed by an additional method. We measured mRNA expression 
levels of mouse housekeeping genes and normalized them with human housekeeping genes. 
As can be seen in Fig. 18B, the relative expressions of mouse GAPDH and HPRT-1 were 3.8 
and 4-fold lower in the kale sprout intervention group compared with the control group (p < 
0.01, Student‘s t-test with n=7). 
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Fig. 18: Dietary kale sprout intervention inhibits invasion of mouse host cells into the human LNCaP 
tumor xenograft. A, Immuno-histochemistry (IHC) staining of mouse IgG in human LNCaP xenograft of 
control and kale sprout intervention groups (magnification, 100x). B, Relative mRNA expression of mouse 
housekeeping genes, GAPDH and HPRT-1 of control and kale sprouts group (n=7). Data are means ± SD, **p< 
0.01 tested by Student‘s t-test from sigma plot software version 10. 
 
To sum up, dietary kale sprout intervention had no direct influence on the tumor growth, but 
the tumors demonstrated dramatically reduced hemorrhage and necrosis, and fewer invasions 
of murine cell types.         
 
 
4.2.2 Induction of vascular maturation  
 
Macroscopic comparison of the tumors indicated striking differences between the two groups: 
Tumors of the control groups showed a blood-red color, whereas tumors of the kale sprout 
group tumors were pale (Fig. 19, left panel). We thus measured the hemoglobin content in the 
xenografts and found a significantly lower Hb level in the kale sprout intervention group 
(mean ± SE: 5.5 ± 2.3 g/mg) in comparison with the control group (32.7 ± 3.7 g/mg, 
p<0.01, Student’s t-test with n=8).   
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Fig. 19: Kale sprouts intervention reduces hemoglobin content in tumors. Total hemoglobin concentration 
in the tumor xenograft was measured in tumor homogenates. (●) hemoglobin content in a single tumor of 
control group, (△) hemoglobin level in a single tumor of dietary kale sprouts. Horizontal lines indicate mean 
values from eight tumors; bars, SE. ** p<0.01, Student‘s t-test. 
 
 
The tumor vasculature often contains non-functional and not properly covered, immature and 
leaky blood vessels (124). To address the question whether the massive hemorrhage and 
increased murine cell infiltrations in the control group were due to uncontrolled angiogenesis, 
we investigated the blood vessel density by staining of the blood vessel marker, CD31 (green). 
Unexpectedly, the vessel density was not different between the groups (Fig. 20A). However, 
when we co-stained CD31 with smooth muscle actinSMA, red), which is an early 
pericyte marker (167), we found significantly more covered vessels (86 ± 1.2%) in the kale 
sprout group compared to the control group (65 ± 3.2%, p<0.001 Student‘s t-test with n=10) 
(Fig. 20B). To confirm the result, we additionally performed a co-staining of CD31 (green) 
and desmin (red), which is an another marker for pericytes when the vessels are more in a 
more mature state (167). The quantification of the desmin positively covered vessels 
yielded an even more significant difference between the two groups with a higher number of 
covered vessels (96 ± 2.8%) when the mice received kale sprout (Fig. 20C) compared with 
control diet group (64 ± 2.9%; p<0.01, Student‘s t-test with n=5). These findings strongly 
suggest that kale sprout diet promotes vessel normalization. Since tumor vessel density was 
not different between the control and the kale sprout group but the vessel coverage was 
higher in the kale sprout intervention group, the huge amount of hemoglobin in the control 
tumors is probably resulting from hemorrhagic vessels.  
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Fig. 20: Dietary kale sprouts induce vascular maturation by coverage of mural cells. A, Total micro vessel 
density was measured by immunohistochemistry. CD31 (green) antibody was used to stain two sections per 
tumor sample in five tumors of each group. CD31 positive endothelial cells were counted by image J, total 
number of vessels were normalized to the area of the photograf (left), each point means ‗number of vessels/ area‘ 
in each section of tumors. Mean values are presented with horizontal lines, bar means SE. B,C SMA or 
Desmin positive cells (indicative of early and mature pericytes, respectively) were counted and the percent of 
covered vessels of total vessel were computed. Mean values are indicated by horizontal lines, bar: SEM. **, 
***p<0.01, 0.001, Student‘s t-test. 
 
 
4.2.3 Inhibition of pro-angiogenic factors and induction of anti-angiogenic 
factors 
 
In the next set of experiments we addressed the question how kale sprout intervention could 
induce vessel maturation and prevent hemorrhage. According to a previous report of Jain et al, 
who described that anti-angiogenic therapy can normalize the tumor vasculature by pruning 
the immature and inefficient vessels and remodel the remaining ones (166), we measured pro- 
RESULTS 
82 
 
and anti-angiogenic factors to check weather kale sprout feeding had a similar effect. A well-
known target of anti-angiogenic therapy, vascular endothelial growth factor (VEGF), was not 
altered upon kale sprout diet (Fig. 21).  
 
Fig. 21: Kale sprout intervention does not inhibit VEGF protein expression. Western blot evaluation of 
VEGF protein expression in LNCaP xenograft. Total cell lysates of seven tumors of the control and kale sprout 
group were used. Numbers indicated band intensity normalized to -actin levels. 
 
However, other growth factors like placenta growth factor (PlGF) and fibroblast growth 
factor  (FGF) demonstrated reduced mRNA levels by kale sprout intervention (Fig. 22A). 
We determined a significant 50% reduction of human PlGF mRNA expression, 60% 
reduction in mouse PlGF mRNA expression and a 75% reduction in mouse FGF by kale 
sprout intervention in comparison to the control group (*,**p< 0.05, 0.01; Student‘s t- test 
with n=7).  
 
 
Fig. 22: The effects of kale sprout intervention on pro-angiogenic factors. Relative mRNA expression of 
human (h) and mouse (m) pro-angiogenic factors (A) and pro-invasive factors (B) were quantified by real-time 
PCR. Gene expression was normalize to human human - actin as a housekeeping gene. Columns, mean: bars, 
SD, *,**p<0.05, 0.01, Student‘s t-test with n=7). 
 
Similar with our findings a previous study by Fischer and colleagues demonstrated that anti-
VEGF treatment reduced vessel density, whereas anti-PlGF therapy promotes vascular 
normalization rather than reducing vessel density (168). Among the tested pro-angiogenic 
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factors, mFGFb was the most significantly down regulated by kale sprout diet (Fig. 22A), 
which is not produced from LNCaP cells (169). One of the most prominent sources of FGF 
are myofibroblasts. Thus, the reduced mFGFb mRNA levels possibly result from a reduced or 
prevented fibroblast activation or infiltration to the xenografts by in the kale sprout 
intervention (Fig. 18B).  
Next, we analysed mRNA expression levels of factors promoting invarsion. Both mouse and 
human MMP2 mRNA expression was significantly inhibited by 50% and 40% by kale sprout 
intervention (**p<0.01, Student‘s t-test with n=7) (Fig. 22B). In addition to MMP2, 
expression of human urokinase plasminogen activator (uPA), a serine protease, was 
significantly down-regulated by kale sprouts by 30% (*p<0.05, Student‘s t-test with n=7) . 
However, MMP-9 mRNA level was not changed between the two groups. To check the MMP 
enzyme activity, we performed a gelatin zymography. The amount of catalytically active 
MMP2 and MMP9 was strongly reduced in the kale sprout group (Fig. 23).  
 
Fig. 23: Enzyme activity of MMP-2 and MMP-9 in tumor cell lysate. The digested band indicating MMP2 
and MMP9 enzyme activity was measured by using gelatin zymography. 
 
After checking pro-angiogenic factors, we further investigated the effect of kale sprout 
intervention on the anti-angiogenic factor angiostatin. The angiostatin protein level, as shown 
by immunoblotting, was significantly higher in the kale sprout intervention group than in 
tumors of the control group (Fig. 24). The average of relative band intensity in tumors of the 
kale sprout group was 2-fold higher than that of control tumors (p<0.05).  
 
 
Fig. 24: Induction of angiostatin by kale sprouts intervention. Protein expression of angiostatin was analysed 
by western blot and normalized by -actin expression in total tumor cell lysates.  
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Taken together, regarding the molecular targets of kale sprouts to promote vascular 
normalization, we found that mRNA expression of mouse FGF and PlGF was inhibited 
rather than VEGF expression. Furthermore kale sprouts induced an anti-angiogenic factor, 
angiostatin. Antiostatin has been investigated as a cleaveage product of plasminogen by PSA 
(170). Therefore we further tested PSA secretion. 
 
 
4.2.4 Influence of kale sprouts on PSA secretion and AR expression  
 
PSA is not only a proliferation marker of hormone-responsive prostate cancer cells such as 
LNCaP cells, but also a proteinase, which targets plasminogen with angiostatin as a 
byproduct (170). Since angiostatin levels were elevated in tumors of the kale sprout group, 
we next tested whether this was related to altered PSA levels. As shown in Fig. 25, dietary 
kale sprout intervention resulted in significantly 6.5-fold elevated PSA mRNA levels in tumor 
tissue and 2.2-fold higher PSA protein secretion in mouse serum (p<0.01 and p<0.05 tested 
by Student‘s t-test (Fig. 25A) .  
 
 
Fig. 25: PSA mRNA and protein levels (A) in relation to tumor weights (B). (A) Relative PSA mRNA and 
protein levels in tumor material of each group were analyzed by real-time RT-PCR and ELISA (n=7). Means ± 
SD, **p < 0.01 (Student‘s t-test). (B), Linear correlation of secreted PSA levels in mouse serum and the sum of 
tumor weights per mouse. () kale sprouts group, () control group; r2; squared correlation coefficient.  
 
 
PSA is produced and secreted from LNCaP tumor cells in the xenografts and has therefore 
been used as a marker of tumor proliferation (171). We found that the serum PSA 
concentration correlated very well with tumor weights in both the control and the kale sprout 
group (r
2
=0.83-0.89) (Fig. 25B). Interestingly, the slope of the kale sprout group was 2.2-fold 
r
2
= 0.83 
r
2
= 0.89 
** 
** 
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higher than that of control group (Fig. 25B). This indicated that, although the tumor sizes 
were not different, the tumors of the kale sprout group produced more PSA than control 
tumors. To understand the mechanisms how kale sprouts induced PSA, we focused on AR 
signaling because the androgen receptor (AR) is a key transcription factor to induced PSA 
(12).  
Thus, we next analyzed the AR protein levels in the two groups by immunoblotting and 
immunostaining.  
Fig. 26: Kale sprout intervention prevents down-regulation of AR protein expression and binding to PSA 
promoter. A, Western blotting of AR protein expression (upper panel) of seven tumors in each group. Numbers 
indicated band intensity normalized to -actin expression. AR protein was stained by IHC (lower panel). Ten 
sections of each tumor were stained and positive cells per area was counted. B, Androgen receptor occupancy 
(using AR antibody) of the androgen response element (ARE) in the PSA enhancer and promoter area was 
examined by ChIP analyses in four tumors of each group. Input values were obtained from samples treated in 
the same way as the experimental ones, except immunoprecipitation steps. *p<0.05, Student‘s t-test. 
 
 
RESULTS 
86 
 
By Western blotting of tumor lysates of both intervention groups, we found significantly 
higher levels of AR protein expression in the tumors of mice fed with kale sprouts, compared 
to the control group (p < 0.001, Mann-Whitney Rank Sum test). The mean  SE of relative 
band intensities of control vs. kale sprout group is 1.0 ± 0.1, 1.9 ± 0.2). 
To proof a direct interaction of AR with the promoter and enhancer sequences of PSA, we 
conducted a ChIP assay. There we could demonstrate that the binding affinity of AR to the 
enhancer area of PSA was significantly 3-fold elevated in tumors of the kale sprout group 
compared to the control group tumors (*p < 0.05, Student‘s t-test with n=4) (Fig. 26B). 
One possible explanation of these findings was that kale sprout intervention might induce 
androgen receptor protein expression in the LNCaP xenografts. However, when we treated 
LNCaP cells in vitro with kale sprout extract at different doses and different time points we 
could neither observe any induction of the androgen receptor, nor increased PSA secretion 
(data not shown).  
Gastric condensation products of indole-based glucosinolate-derived compounds such as I3C 
have been reported to modulate the metabolism of estrogen by inducing phase I metabolizing 
enzymes (172). Since similar mechanisms might be involved in our observations, we 
performed an in vitro digestion experiment with kale sprouts. 
 
 
Fig. 27: In-vitro digestion of kale sprouts. Kale sprouts or vehicle (PBS) were homogenized in PBS by using a 
dismembrator at 3000 rpm for 2 x 30 sec. By adding HCl, the pH was adjusted to 2, and pepsin was added.   
After 1 hr incubation at 37°C, NaHCO3 and bovine pancreatic–bile extract was added. After 2 hr incubation at  
37°C, extract or vehicle was filtered. 
 
 
To mimic the in vivo situation including gastric and intestinal digestion of kale sprouts more 
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closely in our in vitro experiment, we performed an in vitro digestion with the kale sprouts 
(scheme in Fig. 27). Kale sprouts were first homogenized in PBS by using a dismembrator to 
mimic chewing and to activate myrosinase. Next, by adjusting the pH to 2 and addition of 
pepsin, gastric conditions were mimicked. After 1 hr incubation at 37 °C, NaHCO3 and 
bovine pancreatic–bile extract was added to mimic intestinal conditions. After 2 hr incubation 
at 37 °C, extract or vehicle was filtered. LNCaP cells were treated with both ‗non-digested‘ 
and ‗digested‘ kale sprouts for 24 hr in a concentration range of 0 – 200 µg/ml. However, 
even under these more ‗in vivo‘ adjusted incubation conditions, AR expression in the total 
cell lysate as well as PSA secretion in the conditioned media were not induced by kale 
sprouts treatment (Fig. 28 A, B) 
 
 
Fig. 28: Kale sprouts do not induced androgen receptor protein expression and PSA secretion in LNCaP 
cells in vitro. A, Androgen receptor protein expression analyzed by Western blotting. Numbers above  
immunoreactive bands indicate band intensity normalized to -actin. LNCaP cells were treated with native or in 
vitro digested kale sprout extracts for 24 hrs at the indicated concentration. For the vehicle control, cells were 
treated with PBS or digested PBS for 24 hrs. B, Secreted PSA concentrations in conditioned media after 
treatment of with native or digested kale sprouts extract. 
 
 
As a last test to explain elevated AR levels, we treated LNCaP cells with mouse serum, which 
was obtained from mice receiving kale sprouts diet. Again, the AR protein expression was not 
changed compared to treatment with control serum (data not shown). We conclude from these 
experiments that kale sprout did not directly induce AR signaling, although higher AR levels 
were detectable in tumors of the kale sprout group, which correlated with the higher PSA 
levels.  
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4.2.5 Expression of AR mediated by TNF 
 
Since neither native nor digested kale sprouts as well as mouse serum which was obtained 
from the in vivo kale sprout intervention study did not induce AR protein expression in 
LNCaP cells in vitro, we hypothesized that kale sprout intervention may alternatively block  
down-regulation of AR expression in control tumors.  
Mizokami et al. reported previously that TNFtreatment down-regulates AR protein 
expression in LNCaP cells (173). When repeating these experiments, we could indeed 
confirm that LNCaP cells showed reduced AR protein expression upon TNF stimulation in a 
dose- and time-dependent manner (Fig. 29).  
 
Fig. 29: TNF treatment down-regulates androgen receptor protein expression. Immunoblotting of AR 
protein expression after treatment with TNF at the indicated doses and times in LNCaP cells in vitro. 
 
 
Therefore we hypothesized that kale sprouts intervention blocks TNF expression as a 
potential mechanisms to inhibit AR protein expression. To check whether dietary kale sprout 
had an influence on the TNF protein levels, we analyzed the protein expression of this 
cytokine in LNCaP tumor xenograft by western blot analysis. Interestingly, TNF expression 
was completely blocked by kale sprout intervention in the tumors (Fig. 30A). Moreover, 
murine TNF mRNA levels were significantly inhibited in tumors of the kale sprout fed 
animals (3.7-fold reduction, p<0.05, Student‘s t–test with n=7), whereas human TNF 
mRNA levels were not affected (Fig. 30B). 
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Fig. 30: Kale sprouts block TNF protein and mRNA expression. A, Immunoblotting of TNF protein 
expression using total cell lysates from seven tumors of the control and kale sprout intervention group. B, 
Relative mRNA expression of human and mouse TNF was analyzed by quantitative RT-PCR. Means  SD, 
*p<0.05, Student‘s t–test with n=7. 
 
 
Heiss and colleagues described earlier that SFN inhibits LPS-induced TNF secretion in 
mouse macrophages (49). Kale sprouts contain relatively high amount of glucoraphanin, the 
precursor of SFN, and structurally related glucosinolates, which maybe inhibit TNF 
secretion in the LNCaP xenograft. Therefore we next tested whether TNF mediated down-
regulation of AR expression is prevented by kale sprouts. Treatment of LNCaP cells with 5 
nM TNF for 24 hrs reduced AR protein expression by 40%. This down-regulation was 
blocked by co-treatment with kale sprout (Fig. 31A). Furthermore, the significant reduction 
in PSA secretion by LNCaP cells upon stimulation with 5 nM TNF for 36 hrs was potently 
inhibited by co-treatment with kale sprouts in a dose dependent manner (Fig. 31B).  
 
 
 
Fig. 31: Kale sprouts prevent TNFmediated AR down-regulation in LNCaP cells. A, AR protein 
expression. Cells were treated with TNF alone or co-treated with kale sprout (KS) extract at the indicated 
concentrations. After 24 hrs incubation total protein was harvested and AR protein expression was measured by 
Western blotting. Numbers above the immuno-reactive bands indicate expression intensity of AR normalized to 
-actin levels. B, Secreted PSA in conditioned media after treatment of TNF alone or in combination with kale 
sprouts. Columns, mean; bars, SD, **,***p<0.01, 0.001 analyzed by AVOVA with Tukey post-hoc test for 
multiple comparisons. 
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Finally, we were curious whether we could link the elevated PSA levels in the kale sprout 
group in the in vivo xenograft model to the induction of angiostasis. Therefore, we correlated 
the PSA levels with the hemoglobin concentration which stands for angiostasis in both groups. 
Interestingly, we observed an inverse correlation both between PSA mRNA levels and 
secreted PSA with the Hb concentration (r
2
= 0.75 and r
2
= 0.62) (Fig. 32). 
Fig. 32: Inverse correlation between Hb concentration and PSA in LNCaP xenograft model. (A) PSA 
relative mRNA expression and Hb concentration of each tumor of the control and kale sprout group was 
correlated, r
2
 squared correlation coefficient, tested by Sigma plot version 10. (B) Secreted PSA level in mouse 
serum and Hb concentration in tumors of control and kale sprouts group was correlated, r
2
 squared correlation 
coefficient, tested by Sigma plot version 10. 
 
 
4.2.6 Summary  
 
The angiogenic potential of cancer cells is regulated by several pro- and anti-angiogenic 
factors as well as growth factors, cytokines and MMPs. We here could demonstrate that kale 
sprout intervention inhibited the expression of pro-angiogenic factors, like FGFb and PlGF, 
and MMPs, and induced the anti-angiogenic factors angiostatin and PSA via inhibition of 
TNF. The combination of these factors led to vascular normalization, thus prevented the 
leakage of blood and thereby reduced tumor necrosis (Fig. 33).  
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Fig. 33: Scheme of anti-necrotic and angiostatic potential of kale sprouts in LNCaP xenograft model. 
Based on our results we propose:1) Kale sprouts inhibit tumor necrosis. 2) TNF secretion is blocked by kale 
sprouts which leads to maintained AR protein expression and PSA secretion. PSA has been studied as an anti-
angiogenic factor in prostate cancer because it promotes angiostatin production by degradation of plasminogen. 
3) Induced blood vessel maturation (angiostasis) by inhibition of pro-angiogenic factors and induction of anti-
angiogenic factors by dietary kale sprouts may block hemorrhage and tumor necrosis. Dietary kale sprouts play 
a dual role with respect to tumor growth, on the one hand blocking of necrosis may induced tumor growth but in 
the other hand angiostasis inhibits tumor growth. Overall tumor growth is not changed even though many 
factors inside of the tumors are changed.  
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4.3 Epigenetic modifications by kale sprout intervention in LNCaP 
xenografts 
 
Since several ITCs have been identified as HDAC inhibitors in various cancer cell lines 
including prostate cancer cell lines, the last part of this thesis sought to verify whether dietary 
kale sprouts, rich in glucosinolates, also acts as an HDAC inhibitor in the prostate cancer 
xenograft model.  
 
4.3.1 Induction of histone acetylation but no inhibition of HDAC activity 
 
As a first approach to analyze the effect of kale sprout intervention on histone acetylation, we 
isolated histones from xenograft samples and determined their acetylation status by Western 
blotting using pan specific antibodies for acetylated histones H3 and H4. As shown in Fig. 34, 
daily intervention with kale sprouts for 7.5 weeks induced histone acetylation at H4 rather 
than at H3 (Fig. 34 A) in LNCaP xenografts. The immunoblotting confirmed that level of 
acetylated H4 was 2-fold increased in the kale sprout dietary group compared to the control 
group. This was in line with earlier findings that oral administration of SFN for 21 day 
induced 50 % of acetylation at histone H4 in a PC-3 xenograft model (174). 
 
 
Fig. 34: Increased global histone acetylation at histone H4 after intervention of kale sprouts. Acetylation of 
histones H3 and H4 was measured in acid-extracted histone samples from seven tumors of each group. Total H4 
was used as a loading control.   
 
Since we could confirm that histone acetylation was induced by kale sprout intervention, we 
further determined the enzymatic activity of HDAC, which is the key enzyme to modulate 
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histone acetylation status. Interestingly, when nuclear fractions of tumor samples were 
analyzed for HDAC activity using the Fluor-de-Lys assay, no change in HDAC activity by 
kale sprout intervention could be observed (Fig. 34B).  
 
 
Fig. 34: Kale sprout intervention does not inhibit HDAC activity. HDAC activity in nuclear fraction of eight 
tumors in each groups was measured by the Fluor-de Lys assay and normalized to protein concentration. 
Columns: Means, bars: SD.  
 
 
4.3.2 Acetylation on each lysine residue and HDACs expression 
 
After demonstrating up-regulated global histone acetylation, but lack of inhibition of  
HDAC activity by kale sprout intervention in the LNCaP xenograft model, we decided to 
next determine the acetylation status at each individual lysine residue on histone H4 to 
identify whether selected lysines were particularly acetylated. 
 
Fig. 35: Histone aceylation at each H4 lysine group in tumors after kale sprouts intervention. Acid-
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extracted histone samples of seven tumors of the control and kale sprout intervention groups were used to detect 
acetylation at each lysine group K5, K8, K12 and K16 of histone H4. Total H4 was used as a loading control. 
 
Acetylation at H4-K12, preferentially acetylated at newly synthesized histones, was mostly 
induced in tumors of mice fed the kale sprout diet. However, increased acetylation was also 
detected at all other the lysine residue of H4 in LNCaP xenograft samples after kale sprout 
intervention (Fig. 35).  
As outlined in Chapter 1.6, HDACs are a large enzyme family with several subclasses. Since 
kale sprout intervention induced histone acetylation, but did not inhibit total nuclear HDAC 
activity, we further investigated the influence of kale sprout intervention on the expression of 
individual classes of HDACs, using whole cell lysates of xenografts of both intervention 
groups.  
 
 
Fig. 36: HDAC expression in tumors after kale sprouts intervention. Expression of HDAC 1-5 and Sirt 1 in   
seven tumors of each group was determined by Western blot analysis using specific antibodies.  
 
Interestingly, kale sprout intervention differentially influenced expression of individual 
HDACs (Fig. 36). Of the class I HDACs, HDAC1 expression was not influenced, whereas 
HDAC 2 and 3 were weakly induced by the kale sprout intervention. Of the class II HDACS, 
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HDAC4 was almost undetectable in tumors of the control group, and was also weakly 
induced in the kale sprout group. Only HDAC5 expression was reduced by kale sprout 
intervention. Sirt1 was analyzed as an example of a class III HDAC. There was no difference 
in expression detectable between both intervention groups. These data did not help to 
understand why lysines at histone H4 were consistently hyperacetylated in tumors of the kale 
sprout group.   
 
 
4.3.3 Induction of HAT expression  
 
The histone acetylation status is balanced by the opposing activities of HDACs removing 
acetyl groups and HATs (histone acetyl transferases) adding acetyl groups. Since we could 
not detect any inhibitory effect of the kale sprout intervention on the activity or protein 
expression of selected HDACs, we next investigated the influence of kale sprouts on the 
expression of selected HATs.  
 
 
 
 
 
Fig. 37: Kale sprouts intervention increases PCAF mRNA and protein expression. (A) Relative mRNA 
expression of four HATs in LNCaP xenografts, measured by quantitative RT-PCR. Data gene expression of 
HATs were normalized to human -actin and calibrated to levels in control samples (n=7). Columns: mean; bars, 
SD, *, ***p<0.05, 0.001, Student‘s t-test. (B) PCAF protein levels in nuclear fractions of seven individual 
tumors in each group were detected by Western blotting. -Actin was used as a loading control. 
 
B 
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Certain transcriptional co-activators, including CREB-binding protein (CBP), p300, and 
p300/CBP-associated factor (PCAF) possess intrinsic HAT activity. As shown in Fig. 37A, 
relative mRNA expression of p300 and PCAF was significantly increased by dietary kale 
sprouts by 20% and 40% in xenograft samples (*,***p< 0.05, 0.001, Student‘s t-test with 
n=7), whereas mRNA levels of CBP and HAT1 were not influenced. We could confirm the 
induction of PCAF by kale sprout intervention also at the protein level in nuclear extracts of 
LNCaP xenografts (Fig. 37B).  
To investigate the possible mechanism why PCAF mRNA and protein expression was 
induced, we analyzed the acetylation status at the PCAF promoter area by chromatin 
immunoprecipitation (ChIP). Interestingly, acetylation at H4 at the PCAF promoter was 
increased 2-fold in tumors of the kale sprout group compared to samples from the control 
group (**p<0.01, Student‘s t–test with n=4) (Fig. 38). IgG served as a negative control with 
samples processed by the same protocol except immunoprecipitation with Ac-H4 antibody. 
These results indicated that increased histone acetylation was associated with increased 
PCAF mRNA expression.  
 
 
 
Fig. 38: Increased association of acetylated H4 at the promoter region of PCAF by kale sprout 
intervention. Fold enrichment of acetylated histone H4 at the PCAF promoter area was measured in four 
tumors of each group. IgG was used as negative control with the same tumor samples of each group. Columns: 
mean; bars, SD, **p< 0.01, Student‘s t–test with n=4. 
 
 
4.3.4 Influence on cell cycle inhibitor p21 expression  
 
It is well established that the expression of the cyclin-dependent kinase inhibitor and cell 
cycle regulator p21 is induced by HDAC inhibitors (175). To further determine functional 
consequences of increased histone acetylation in tumors of mice on a kale sprout diet, we 
measured p21 mRNA and protein expression and acetylated histone enrichment in the 
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promoter region of the p21 gene. The relative mRNA expression of p21 was significantly 2-
fold induced by kale sprout intervention in LNCaP xenografts (**p<0.01, Student‘s t–test 
with n=7) (Fig. 39A) and this was in line with enhanced protein expression (Fig. 39B).  
 
 
Fig. 39: p21 expression is elevated in xenografts by kale sprout intervention. (A) Relative mRNA 
expression of p21 in LNCaP xenograft was measured by quantitative RT-PCR. Column: mean, bar: SD, 
**p<0.01, Student‘s t–test with n=7. (B) p21 protein expression was measured by Western blot analysis.  
 
To clarify whether p21 gene expression in xenografts of the kale sprout group was due to the   
increased histone acetylation, we further measured binding of acetylated H4 in the promoter 
region of p21 by chromatin immunoprecipitation. Kale sprout intervention significantly 
increased the association of acetylated histone H4 at the promoter area of p21 gene compared 
to samples of mice on the control diet (*p<0.05, Student‘s t–test with n=4) (Fig. 40). 
 
 
 
Fig. 40: p21 expression is associated with increased histone acetylation at H4. Relative enrichment of 
acetylated histone H3 and H4 versus IP control at the p21 promoter area was measured in four tumors of each 
group. IgG was used as negative control using the same tumor samples. Columns: mean, bars: SD, *p< 0.05, 
Student‘s t–test with n=4. 
 
4.3.5 Mitotic arrest  
 
To determine the downstream effects of histone acetylation and p21 induction by kale sprouts, 
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mitotic arrest was examined by immunohistochemistry and immunoblotting, using the mitotic 
cell marker, phospho-H3 (p-H3). We could demonstrate that kale sprout intervention induced 
mitotic cell cycle arrest in LNCaP xenografts. Immunohistochemical detection of p-H3 in 
paraffin-embedded xenograft sections indicated that in tumors of the kale sprout group, the 
number of p-H3 positive cells was increased (Fig. 41A). When we counted the number of 
positive cells per 1000 cells which indicates the mitotic index, tumors of the kale sprout 
group had a significantly 30% increased mitotic index compared with control tumors 
(***p<0.001, Student‘s t–test with n=6) (Fig. 41B).   
 
 
 
Fig. 41: Evidence of mitotic arrest in tumors by kale sprout intervention. (A) Phospho-H3 was detected by 
immunohistochemistry in paraffin-embedded tumor sections. 10 slides from each tumor were stained with 
phospho-H3 and counterstained. (B) Phospho-H3 positive cells in each slide were counted by image J. Mitotic 
index indicates numbers of positive cells in 1000 cells. ***p<0.001, Student‘s t–test with n=6 
 
Increased histone H3 protein phosphorylation was also shown in total cell lysate of tumor 
tissue of the kale sprout group compared with control by Western blotting, confirming our 
immunohistochemistry data (Fig. 42). 
 
 
Fig. 42: Increased histone H3 phosphorylation, a mitotic marker, by kale sprout intervention. Phospho-H3 
levels were measured by Western blot analysis. 30 µg of total protein from seven tumors in each group were 
analyzed. Actin was blotted after stripping the membrane as a loading control. 
 
In summary, although average tumor weights in both intervention groups were not 
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significantly different (as shown in Chapter 4.2.1) we could demonstrate that control tumors 
contained significantly larger necrotic areas than tumors of the kale sprout group (Fig. 17). 
Also, kale sprout intervention causes histone hyperacetylation, resulting in PCAF and p21 
upregulation and mitotic arrest. Overall, these mechanisms may lead to a reduction of tumor 
growth or of tumor-associated death in more long term carcinogenesis models.  
 
 
4.3.6 Human intervention study- induction of histone acetylation in PBMC 
 
Although efficacy in animal models gives a good indication whether an intervention might be 
relevant for the human situation, ultimately effects need to be demonstrated in humans. As a 
first test to address the question whether kale sprouts affect histone acetylation in humans, we 
performed a small pilot study with five female subjects. We decided to analyze H4 
acetylation  in peripheral blood mononuclear cells (PBMC) as a surrogate biomaterial after 
kale sprout intervention. Healthy women volunteers in the age range 20-50 years, with no 
history of non-nutritional supplement use, refrained from cruciferous vegetable intake for 24 
hr. They consumed 10 g of kale sprouts, containing approximately 800 mol of total 
glucosinolates, with some water. After a light lunch, blood was drawn 1.5 and 3 hrs after kale 
sprout consumption. PBMCs were isolated, lysed, and whole cell lysates were used for 
Western blotting. In comparison to ac-H4 levels before intervention (time 0h), a time-
dependent increase in histone H4 acetylation was detected in PBMCs of all volunteers (Fig. 
43). Induction was already detectable 1.5 h after kale sprout consumption, and further 
increased up to 3 h. Maximum induction differed between individuals. This was partly due to 
differences in basal levels, and might additionally depend on differences in bodyweight-
adjusted doses. This data indicate that histone acetylation is regulated very rapidly. Also, we 
could demonstrate that it is possible to consume biological effective doses by dietary 
consumption. So far we have no further information on organ-specific histone modifications. 
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Fig. 43: Induction of histone acetylation by kale sprout intervention in human volunteers. Five healthy 
female volunteers (W1-W5) consumed 10 g kale sprouts with water. Blood was collected at the indicated times. 
Acetyl-H4 was detected in total PBMC lysates by immuno-blotting, using -actin as a loading control.  
 
 
 
4.3.7 Summary – histone modifications by kale sprouts 
 
Recently the potential of various isothiocyanates to inhibit HDAC activity was investigated. 
The present investigation has shown that dietary kale sprouts, rich in isothiocyanate 
precursors, increased histone acetylation associated with increased HAT rather than inhibition 
of HDAC activity in the LNCaP xenograft model. The changing balance between HAT and 
HDAC activity and expression by kale sprouts was associated with increased histone 
acetylation at the promoter of p21 and gene expression in the LNCaP xenograft model. 
Mitotic arrest was observed as a consequence.  
 
 
Fig. 44: Summary - histone modifications by kale sprouts. Dietary consumption of kale sprouts increased 
global acetylation of histone H4 in tumor xenografts even though it had no effect on tumor growth. Hyper-
acetylation of histone is possibly due to induction of HAT expression rather than inhibition of HDAC activity.
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5 DISCUSSION 
 
Dietary factors are major elements accounting for international and interethnic differences in 
prostate cancer rates (176). Chemoprevention is defined as the use of pharmaceutical agents, 
dietary components, natural products, food supplements (vitamins, selenium) or other agents 
in order to reduce the risk, delay the development, or prevent the recurrence of cancer (19). 
Prostate cancer is believed to be a suitable candidate for chemopreventive strategies as it 
develops in a multistep process with involvement of genetic mutations, inflammation, 
impaired differentiation, proliferation, hormone dependence and metastasis as important 
factors during prostate cancer development (Chapter 1.1.2).  
Various agents have been evaluated for their primary and secondary chemopreventive 
potential targeting different stages and molecular signaling pathways of prostate cancer, 
which include selenium and cruciferous vegetables.  
Selenium, a macronutrient exists naturally in food predominantly in the an organic form. It 
has the potential to reduce prostate cancer risk by targeting aspects of prostate cancer 
carcinogenesis including proliferation and the redox status (previously described in Chapter 
1.2.2.1).  
Cruciferous vegetables include the Brassicaceae family with most prominent members such 
as broccoli, cauliflower, and kale. As a family they have the unique feature to contain large 
amounts of glucosinolates. The metabolic product of glucosinolates, isothiocyanates (ITCs), 
exerts a very broad spectrum of chemopreventive activities in prostate cancer development 
(described in Chapter 1.2.2.2).  
Combination of potential agents to prevent prostate cancer may synergistically reduce 
prostate cancer development. Following this approach, the first aim of the present thesis was 
to investigate potential synergistic effects of selenium and broccoli constituents as an even 
better chemopreventive agent in prostate cancer when they are combined as selenium-
enriched broccoli.  
In a second approach we aimed to reduce prostate cancer risk efficiently using cruciferous 
vegetables that are especially rich in glucosinolates. The young seedlings or sprouts of 
cruciferous vegetables contain about 10-100 times more glucosinolates when compared to 
corresponding mature vegetables (98). The second aim of the present thesis was therefore to 
investigate the chemopreventive potential of glucosinolate–rich kale sprouts with regard to 
anti-angiogenic effects and its capability to modulate histone acetylation.  
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5.1 Potential of Se-enriched broccoli as a chemopreventive agent in prostate 
cancer 
 
A series of studies examined how Se-enrichment in broccoli affects plant physiology and the 
physiology of broccoli consuming animals. In the plant physiology Se fertilization has been 
described to cause a modest decrease of indole-based and aliphatic glucosinolates (177). 
Robbins and co-workers previously reported that fertilization with Se increased Se 
concentration in broccoli in a dose-dependent manner (178). However, increasing Se 
concentration led at the same time to a dramatic reduction of glucoraphanin and sulforaphane 
content down to 41% and 82% respectively (178). This limitation may be attributed to the 
fact that Se and sulfur share the same transporter during the initial route of uptake (89, 163). 
To avoid this expected competition, a different fertilization method to enhance selenium 
levels was been considered.  
One method has been developed by our collaboration partner (group of Prof. T. Rausch, 
Heidelberg Institute of Plant Science) (179). The procedure is based on spraying Se onto the 
broccoli leaves, while the broccoli florets and soil were protected in order to avoid a direct 
inpact of Se (179). Spraying sodium selenate in a concentration of 2 mg or 20 mg/plant 
increased the total Se concentration in the broccoli florets without changing glucoraphanin 
contents in the broccoli florets compared to plants that were not sprayed upon.  
Another possible method is to develop Se fertilization in the broccoli young sprouts. It has 
been reported that glucoraphanin contents does not change during two or three weeks of 
culturing time (92). This is mainly because broccoli seed do not synthesize glucoraphanin per 
se, highly concentrated glucosinolates in the seed are distributed while they grow to sprouts 
(180). Therefore using selenium fertilization in young broccoli sprouts may be a promising 
method to avoid competition. 
With respect to the animal physiology, Se-enriched broccoli was considered to have greater 
chemopreventive potential than that contributed to the two single agents, broccoli or Se.  
The primary chemopreventive mechanism of broccoli is attributed to the alteration of phase I 
and II enzyme detoxification pathways (50). Sulforaphane, which is a major glucosinolate 
hydrolysis product, activates phase II enzymes through thiol modification of Keap-1. This 
leads to translocation of the Nrf-2 transcription factor to the nucleus where it interacts with 
transcriptional regulatory elements, which are common to multiple genes involved in redox 
signaling, such as QR, GST and Trx-R (181, 182). On the other hand, the primary mechanism 
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of Se is modulating redox signaling by induction of selenoproteins such as GPx and Trx-R 
(183). The combination of selenium and broccoli can be hypothesized to target both 
mechanisms in a synergistic manner. However, it has been reported that QR activity was 
highest in low-Se broccoli extract treatment compare to high-Se broccoli extract treatment in  
murine hepatoma cells. These previous findings were explained by reduced contents of 
glucoraphanin in high-Se broccoli compared to low-Se broccoli (184).  
In our present study, we found that although the glucoraphanin contents was similar in the 
selenium fertilized broccoli (or sprouts) compare with standard broccoli (or sprouts), the 
induction of QR activity was lower by treatment of selenium-fertilized broccoli than standard 
broccoli in both BPH-1 and LNCaP cell lines. In addition, treatment of prostate (cancer ) cells 
with SeMSC as a selenium source together with broccoli extract showed moderately reduced 
QR activity compared with treatment of the same concentration of broccoli extract, although  
treatment with selenium alone had no influence on QR enzyme activity. It is possible that a 
competitive mechanism between ITCs and Se is not only presented in plant physiology but 
also in cell physiology. The induction of phase II detoxifying enzymes by SFN may be 
interfered by co-treatment with Se in the cells. Detailed underlying mechanisms have to be 
the subject of further investigations.  
Besides the competitive effect or antagonistic effect on QR induction, we found that there 
was a synergistic effect between broccoli and Se with respect to the induction of TRx-R. Both 
Se and broccoli contributed to Trx-R activity induction. The inducing potential of Se-
enriched broccoli was higher than standard broccoli. In addition, Se-fertilized broccoli 
sprouts also had higher potential to induce TRx-R activity compared with standard sprouts, 
although the glucoraphanin contents were similar in both sprout types. There are two possible 
mechanisms to induce Trx-R expression. The primary mechanism is Nrf-2-dependent 
expression of the Trx-R gene (181, 182). As described previously, ITCs contain an 
electrophilic carbon moiety which actively interacts with thiol groups. Keap-1 is one of the 
candidate molecules which are targeted by the electrophilic moiety of ITCs, since it contains 
a cysteine thiol group (50). The interaction of ITCs with Keap-1 results in a release of the 
Nrf-2 transcription factor from Keap-1 and translocation to the nucleus. Binding of Nrf-2 to 
the antioxidant responsive element (ARE) leads to the transactivation of TRx-R gene 
expression (50). The secondary mechanism to increase TRx-R activity is by Se-cysteine 
(SeCys) incorporation during Trx-R protein synthesis. SeCys incorporation into 
selenoproteins is encoded by a UGA codon which is more frequently the signal for the 
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termination of protein synthesis (185, 186). The reading of UGA during translation as a 
SeCys codon occurs in the presence of specific 3‘-untranslated region (UTR) mRNA 
secondary structures termed SECIS (selenocysteine insertion sequence) elements. Potential 
SECIS elements have been identified in the 3‘-UTR of Trx-R [28, 29]. Similarly, the 3‘-UTR 
of GPx contains SECIS elements, therefore GPx protein synthesis is induced in the presence 
of Se (187). Se-enriched broccoli contains active compounds to induce TRx-R activity by 
both mechanisms. This explains why induction of TRx-R activity by Se-enriched broccoli 
was higher than after treatment with standard broccoli.   
Different plants contain different amounts and different chemical forms of Se (29). As listed 
in Table 2 and described in Chapter 1.2.2.1, various chemical forms of Se have been reported 
to target diverse mechanisms and possess varying potential to protect against prostate cancer 
development. In addition, two recent clinical trials, that is the NPC and SELECT trials, 
showed dramatically opposite results of two forms of selenium. NPC reported an inverse 
correlation between Se consumption and prostate cancer risk, whereas the SELECT study 
could not find any relationship (27, 28). This might be due to the fact that the NPC study used 
selenized yeast, whereas in the SELECT trial, selenomethionine was used for intervention. 
Considering these previous reports, it is reasonable to assume that different chemical forms of 
Se which accumulated in broccoli might lead to diverse biological effects in the cells. 
Presently, we could only compare total amounts of Se after fertilization of sprouts, florets or 
broccoli. Further investigations are required to identify which forms of Se are predominant 
incorporated by selenium fertilization in the sprouts and broccoli florets. As a preliminary 
result, we observed that treatment of cultured prostate cancer cells with selenite, selenate or 
SeMSC at identical concentrations induced seleno-enzymes to different degrees, with selenite 
treatment being most potent. In addition, we observed that broccoli sprouts cultured in media 
containing selenite and selenate differentially accumulate Se in the plant, and also differed in 
their potential to induce Se-containing enzymes in cell culture. Cultivation with selenite 
resulted in a higher accumulation of Se compared to selenate cultivation in broccoli sprouts. 
Also, sprouts cultivated with selenite more potently induced GPx expression and TRx-R 
activity in the prostate cancer cells. Although we found that total selenium concentration was 
higher after selenite fertilization than after selenate fertilization, to better understand 
differences in biological response in the sprouts the major form of Se needs to be determined. 
One of our major interests in the present study was to compare the effect of Se-enriched 
broccoli in vitro and in an in vivo prostate cancer model. Induction of phase II enzymes and 
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selenoproteins by Se-enriched broccoli could not reproduced in vivo in the LNCaP xenograft 
model. However, although the tested broccoli preparations failed to induce antioxidant 
enzymes in the tumor tissue, liver antioxidant enzymes were significantly induced. Moreover, 
inducted of liver enzyme activities such as QR activity linearly correlated with glucoraphanin 
metabolites in mouse serum as well as glucosinolates contents in broccoli samples. However, 
selenoproteins were not induced by Se-enriched broccoli preparations both in tumor and liver 
samples. This was surprising since the animals received 6.2 µg Se per day, which was five-
fold more than the Se-content in the control diet group or standard broccoli group. Limited 
work in our study has been conducted to determine the chemical form of Se in our Se-
enriched broccoli and biological samples. It has been reported that broccoli contains large 
amounts of SeMSC, and that SeMSC in the broccoli does not accumulate in the rat or human 
to the same extent as other forms of Se do (188-190), presumably because SeMSC is 
metabolized directly to methylselenol and enters the excretory pathway. We still need to 
determine the percentage of SeMSC within the total selenium content in our Se-enriched 
experimental broccoli and derived products. 
The dose of selenium in clinical trials and bench experiments is another the key factor 
relevant for biological effects (39, 40). The relationship between selenium dose and 
biological effect showed a U-shaped dose-response in an animal model with beagle dogs 
when comparing selenium status and the extent of DNA damage within the prostate (39, 40). 
In our present study we observed that results of our in vitro cell culture experiment regarding 
induction of selenoproteins by Se-enriched broccoli was not transferrable to the animal model. 
It is possible that the Se concentration in mouse serum is already high enough to maximally 
induce selenoproteins by the basal Se contents in the control diet. In contrast, cell culture 
medium without added Se containing 10% fetal-bovine serum has a Se concentration of less 
than 0.01 µM (191) therefore additional Se potently induces Se containing proteins.  
Se-enriched food intervention may be beneficial to not with respect to cancer prevention 
under defined conditions, but also to Se deficiency diseases which are caused by extremely 
low dietary Se-intakes such as Kehan disease in humans and white muscle disease in 
domestic live stocks (192, 193). Se-enriched broccoli as a functional food may help to 
increase the uptake of Se also under these conditions. In the present study, we made 
Se-enriched broccoli puree. However during the food making process, some part of Se and a 
large percentage of glucosinolates was destroyed. It is still remains a question how we can 
maintain the beneficial compounds in the plant during food processing as well as improve 
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bioavailability of both compounds for humans in a synergistic manner.  
 
5.2 Anti-angiogenic potential of kale sprouts 
 
Various mechanisms have been described how ITCs interfere with prostate cancer 
development (24, 50). Relatively recent studies reported that tumor angiogenesis is a 
potential target of ITCs (100, 108, 127, 128). Sprouts of cruciferous vegetables are a good 
source of ITCs since they contain about 10-100 fold more of glucosinolates than the adult 
plant (98). Although there has not been any report regarding kale sprouts, we hypothesized 
that glucosinolate-rich kale sprouts may reduce prostate cancer progression via mechanisms 
related to anti-angiogenesis. 
In the present thesis, we analyzed the influence of kale sprouts on angiogenesis using a 
LNCaP xerograph model, modeling hormone-dependent human prostate cancer. We observed 
that dietary kale sprout intervention induced vascular maturation and prevented tumor 
necrosis whereas control tumors showed massive hemorrhage, more necrosis, less mature 
vessels and a more aggressive tumor appearance. To our knowledge, this is the first report 
showing glucosinolate-rich cruciferous vegetable sprout-dependant induction of vascular 
maturation and the respective underlying mechanisms in a human prostate cancer model. The 
statistically significant inhibition of hemorrhage as a consequence of a matured blood 
vasculature was evident with the addition of 20% of kale sprout to the regular diet. Dose-
dependent effects were not analyzed in this study.  
The maturation of blood vessel vasculature is the last step of angiogenesis, which includes 
the specialization of the vessel wall for structural support and regulation of the recruitment of 
mural cells like pericytes (166). The recruitment of pericytes is one of the final but, at the 
same time, most important steps during angiogenesis, leading to vessel maturation and 
stabilization (116). Stabilized blood vessels block hemorrhage, which causes leakage of blood 
and causes necrosis. However, vessel stabilization also helps to deliver oxygen and nutrients 
to the tumors (124). Thus, it has been an important strategy of anti-cancer drug development 
to reduce vessel density (166). Although there is no doubt about anti-angiogenic drugs having 
success in cancer therapy regarding some tumor types, there are some cancers that do not 
respond well to anti-angiogenic therapy (194, 195). It has recently been reported that the 
main cause of resistance to anti-angiogenic therapy is due to reduced vessel density (166). As 
a result of anti-angiogenic therapy, oxygen and nutrients cannot be delivered to the tumor, 
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which leads to a hypoxic condition of the tumor environment (166). Hypoxia is considered to 
be one of the triggers to increase tumor growth through activation of hypoxia inducible factor 
alpha (HIF-1)-dependent transcription (196). In addition, anti-cancer drugs, which need to 
be delivered inside of the tumor may not reach the cancer properly due to immature vessels. 
Therefore, recent studies suggested that vascular normalization is one of the next goals of 
anti-angiogenic therapy (124, 197).  
In the present thesis we could show that supplementation of the diet with 20 % kale sprouts 
induces vascular normalization via increased pericyte attachment to the blood vessel. 
Although the tumor size was not reduced, our results may indicate that vascular 
normalization by dietary kale sprouts could increase the sensitivity to chemotherapy in co-
treatment with chemotherapeutic drugs. Recent studies showed similar result by targeting 
PlGF, which is an pro-angiogenic factor. Treatment did not reduce tumor size but via this 
approach normalization of the vasculature was induced (168). However, co-treatment of the 
anti-PlGF drug with chemotherapeutic drugs inhibited tumor growth effectively (168). 
It is now widely accepted that the ‗angiogenic switch‘ is ‗off‘ when the effect of pro-
angiogenic molecules is balanced with anti-angiogenic molecules, and can be switched to  
‗on‘ when the net balance is tipped in favor of angiogenesis (112). It has been suggested that 
an abnormal vasculature arises from an imbalance of angiogenic regulators, such as VEGF, 
FGF, PIGF, angiopoietins, and anti-angiogenic factors like angiostatins (124). The present 
study revealed that dietary kale sprout intervention inhibited pro-angiogenic factors such as 
FGFb, PlGF and MMPs. At the same time it induced anti-angiogenic factors like angiostatin 
and PSA. Induction of anti-angiogenic factors and inhibition of pro-angiogenic factors upon 
regular kale sprout intake may favor the angiogenesis balance to the ‗switched-off‘ state, 
leading to a more controlled angiogenesis. It has been reported that ITCs inhibit NF-B 
mediated expression of pro-angiogenic factors such as VEGF and MMPs (198, 199). 
However, the detailed mechanisms by which kale sprout cause inhibition of pro-angiogenic 
factors such as FGFb, PlGF, and MMPs in the LNCaP xenograft model remain to be 
elucidated.  
The anti-angiogenic factor angiostatin consists of four to five kringle domains of 
plasminogen and can be generated by proteolytic cleavage of plasminogen by proteases such 
as PSA and MMP 11 (170, 200, 201). Secretion of PSA has been used as a marker of prostate 
cancer and it has been shown that PSA is able to convert plasminogen into biologically active 
angiostatin-like fragments (170, 200, 201).   
DISCUSSIONS 
108 
 
In the present study, we showed that dietary intake of kale sprouts induces angiostatin protein 
expression and PSA secretion. In addition, there was a inverse linear correlation between PSA 
levels and hemoglobin concentration. Although the detailed mechanisms about kale sprout-
induced angiostatin expression still has to be described, we can assume that maintenance of 
PSA levels by dietary kale sprouts may lead to an increased production of angiostatin protein 
expression. 
Recently, several groups showed growth inhibitory effects of SFN, PEITC or AITC in a dose 
range of 6-12 µmol/per mouse/day in both the PC-3 human prostate cancer xenograft model 
and the TRAMP mouse model (99, 174, 202-204). Taking these published findings into 
consideration, our findings suggest that glucosinolates-rich kale sprouts have a potential to 
inhibit cancer growth in the prostate cancer xenograft model. However, in the present study 
we could not observe an anti-proliferation effect using dietary kale sprouts. There are some 
possible reasons for these controversial results. First of all, the explanation might be the 
hormone-dependency of the LNCaP xenograft prostate cancer model. To our knowledge, 
most of the previously used animal models to investigate effects of ITCs were hormone-
independent prostate cancer xenograft or (allograft) tumor models (108, 127, 174) such as 
PC-3 and TRAMP-1C. These xenografts do not lead to a secretion of PSA and less 
expression of AR and they are growth hormone independent. Therefore, the mechanisms of 
ITCs-mediated anti-proliferation were related to cell cycle arrest and apoptosis rather than 
anti-hormonal effects (99, 174, 202-204). In contrast, the LNCaP xenograft model is a 
hormone dependent, AR-sensitive prostate cancer model. Although kale sprouts induced cell 
cycle arrest in the mitotic phase, AR protein expression was maintained as well as PSA 
secretion. The balance between these effects may result in inhibition of cell proliferation. 
Secondly, the explanation might be found in the different population of cancer stem cells 
which contribute to cancer initiation and progression in hormone-dependent LNCaP cells and 
hormone-independent PC-3 cells. Patrawala et al. showed that prostate stem cell markers 
were detectable in PC-3 cells but not in LNCaP cells (205). Similarly, another recent report 
demonstrated that ALDH1A1, a marker for malignant prostate stem cells, clonogenicity, and 
tumorigenicity presented higher levels in PC-3 than LNCaP cells (206). Recently, the effects 
of SFN to inhibit proliferation by abolishing cancer stem cell characteristics have been 
identified (207, 208). Anti-proliferative potential of SFN on cancer stem cells may lead to 
differences in the response of PC-3 and LNCaP cells.  
Thirdly, a possible explanation could be tumor necrosis. We found that kale sprouts inhibited 
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tumor necrosis which is a key mechanism to reduce cancer cell proliferation in the LNCaP 
xenograft model. Inhibition of necrosis may set off an anti-proliferative potential of dietary 
kale sprouts by inhibition of the cell cycle and angiostasis.  
Induction of tumor necrosis is associated with tumor necrosis factor  (TNF), which is a 
potent pro-inflammatory cytokine and plays an important role in angiogenesis (209). It exists 
both in a membrane-bound and a soluble form, and is secreted by macrophages, monocytes, 
neutrophils, T cells, natural killer cells and other cell types after stimulation, for example by 
lipopolysaccharide (LPS) (210). Certain stimulated cells and a number of transformed cell 
lines, like astrocytes, microglia, smooth muscle cells, and fibroblasts also secrete TNF (210). 
Based on the stimuli, TNF can function both as a pro-survival, or a pro-apoptotic factor 
thereby leading either to cell survival, or cell death (210). Elevated levels of TNF and 
increased expression of TNF have been found in tumor tissues and in the serum of cancer 
patients, which implies that TNF plays a major role in tumor progression (211). High 
expression of TNF alpha has been correlated with proliferation and survival of malignant 
cells, stimulation of angiogenesis, and metastasis. In the present study, we could show that 
dietary kale sprout inhibits TNF protein expression and murine TNF mRNA levels in the 
xenografts. Although the mechanism by which kale sprout caused the suppression of TNF 
secretion remains to be elucidated in the LNCaP xenograft model, there are possibilities to 
explain these effects. For instance, transcription factors, including NF-B, bind to the TNF 
promoter to initiate and activate its transcription (211, 212). It is likely that kale sprouts 
inhibit transcriptional activation of NF-B to suppress TNF expression. Suppression of NF-
B and NF-B regulated gene expression including TNF by ITCs has already been 
documented in several cell lines (50), including our own previous finding (49, 213).  
Another possible explanation could be found in mouse tissue infiltrates, including 
macrophages and fibroblasts. Our findings indeed support this hypothesis, since we observed 
relatively high levels of inflammatory cells and invading fibroblast in the control tumors 
compared to kale sprout tumors. The inhibition of invading murine cells by kale sprout could 
be the possible cause of globally suppressed murine TNF secretion.  
The present study showed that glucosinolate-rich dietary kale sprout intervention led to 
vascular maturation and prevented hemorrhage-related tumor necrosis in the human prostate 
cancer LNCaP xenograft model. These results have the potential to be translated to the 
prevention or treatment of human prostate cancer. 
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5.3 Histone modification by kale sprouts 
 
Recently the potential of various isothiocyanates to inhibit HDAC activity was investigated 
(60, 150, 152, 153). It has been shown that dietary kale sprouts, rich in isothiocyanates 
precursors, increased histone acetylation, which is associated with increased HAT rather than 
inhibition of HDAC activity in the LNCaP xenograft model. The changing balance between 
HAT and HDAC induced by kale sprouts was associated with increased acetylated histones  
at the promoter of p21 and elevated gene expression in the LNCaP xenograft model. In 
addition, mitotic arrest was observed.  
Unlike a previous report that dietary SFN at a dose of about 7.5 µmol/mouse/day for 21 days 
inhibited HDAC activity in the PC-3 xenograft model (174), we observed that dietary kale 
sprout at a dose of about 70 µmoles glucosinolates/mouse/day / (9 µmoles SFN/mouse /day) 
for 7.5 weeks did not inhibit HDAC activity in the LNCaP xenograft model. Early findings 
showed that treatment with SFN had different HDAC inhibitory effects on different stages of 
prostate cancer cells (149). The PC-3 cell line was the cell line most sensitive to SFN with 
respect to HDAC inhibition. However, in LNCaP cells SFN and the HDAC inhibitor TSA 
showed moderate inhibitory effects at concentration required to inhibit HDAC activity in PC-
3 and BPH-1 cells (149) . The authors explained that basal levels of HDAC activity in PC-3 
cells are much higher than in LNCaP cells, therefore HDAC inhibitors exhibit greater effects 
toward PC-3 cells (149).  
SFN itself has only a borderline inhibitory effect on the activity of HDAC but its metabolite, 
the cysteine conjugate of SFN, is more effective as an HDAC inhibitor (214, 215). After 
intervention with kale sprouts we found that SFN-Cys concentrations in the plasma were 
quite low compared to other metabolites (Table 9). Most of the SFN was presented as SNF-
NAC conjugates or free SFN in the plasma. The contribution on HDAC inhibitory effects by 
different SFN metabolites should be further investigated in the prostate cancer cell lines.  
The effect of isothiocyanates on HATs has not been well investigated, yet. Few studies 
showed controversial results, since different kinds of isothiocyanates have been investigated 
(151, 152, 216). A recent study showed the possibility of isothiocyanate to induce HAT 
expression. A synthetic isothiocyanate, phenhexyl isothiocyanate, increased levels of the 
histone acetyl transferase p300, which led to an accumulation of acetylated histones in a 
leukemia cell line (151). However, another study showed that BITC inhibited p300/CBP 
expression in pancreatic carcinoma cell lines (152). Kale sprouts contain different kinds of 
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glucosinolates. A major content is sinigrin, a precursor of AITC. A second one is glucoiberin, 
which can be metabolized to iberin. To better understand which kinds of isothiocyanate 
contribute to increased histone acetylation by kale sprouts, further studies with individual 
compounds have to be performed.  
Hyperacetylation of histones, particularly at certain lysine residues of histone tails, is 
associated with active transcription of certain genes (130). Hypoacetylation of histones, on 
the other hand, is associated with the formation of heterochromatin and gene silencing (130). 
Although dietary kale sprouts did not inhibit HDAC activity, the action of kale sprouts on the 
enhancement of HAT may effectively induce acetylation of core histones. Particularly the 
promoter region of the p21 gene shows enrichment with acetylated histone H4 induced by 
dietary kale sprouts. Interestingly, we found that the increase of p21 gene expression was 
higher than the increase of acetylated histone enrichment by kale sprouts. Notably, induction 
of p21 by isothiocyanates was not only contributed to by histone acetylation. Earlier studies 
suggested other mechanisms to induce p21 gene expression by ITCs. has It has previously 
been shown that phosphorylation of the G2/M enforcer chk2 by PEITC or BITC mediated p21 
gene expression in Caco-2 cells (217). Also, increased p21 protein expression mediated by 
phosphorylation of chk2 and cdc25C by sulforaphane has previously been reported (58, 
218). . 
In summary, the present investigation has provided evidence for the induction of histone 
acetylation in the LNCaP xenograft model after daily application of kale sprouts as a food 
supplement. In this study, we suggested that increased histone acetylation may be caused by 
increased HAT levels. There was an increased H4 acetylation together with localized 
increases in acetylation histones H4 associated with the promoter region of PCAF and p21. 
Increased histone H4 acetylation was also detectable in human PBMC samples after a single 
administration of kale sprouts.  
Conclusively, we have described increased histone acetylation in a prostate cancer xenograft 
as well as normal human PBMC. Since these activities occur rapidly after kale sprout 
intervention, but were not related to inhibition of tumor growth, further studies have to 
demonstrate the functional relevance of these findings for chemopreventive or 
chemotherapeutic efficacy of kale sprouts in vivo.  
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5.4 Outlook 
 
Intervention with Se-enriched broccoli and kale sprouts resulted in the activation of several 
anti-cancerous and potential chemopreventive mechanisms in the LNCaP xenograft model. 
However, we did not observe a direct effect on the tumor size, which might be due to a 
variety of factors as outlined above. Regarding their biological activities, both Se-enriched 
broccoli as well as kale sprouts represent promising factors for prostate cancer 
chemoprevention. Considering the development and different stages of prostate cancer, the 
LNCaP xenograft model might have been not the ideal model to demonstrate preventive 
efficacy. Based on our results, the chemopreventive potential of Se-enriched broccoli and 
kale sprouts should be further investigated in more relevant models for prostate cancer 
development.   
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6. SUMMARY 
 
Prostate cancer is the most commonly diagnosed malignancy in men in industrialized 
countries and the second leading cause of male cancer related death. Despite a recent increase 
of prostate cancer cases and related death, the prevalence of prostate cancer in Asia is much 
lower than in Western countries. This geographic variation reflects differences in life style 
and diet, which is in Western countries rich in highly saturated fat and meat, and low in 
vegetables. Many epidemiologic studies continue to support the idea that dietary intake of 
chemopreventive agents may be protective against prostate cancer.  
 
From the several chemopreventive agents we focused on selenium and cruciferous vegetables. 
The first aim was to produce selenium enriched broccoli and to evaluate the effects. For 
optimization of selenium fertilization, we evaluated selenium and glucoraphanin contents in 
plants as well as antioxidant enzyme induction in prostate cancer cell lines in vitro. Spraying 
selenate onto broccoli leaves increased selenium contents in the broccoli without changing 
glucoraphanin contents. Se-accumulated broccoli induced phase II detoxifying enzymes such 
as QR, TRx-R and Se-containing antioxidant enzymes GPx-1, GPx-4 and TRx-R in vitro. In 
addition, Se-enriched broccoli increased these enzymes in vivo in the mouse liver. However, 
supplementation had no effect on LNCaP xenograft tumor growth as well as on antioxidant 
enzyme induction in tumor tissue although sulforaphane metabolites were detectable in the 
mouse plasma. In conclusion, Se-enriched broccoli potently increases phase II detoxifying 
enzymes and Se-containing antioxidant enzymes in vitro, however 20% of dietary Se-
enriched broccoli and the functional foods produced from it had no influence on enzyme 
induction and tumor growth in vivo in the LNCaP xenograft model.  
 
The second aim of this study was to investigate the effect of kale sprouts in the LNCaP 
xenograft model. Kale sprouts are a good source of glucosinolates, since they contain 4-fold 
more glucosinolates than the standard broccoli. Therefore we aimed to evaluate anti-
proliferative effects of kale sprouts and underlying mechanisms in the LNCaP xenograft 
model. Unlike our expectation, dietary kale sprouts for 6.5 weeks did not show growth 
inhibitory effects in the LNCaP prostate cancer xenograft model. However, we observed 
much evidence that kale sprouts reduced the development of prostate cancer and 
aggressiveness. First of all, the tumors contained less hemorrhage and necrotic areas. Also, 
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invasion of mouse-derived cells into xenografts was reduced by the intervention. Although 
the vessel density was not different between the groups, vessel maturation in the kale sprout 
group was increased, which was indicated by increased pericyte coverage of endothelial cells. 
Vascular maturation was associated with down-regulation of the pro-angiogenic factors and 
up-regulation of an anti-angiogenic factor, angiostatin. According to the vascular maturation, 
hemorrhage could be prevented leading to prevention of necrosis. Secondly, TNF-mediated 
down regulation of AR protein expression and PSA secretion was prevented by kale sprouts. 
TNF-reduced AR protein expression has been considered to desensitize LNCaP cells for the 
binding of the ligand. In conclusion, dietary kale sprouts play a dual role in aspect of tumor 
growth. On the one hand they block necrosis, which may induce tumor growth but on the 
other hand kale sprouts induced angiostasis to inhibit tumor growth. Overall tumor sizes were 
not changed even though many characteristics of the tumors are influenced which would 
indicate anti-tumor effects of kale sprouts. 
 
As the third part of the study, we further investigated effects of kale sprouts on epigenetic 
histone modifications. Histone marks have been suggested to be an important target 
mechanism of prostate cancer progression and ITCs have been demonstrated recently to act 
as HDAC inhibitors. Dietary kale sprouts increased histone acetylation associated with 
increased HAT levels rather than inhibition of HDAC activity in the LNCaP xenograft model. 
The change of balance between HAT and HDAC by kale sprouts was associated with 
increased histone acetylation at the promoter of p21 and its gene expression in the LNCaP 
xenograft model. A well known consequence of histone acetylation mediated p21 gene 
induction is cell cycle arrest and apoptosis. Dietary kale sprouts indeed increased mitotic 
arrest. Interestingly, these effects were not only limited to the xenograft model but could also 
be shown in human PBMC after intervention. 10 g of kale sprouts intervention increased 
histone H4 acetylation in human PBMC after 1.5 to 3 h. In conclusion, dietary supplement of 
kale sprouts may help to affect gene transcription by promotion of histone acetylation. This 
may contribute to cancer prevention. 
 
In summary, the presented thesis describes novel mechanistic modes of cruciferous 
vegetables, which contain potent cancer chemopreventive compounds. Selenium fertilization 
may increase the effects of broccoli to prevent prostate cancer by inducing selenium-
containing antioxidant enzymes although there is no influence on tumor growth in the models 
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analyzed. Kale sprouts were for the first time suggested to be used as a potential 
chemopreventive agent in order to increase vascular maturation and prevent hemorrhage and 
necrosis in tumors. Another important mechanism, which was targeted by kale spouts was 
histone acetylation. Importantly these effects were shown in relevant concentration that they 
could be used as a dietary supplement.
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7 ZUSAMMENFASSUNG 
 
Prostatakrebs ist der am häufigsten diagnostizierte bösartige Tumor in Männern in der 
industrialisierten Welt und die zweithäufigste Todesursache von Krebserkrankungen in 
Männern. Obwohl die Inzidenz- und Todesrate von Prostatakrebs in den letzten Jahren 
angestiegen ist, ist die Prostatakrebsprävalenz in asiatischen Ländern deutlich geringer als in 
westlichen Ländern. Diese geographischen Unterschiede sind auf Unterschiede im Lebensstil 
und in der Ernährung der westlichen Welt, das heißt viele gesättigte Fettsäuren und Fleisch 
und wenig Gemüse, zurückzuführen. Mehrere epidemiologische Studien haben wiederholt 
gezeigt, dass der Verzehr von chemopräventiven Substanzen in der täglichen Nahrung das 
Risiko an Prostatakrebs zu erkranken reduzieren kann. 
Unter den vielen chemopräventiven Substanzen konzentriert sich die vorliegende Arbeit auf 
Selenium und Kreuzblütengewächse (Cruciferen). Das erste Ziel dieser Arbeit war es durch 
Düngung Brokkoli mit erhöhtem Selengehalt zu züchten und seine krebspräventive Wirkung 
zu untersuchen. Um die Selendüngung zu optimieren, ermittelten wir den Selen- und 
Glucoraphaningehalt in den Pflanzen, sowie die Induktion von antioxidativen Enzymen in 
Prostatakrebszelllinien in vitro. Das Aufsprühen von Selenat auf die Blätter der 
Brokkolipflanzen erhöhte den Selengehalt im Brokkoli, ohne den Glucoraphaningehalt zu 
verändern. Se-angereicherter Brokkoli induzierte die Phase II detoxifizierenden Enzyme QR, 
TRx-R und die Se-haltigen Enzyme GPx-1, GPx-4 und TRX-R in vitro. Darüber hinaus 
induzierte Se-angereicherter Brokkoli und daraus generierte „funktionelle 
Nahrungsmittel― diese Enzyme ebenfalls in Mausleber in einem in vivo Tiermodell. Jedoch 
zeigte der Brokkoli keinen hemmenden Effekt auf das Tumorwachstum, wie auch keinen 
induzierenden Effekt auf die antioxidativen Enzyme in den Tumoren aus dem LNCaP Tumor 
Xenograft-Modell, obwohl Sulforaphan-Metaboliten im Plasma der Mäuse detektiert werden 
konnten. Schlussfolgernd wurde gezeigt, dass Se-angereicherter Brokkoli das Potenzial hat 
Phase II detoxifizierende Enzyme und Se-enthaltende Enzyme in vitro zu induzieren, aber 
Futter, das zu 20% Se-angereicherten Brokkoli enthält bzw. daraus generierte „funktionelle 
Nahrungsmittel― keinen Einfluss auf die Enzyminduktion und das Tumorwachstum in vivo 
hatten. 
Das zweite Ziel dieser Arbeit war es die Effekte von Grünkohlkeimlingen im LNCaP Tumor 
Xenograft-Modell zu untersuchen. Grünkohlkeimlinge sind eine reiche Quelle an 
Glucosinolaten und enthalten viermal so viel Glucosinolate wie gewöhnlicher Brokkoli. 
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Daher war es unser Ziel die anti-proliferativen Effekte von Grünkohlkeimlingen und die 
zugrundeliegenden Mechanismen im LNCaP Tumor Xenograft-Modell zu ermitteln. 
Entgegen unseren Erwartungen hatte die 6.5-wöchige Intervention mit Grünkohlkeimlingen 
im Futter keinen wachstumshemmenden Effekt in dem LNCaP Tumor Xenograft-Modell. 
Allerdings beobachteten wir Hinweise darauf, dass Grünkohlkeimlinge die Entwicklung von 
malignem Prostatakrebs dennoch positiv beeinflussen. Zunächst enthielten die Tumoren 
weniger Blut und nekrotische Zonen. Des Weitern wurde die Invasion von endogenen 
Mauszellen in die Xenograft-Gewebe durch die Intervention reduziert. Obwohl die 
Blutgefäßdichte in beiden Gruppen gleich war, war die Blutgefäß-Ausbildung in der 
Grünkohlgruppe deutlich erhöht, da die Endothelzellen mit einer größeren Anzahl von 
Pericyten bedeckt waren. Die Blutgefäßbildung wurde mit der Herunterregulierung von pro-
angiongenen Faktoren und der Hochregulierung des anti-angiogenen Faktors Angiostatin 
korreliert. Dementsprechend waren die tumor-internen Blutungen und Nekrosen reduziert. 
Darüber hinaus wurde die TNFα-induzierte Herunterregulierung der AR Proteinexpression 
und PSA Sekretion durch Grünkohl gehemmt. Die Reduktion von AR durch TNFα wird für 
die Desensibilisierung von LNCaP auf Androgene verantwortlich gemacht, da die 
Ligandenbindung an den AR geschwächt wird. Zusammenfassend zeigt die 
Nahrungsergänzung mit Grünkohl zweierlei Effekte: einerseits könnte die Hemmung von 
Nekrosen zu vermehrtem Tumorwachstum führen, anderseits aber hemmt die 
Hochregulierung von Angiostatin das Tumorwachstum. Insgesamt war das Tumorwachstum 
nicht verändert, obwohl viele Parameter innerhalb des Tumors von Grünkohlkeimlingen 
beeinflusst wurden. 
In einem dritten Teil dieser Arbeit untersuchten wir Effekte von Grünkohlkeimlingen auf 
epigenetische Veränderungen. Histonmodifikationen werden als wichtige Mediatoren der 
Prostatakrebsprogression gesehen und ITCs wurden kürzlich als HDAC-Inhibitoren 
identifiziert. Die Aufnahme von Grünkohlkeimlingen mit der Nahrung erhöhte die 
Histonacetylierung, was mit erhöhter HAT- und gehemmter HDAC-Aktivität im LNCaP 
Xenograft-Modell einherging. Die veränderte Balance zwischen HAT und HDAC durch 
Grünkohlkeimlinge resultierte in vermehrter Histonacetylierung in der Promoterregion von 
p21 und dessen Genexpression. Normalerweise führt die Induktion der p21 Expression zum 
Zellzyklusarrest und Apoptose. Und tatsächlich erhöhte die Grünkohlkeimling-Diät den 
mitotischen Arrest. Interessanterweise war die erhöhte Histon Acetylierung nicht nur im 
LNCaP Xenograft-Modell, sondern auch in menschlichen PBMC zu messen. Die Intervention 
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mit 10g Grünkohlkeimlingen erhöhte die Histon-H4-Acetylierung nach 1.5 bis 3h. 
Abschließend lässt sich feststellen, dass die Nahrungsergänzung mit Grünkohlkeimlingen 
dazu beitragen kann die Gentranskription durch Erhöhung der Histonacetylierung zu 
beeinflussen. Dies könnte zur Prostatakrebsprävention beitragen.  
 
Zusammenfassend beschreibt die vorliegende Arbeit neue mechanistische Aktivitäten von 
Cruciferen, die sehr potente prostatachemopräventive Agenzien beinhalten. Selendüngung 
trägt dazu bei die Prostatakrebs-präventiven Effekte von Brokkoli zu erhöhen, indem die 
Selenhaltigen antioxidativen Enzyme induziert werden, allerdings ohne einen Einfluss auf 
das Tumorwachstum zu haben. Zum ersten Mal wurde gezeigt, dass Grünkohlkeimlinge 
chemopräventives Potenzial besitzen, da diese die Ausbildung von Blutgefäßen erhöhen und 
Blutungen sowie Nekrosen im Tumor verringern. Ein weiterer wichtiger Angriffspunkt von 
Grünkohlkeimlingen ist die Histonacetylierung. Erwähnenswert hierbei sind die geringen 
Konzentrationen der eingesetzten chemopräventiven Agenzien, die jenen Konzentrationen 
entsprechen, die mit Nahrungsergänzungsmitteln mit der täglichen Nahrung aufgenommen 
werden. 
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8 COLLABORATORS 
 
8.1 Potential of Se-enriched broccoli as a chemopreventive agent in prostate 
cancer 
 
Selenium fertilization of broccoli was provided by  
Fu-Chou Hsu, Thomas Rausch 
Heidelberger Institut für Pflanzenforschung, Heidelberg University, Heidelberg, Germany 
 
Total selenium contents and glucoraphanin concentration in broccoli sprouts and florets were  
measured by  
Fu-Chou Hsu, Thomas Rausch 
Heidelberger Institut für Pflanzenforschung, Heidelberg University, Heidelberg, Germany 
 
Sulforaphan metabolites from mouse plasma, urine, feces were measured by  
Johanna Hauder, Veronika Somoza
 
German Research Center for Food Chemistry, Garching, Germany 
 
Glucosinolates contents in the broccoli preparations and kale sprouts were measured by  
1
Corinna Rüfer, Gina De Nicola
2
, Renato Iori
2
 
1
Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Karlsruhe, Germany 
2
University of Bologna, Bologna, Italy 
 
8.2 Anti-angiogenic potential of kale sprouts 
 
Staining of blood vessels and pericytes were done by 
Mattthias Wieland, Hellmut G Augustin 
Joint Research Division Vascular Biology of the Medical Faculty Mannheim, University of Heidelberg, and the 
German Cancer Research Center (DKFZ), Vascular Oncology and Metastasis, Germany 
 
Pathological evaluation was done by  
Carolin Mogler 
Institute of Pathology, university of Heidelberg 
 
Secreted PSA was measured by  
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Achim Bub 
Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Karlsruhe, Germany 
 
8.3 Histone modification by kale sprouts 
 
HDAC activity was measured by  
Julia M. Wagner, Manfred Jung 
Institute of Pharmaceutical Science, Albert-Ludwigs-University Freiburg, Germany 
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